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3 INTRODUCTION 
3.1 Significance of natural products 
 Throughout evolution, the dependence of human beings on nature has been everlasting. 
Natural products have been one of the important sources of medicine for millennium to alleviate 
and treat various diseases. The increasing prevalence of new diseases results in the continuous need 
of exploiting natural products for drugs (Li et al. 2019). Especially, the emergence of multidrug-
resistant microbes increases the urge to find novel therapeutic lead (Spera et al. 2019). Despite the 
rise of combinatorial chemistry as an integral part of lead discovery process, natural products still 
play a major role in providing novel and interesting chemical scaffolds for drug discovery with an 
outstanding development in the areas of separation science (Liu et al. 2019). The comprehensive 
review by Newmann and Cragg (2016), provides detailed information about the natural compounds 
discovered in between 1981-2014. Out of 1562 new chemical entities (NCE) discovered in this 
period, 73% belongs to natural products and their derivatives and only 27% of the drugs were of 
synthetic origin. The technological advancement in omics enhances the domineering contributions 
of natural products in drug discovery (Newman and Cragg, 2016). 
 Natural products include either a complete organism like a microbe, a plant or an animal or 
part of an organism or the extracts of an organism and in most cases the term natural products 
denotes to secondary metabolites, which are small molecules (MW < 2000 Da) produced by 
organisms that are not firmly needed for the existence of an organism. The secondary metabolites 
like terpenoids, coumarins, alkaloids, glycosides, flavonoids, steroids, sugars, lignans etc., are 
generally considered as medicinally important (Mushtaq et al. 2018).  According to the analysis 
reported on Annual reports of Medicinal Chemistry, over 65% to 75% of drugs developed from 
1983 to 1994 for infectious diseases and deadly diseases like cancer are derived from natural 
sources (Arnold, 2007). 
 Although plants are considered as the bio factories of many valuable bioactive compounds, 
they possess the disadvantage of slow growth rate and harvesting rare and endangered species also 
poses a risk (Jia et al. 2016). Therefore, it is necessary to find alternative approaches to produce 
medicinal plant derived bioactive metabolites. Discovery of penicillin in 1929 paved the way to 
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use microorganisms as a source of potential drug candidates (Gaynes, 2017). According to recent 
reports, only 5 % of the world's fungal and 0.1 % of bacterial species have been described yet and 
a small fraction of them has been explored for their bioactive compounds (Thomas et al. 2011). 
Recent research estimates that currently more than 1 million natural compounds have been isolated, 
from which 50-60 % have plant and 5 % have microbial origins (Demain and Sanchez, 2009). In 
recent decades, endophytes have been recognized as a source of several bioactive compounds and 
are studied as potential sources of novel natural products for medical and commercial exploitation 
(Selvakumar et al. 2018). The endophytic bioactive metabolites possess a wide variety of biological 
activities as their antimicrobial-, antitumor-, antioxidant-, anti-inflammatory, etc. activities have 
been previously identified (Selvakumar et al. 2018). 
3.2 Endophytic fungi – The hidden world within plants 
3.2.1 General characterization of endophytic fungi 
 Endophytic microbes are an intriguing group of microorganisms that play a vital role in 
enhancing plant growth and are also a well-known source of bioactive secondary metabolites 
(Sahoo et al. 2017). The term “endophyte” originally introduced by de Bary to distinguish fungi -
living inside host tissues - from epiphytes, is derived from the Greek word “endon” meaning inside 
or within and “phyton” meaning plant (Bary, 1866). The meaning of the word has evolved to 
include any microorganism that inhabits plants during a period of its life cycle, especially within 
their leaves, branches, and stems, without causing significant damage to its host (Wilson, 1995). 
They are mainly fungi, which have been in co-evolution with their eukaryotic hosts for millions of 
years (Heckman et al. 2001). Endophytic fungi (EF) can also be defined as an ecological group of 
fungi colonizing the inner tissues of plants without any recognizable features of their presence. The 
ubiquity of EF has been revealed by many studies that estimate close to one million species residing 
in plants (Dreyfuss and Chapela, 1994) lichens (Li et al. 2007) and mosses (Zhang et al. 2013). 
  Endophytes possess a complex relationship with their hosts. They are symbiotic in nature, 
which may be mutualism, commensalism or saprophytism (Clay and Schardl, 2002; Strobel and 
Daisy, 2003). Although, almost all higher plants contain at least one endophytic microbe, the 
relationship between microbes and their plant hosts remains one of the least studied biochemical 
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systems, because it is difficult to find the exact physical relationship in the interaction (Strobel, 
2003).  It has been reported that these endophytes have co-evolved with the higher plants since 
their existence as they have been isolated from fossilized tissues of stems and leaves (Bacon and 
White, 2000). Given this fact, this long-held association might have created a specific genetic 
system in endophytes their relationship with plants or vice versa (Strobel, 2003). Furthermore, the 
independent evolution of the endophytes might also have devised them for better adaptation to their 
host and contributes to their biochemical pathway (Strobel, 2003). 
Endophytes are considered to be evolved within distant phylogenetic groups of fungi 
similar to mycorrhizal fungi. According to Brundrett et al. (2006), EF are facultative plant 
symbionts. Unlike mycorrhizal fungi, their development does not synchronize with the 
development of their host and they can complete their life cycle outside the host organism 
(Brundrett et al. 2006). Another distinctive feature that differentiates endophytes from mycorrhizal 
fungi is that they can also inhabit host tissues above the ground level like stem, leaves and barks 
(Petrini, 1996).   
3.2.2 Classification of fungal endophytes 
 According to Schaechter (2012), EF have been divided into two groups based on their 
taxonomical difference, host range, patterns of colonization and transmissions, ecological function 
and tissue specificity (Schaechter, 2012). The two groups are the clavicipitaceous and non-
clavicipitaceous (NC) EF infecting grass and found in vascular and non-vascular plants, 
respectively.  
 Another classification is proposed by Rodriguez et al. (2009), in which EF are classified 
into four classes based on the phylogeny data and life history traits (Rodriguez et al. 2009). The 
class I includes symbiotic species associated with insects, fungi, grasses, and rushes (Bacon and 
White, 2000). They are mainly found in grass family Poaceae, rarely in Cyperaceae, and are often 
vertically transmitted through seeds that mostly belong to the Hypocreales order of the Ascomycota 
phylum. Most of the clavicipitaceous fungi belonging to this class colonize intracellular spaces of 
leaf sheaths, rhizomes, and leaf blades (White et al. 1996). They play a major role in insects and 
mammalian herbivore deterrence by producing alkoloidic compounds such as loline, peramine 
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(Clay, 1990) as well as ergot and lolitrem alkaloids (White and Bultmann, 1987; Gentile et al. 
2005). Studies have also proved that EF of this class are active against nematodes as the infection 
of Festuca arundinacea with an endophytic fungus Acremonium coenophialum has been shown to 
reduce the nematode populations in agricultural field soils (Kimmons et al. 1990). Some 
clavicipitaceous endophytes from Epichloe festucae were found to be producing indole derivative 
compounds, sesquiterpene and diacetamide that can inhibit plant pathogenic fungi (Yue et al. 2000)  
 Rodriguez et al. (2009) proposed that NC endophytes represent three groups (class II, class 
III and class IV based on host colonization, transmission in biodiversity of plants and benefits 
conferred to hosts (Rodriguez et al. 2009).  Class II EF colonize roots, shoots and leaves of 
monocotyledon and dicotyledon plants. They form a specific ecological group, which colonizes 
plants growing in stressful habitats and are highly diverse (Watkinson, 2016). Class III endophytes 
are distinct as they restrict their colonization to above-ground plant tissues, and their infection is 
localized mainly on leaves and twigs of host plants (Arnold, 2007). This group is also highly 
diverse and consists of mainly Pezizomycotina and Saccharomycotina (Ascomycota) species, as 
well as Agaricomycotina, Pucciniomycotina and Ustilagomycotina (Basidiomycota) species. They 
spread horizontally through spores and hyphal fragments (Arnold, 2007). 
 Class IV endophytes are found in the rhizosphere, which is another common habitat with 
high diversity. These endophytes are often misidentified as mycorrhizal fungi (Jumpponen, 2001; 
Rodriguez et al. 2009). The endophytes of this class have a broad host range, with over 600 known 
plant species as hosts (Jumpponen and Trappe, 1998). 
3.2.3 Biodiversity of endophytic fungi 
 EF are highly diverse, and more than 1 million species of this fungal group is estimated to 
be undiscovered (Sun and Guo 2012). A survey conducted on fungi of various hosts in the past 20-
30 years demonstrates that colonization of endophytes on land plants is ubiquitous (Petrini, 1996; 
Nisa et al. 2015). Extensive studies on species distribution, biological and ecological aspects of 
endophytes in Europe and North America have been conducted for years (Petrini, 1996;). Although 
endophytes have been identified from plants in various habitats in tropical, temperate and boreal 
forests (U’Ren et al. 2019), they are mostly confined to gymnosperms in temperate regions 
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(Bernstein and Carroll, 1977). EF have also been detected in grasses (Bacon et al. 1977) and 
hepatics (Stone et al. 2004). They are also found in non-vascular plants (Zhang et al. 2013), algae 
(Hawksworth, 2001), ferns, fern allies (Schulz et al. 1993; Fisher, 1996) and mosses (Zhang et al. 
2013). Endophytic fungal diversity is high in tropical forests where the diversity of woody 
angiosperm is also high (Banerjee, 2011). 
 EF represent an important component of fungal biodiversity and it has also been observed 
that almost every plant examined to date harbors at least one species of EF and many plants, 
particularly woody plants, contain hundreds of endophytic species (Petrini, 1986; Sahoo et al. 
2016). Remarkable efforts have been made to estimate the total number of fungi on the basis of 
their association with plants (Hawksworth, 2001). The magnitude of fungal diversity was estimated 
to be around 1.5 million species (primarily based on a ratio of vascular plants to fungal species of 
1:6) that has been later revised to 2.27 million (Hawksworth, 2001). Dreyfuss and Chapela (1994) 
estimated that EF of the 270,000 plant species that exist on this planet could be colonized by 1.38 
× 106 unique fungal species. However, the number of fungal species may vary because of the 
availability of modern tools and techniques of identification.  
 It has been reported that EF belong to diverse phyla, which includes Ascomycota, 
Basidiomycota and Mucormycota groups. Various factors affect the distribution of the EF 
community such as environmental factors (temperature, humidity), and the type and age of the 
colonized host tissue (Sanchez-Azofeifa et al. 2012). Several studies showed that distribution of 
EF is higher in older tissues than in younger tissues (Sanchez-Azofeifa et al. 2012). Most of the 
studies reported that Dothideomycetes and Soradariomycetes are the dominant classes found in 
medicinal plants, but the EF diversity also differs according to the geographical regions. A study 
carried out by Kharwar et al. showed that most of the EF isolated from Catharanthus roseus 
belonged to Hyphomycetes (Kharwar et al. 2008), whereas Dhayanithy et al. reported 
Dothideomycetes as the dominant class of the EF of C. roseus from coastal regions (Dhayanithy et 
al. 2019). 
In the past two decades, the distribution and biodiversity of EF have been examined in 
different host plants. The most abundant EF species are Alternaria, Aspergillus, Fusarium, 
Cladosporium, Penicillium, Trichoderma, Acremonium, Chaetomium, Neurospora, Epicoccum, 
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Curvularia, Arthrinium (Rana K.L. et al. 2019). Still the number of undiscovered EF must be 
higher, as most of the studies followed traditional culture dependent methods to report EF diversity. 
By employing high throughput sequencing, more EF can be recovered, and EF diversity can be 
well documented (Sengupta et al. 2017). 
3.2.4  Multifaceted interactions between endophytic fungi and the plants  
 Endophytes maintain a dynamic relationship with host plants. They can be symbionts, 
commensals, decomposers or latent pathogens (Promputha et al. 2007). They spend at least a part 
of their lifecycle inside the plant and are mutualistic with the host by increasing its defence 
mechanisms (Schulz et al. 1999). EF usually display a latent state inside their host for the whole 
lifetime of their host or for an extended period. Whenever the environmental conditions become 
appropriate for the fungus or when the ontogenetic state of the host turns to the benefit of the 
fungus, they might become pathogens (Strobel, 2016). Still the precise external or endogenous 
factors responsible for fungal transition from endophyte to pathogen are unknown. Therefore, to 
get better insights into the dynamics of endophytism, comparative studies on gene expressions 
needed to be carried out under conditions, where the same microbe behaves as a mutualist or a 
pathogen (Strobel, 2016). 
 Endophytes also increase the competitive abilities and fitness of plants by increasing their 
nutrient uptake, resistance to drought and water stress, tolerance to heavy metal stress and high 
salinity, or increasing growth rate through biochemical pathways by producing plant growth 
hormones. For example, researchers proved that most of the EF produce indole-3-acetic acid (Tan 
and Zou, 2001). It is also suggested that these endophytes also initiate the biological degradation 
of the dead or dying host tissues (Tan and Zou, 2001) 
 Endophytes are potential biocontrol agents as the ecological niche of their colonization is 
similar to that of phytopathogens. Interaction studies between grass and endophytes suggest that 
they are herbivore antagonists and enhance the growth of the plant (Clay, 1990). The literature also 
suggests that a large number of EF exhibit multiple ecological roles, as the endophytic fungus 
Chaetomium globosum plays a role of saprotrophs and pathogens (Arnold and Engelbrecht, 2007). 
Lateral gene transfer phenomenon (LGT), which is important for colonizing the endosphere 
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region of plants plays a key role in promoting genetic and biochemical diversity (Tisserant et al. 
2013; Arora et al. 2018). Researchers have reported that the number of bioactive natural products 
isolated from endophytes of tropical regions are higher compared to that of endophytes found in 
temperate regions and the metabolism is distinct (Banerjee, 2011). This suggests the significant 
role of the host plant in influencing the general metabolism of endophytic microbes. The presence 
of the putative terpene cyclases in the paclitaxel-producing endophytic Penicillium 
aurantiogriseum from hazel and comparison with 13 known paclitaxel biosynthetic genes from 
Taxus spp. showed high homology (Yang et al. 2014) is one of the remarkable examples showing 
a beneficial role of lateral gene transfer  
There are limited studies related to LGT between endophytes and plants. Today it is possible 
to understand LGT events due to the progression of high-throughput genome analysis methods, 
thus more studies could be carried out to explore genetic recombination events and to examine the 
transfer of metabolic pathway genes between host plants and endophytes. The LGT is a key 
phenomenon that confers novel traits in eukaryotes and prokaryotes. 
The background of host-endophyte interactions is an exciting field that is yet poorly 
investigated. It is uncertain that endophytes are either systemic or host specific and what they 
produce in culture and in nature. Although a range of factors affecting the host might also affect 
the endophytes, more information about physiological interaction with the host would be 
exceedingly helpful to understand their ecology. Between EF, endophytic bacteria have intensive 
cross-talks with associated hosts under the effect of various biotic factors like feeders and insects 
(Figure 1). During this interaction the endophytes could either live in a beneficial association with 
the host or turn into a pathogen lifestyle (Figure 1). 
Furthermore, the cost-benefit interaction of plant-fungus could lead to either a mutual 
benefit/harm or relative benefit/harm (Figure 1D). This complex interaction can be represented as 
mutualism and ardent parasitism or exploitation (Kusari et al. 2014). 
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Figure 1. The complex interaction of plant-endophyte interface (Kusari et al. 2014). (A) 
Biological network and crosstalk connecting EF (B) Fair trade partnership between EF and other 
microbes (C) Cheater life style of EF (D) Plant–EF cost–benefit interactions mutual benefit 
(double thumbs-up) of both partners, relative benefit (single thumbs-up),  relative harm (single 
thumbs-down) to one partner at the cost of the other, or harm to both interacting partners (double 
thumbs-down). 
3.3 Significance of plant selection for bioprospecting endophytic fungi 
 EF of medicinal plants are potential sources of novel bioactive compounds and some have 
also been proved to be producing plant associated therapeutic metabolites (Huang et al. 2007). 
Moreover, the production of medicinally important phytochemicals from microbial sources is 
highly economical and easier, which increases the availability of products at reduced market price 
(Strobel, 2003). Due to the substantial number of plant species in the world, inventive strategies 
should be used to narrow the search and maximize the possibility of discovering endophytes 
producing novel bioactive compounds (Mittermeier et al. 2004) 
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 A specific rationale can be utilized in governing the strategy of plant selection as follows: 
(a) Plants from unique environmental settings, which possess an unusual survival strategy. In one 
study, the significance of endophytes isolated from an aquatic plant Rhyncholacis penicillata - 
collected from a river system in southwest Venezuela - has been investigated. It has been postulated 
that the aquatic environment created many portals, through which common phytopathogenic 
oomycetes could enter the plant tissues. However, the plant population appeared to be healthy, 
possibly due to protection from an endophytic product (Strobel, 2003). 
(b) Plants that have been used by indigenous people with an ethnobotanical history could have 
interesting biological activities. It was found that the endophytes isolated from these plants possess 
higher antimicrobial activity than endophytes isolated from crops and plants in special 
environments (Strobel, 2018).  It is reasonable to assume that the healing processes, might be 
facilitated by compounds produced by one or more plant-associated endophytes as well as the plant 
products themselves. Using this rationale, the plants of Juniperus was selected by Kusari et al. 
which has been used as a folk medicine. It contains therapeutically important anticancer 
compounds lignans, podophyllotoxin and deoxypodophyllotoxin. These compounds were also 
identified in the endophytic fungus Aspergillus fumigatus of J. communis (Kusari et al. 2009a).  
(c) Plants that are endemic, endangered, have an unusual longevity, or that have occupied a certain 
ancient land mass, are also more likely to harbour endophytes with active natural products than 
other plants. Due to the medicinal value and economical importance of Campotheca acuminate, it 
has been harvested by various sectors around the world to isolate camptothecin (Lorence and 
Nessler, 2004; Sankar-Thomas, 2010). It has been proven that EF isolated from these plants also 
produced this compound and they may also serve as an alternative source of camptothecin. 
Similarly, EF isolated from Salvia abrotanoides endemic to Iran, is a source of cryptotanshinone, 
the main bioactive compound of the plant (Teimoori-Boghshani et al. 2020).   
(d) Plants growing in areas of great biodiversity also have the prospect of harbouring endophytes 
with great biodiversity. The diversity of the biological activities could be obtained by the same 
fungal endophyte strain isolated from different medicinal plants, increasing the opportunities to 
isolate a plenty of new compounds by “one strain many compounds approach” (OSMAC). A. 
fumigatus isolated from different plants proved to be synthesising a wide variety of bioactive 
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compounds (Silva et al. 2018; Liu et al. 2004; Ding et al. 2013). Indeed, extensive research in host-
endophyte interaction should be conducted for targeting endophytes in bioprospecting 
(e) The medicinal plants are an excellent source for bioprospecting endophytes. The EF such as 
Acremonium, Alternaria, Aspergillus, Cephalosporium, Chaetomium, Chloridium, Choanephora, 
Colletotrichum, Fusarium, Gliocladium, Hypoxylon, Paecilomyces, Penicillium, Pestalotiopsis, 
Talaromyces, and Trichoderma from different medicinal plants have been reported as a source of 
many bioactive compounds (Rana et al. 2019). Endophytes, which exist in plants providing a strong 
metabolite background might also synthetise unique secondary metabolites. Therefore, EF from 
medicinal plants are worth exploring and they could be a potential reservoir of novel bioactive 
compounds. Bioprospecting these EF has raised the expectation to meet the growing demand for 
plant-derived bioactive compounds (Venieraki, 2017). 
The interactions between the fungus and the plant seems to serve a strong evolutionary 
pressure towards the synthesis of secondary metabolites by the endophytes (Schulz et al. 2002), 
which are usually able to improve the fitness, viability or resistance of the host plant to defend it 
successfully from different pests (Strobel and Daisy, 2003). Indeed, discoveries of parallel 
secondary metabolite production by both higher plants and plant-associated fungi are fascinating 
and provide a potential source of procuring adequate compounds for commercial requirements. 
3.4 Fungal endophytes as sources of natural products 
Natural products from fungal endophytes have a broad spectrum of biological activity and 
can be grouped into several categories including alkaloids, steroids, terpenoids, flavonoids, 
glycosides, xanthones, isocoumarins, quinones, phenylpropanoids, lignans, aliphatic metabolites 
and lactones (Gunatilaka et al. 2006). Investigations of these organisms - distributed worldwide 
from tropical forests to arctic environments indicated that they are excellent producers of 
compounds that can be exploited as both agrochemical and medicinal agents due to their antiviral, 
antibiotic, anticancer, insecticidal, immunosuppressive and antioxidant effects (Strobel and Daisy, 
2003). Furthermore, it has been discovered that the produced compounds are occasionally the same 
as those produced by the respective hosts, which have been exclusively isolated from higher plants 
such as paclitaxel, podophyllotoxin, camptothecin and vinblastine (Zhao et al. 2010; Kusari et al. 
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2015). Furthermore, EF are able to release different types of hydrolytic enzymes to protect 
themselves from plant pathogens, insects and nematodes. In addition, EF produce various unique 
structured natural products, thereby, represent a huge reservoir offering an enormous potential for 
exploitation in agricultural and industrial areas (Tan and Zou, 2001). The bioactive metabolite 
production of EF involves mechanism such as producing compounds that stimulates the plant 
immune response, thereby enhancing their resistance against phytopathogens and to compete with 
their biological niche for colonizing (Pascale et al. 2017). 
3.4.1 Secondary metabolites production of endophytic fungi 
 Secondary metabolites are small organic molecules (MW < 2000 Da) produced by various 
living organisms including plants, microbes (fungi, bacteria), marine organisms (sponges, snails) 
and insects. Comparing with primary metabolites such as nutrients, polysaccharides, proteins, 
nucleic acids and lipids, which are fundamental for survival of the organisms, secondary 
metabolites are not specifically responsible for survival (Sarker, 2006). Until now, tens of 
thousands of natural products have been identified in the world. Recently, there are a huge number 
of bioactive secondary metabolites identified from EF (Table 1), but still a vast number of unknown 
compounds are yet to be discovered and to be utilized for the benefits of mankind (Sarker, 2006). 
  Categorization of natural products commonly encountered include fatty acids, 
polyacetylenes, terpenoids (monoterpenoids, iridoids, sesquiterpenoids, diterpenoids, 
triterpenoids), steroids, essential oils (lower terpenoids and phenylpropanoids), phenolics (simple 
phenolics, phenylpropanoids, flavonoids, tannins, anthocyanins, quinones, coumarins, lignans), 
alkaloids, and glycosidic derivatives (e.g. saponins, cardiac glycosides, flavonoid glycosides) 
(Gonzalez-Mera et al. 2019). As endophytes are chemical synthesizers inside plants, they are 
considered as a novel resource for the aforementioned secondary metabolites for their use in 
medicine and agriculture (Wani et al. 2016). It could also be speculated that due to the symbiotic 
nature of EF with the plants, the bioactive compounds could be less toxic to the eukaryotic cells 
and there will not be any adverse effects of the potential drug compounds on human cells 
(Rajamanikyam et al. 2017). Fungi synthesize secondary metabolites for their own profit, either to 
get rid of their competitors or to interact with the plants under stressful environments (Rodriguez 
et al. 2009). 
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 The biosynthesis of secondary metabolites mainly involves 3 important metabolic pathways 
such as polyketide, shikimate, and mevalonate pathways (Refaei et al. 2014) and are regulated by 
specific gene clusters. Polyketides are an e important class of secondary metabolites produced by 
EF and are synthesized in a series of condensation reactions, which are catalysed by polyketide 
synthases (PKS). There are three groups of PKS, Type I, Type II and Type III (Refaei et al. 2014; 
Feng et al. 2015). The two major gene clusters taking part in the secondary metabolite biosynthesis 
are the polyketide- and non-ribosomal peptide synthases clusters (Hoffmeister and Keller, 2007).  
With the current advancement in genetic engineering, numerous research groups are involved in 
identifying and utilizing these specific gene clusters for synthesizing native metabolites and their 
derivatives.   
 Zeilinger et al. (2016) explored the role of acetyl-CoA, mevalonate and amino acids as 
reaction precursors in the biosynthetic pathway for the synthesis of NRPS such as peptaibiotics, 
siderophores and diketopiperazines, polyketides, terpenes, pyrones, and isocyane metabolites. 
Acetyl-Coenzyme A and malonyl-Coenzyme A act as precursors that are further catalyzed by a 
group of PKS gene clusters containing domains such as ketoacyl synthase, an acyl transferase and 
a phosphopantetheine attachment site.  
Table 1. Representative list of bioactive secondary metabolites isolated from EF. 
Endophytic fungi  Bioactive compound Bioactivity Reference 
Aspergillus fumigatus 
CY018 
Asperfumoid, 
fumigaclavine C, 
fumitremorgin C, 
physcion and helvolic 
acid 
inhibitits Candida albicans Selvakumar et al. 
2018 
Aspergillus niger Lapachol anticancer Nirupama et al. 
2011 
Cephalosporium sp. Diosgenin progesterone precursor, 
cholesterol lowering activity 
Zhao et al. 2010 
Cephalosporium sp. 
IFB-E001 
Graphislactone A antioxidant Selvakumar et al. 
2018 
Cephalotheca faveolata Sclerotiorin antibacterial Selvakumar et al. 
2018 
19 
 
Endophytic fungi  Bioactive compound Bioactivity Reference 
Chaetomium globosum Chaetoglobosins A and 
C 
inhibit Mucor miehei Selvakumar et al. 
2018 
Cladosporium sp. Brefeldin A antifungal activity Selvakumar et al. 
2018 
Emericella 
foeniculicola TR21 
Tanshinone I and IIA cardiotonic, anti-
inflammatory 
Ma et al. 2011 
Entrophospora 
infrequens 
Camptothecin anticancer Selvakumar et al. 
2018 
Eupenicillium parvum Azadirachtin A and B natural pesticide Kusari et al. 2012b 
F. proliferatum BLH51 Sanguinarine anticancer Wang et al. 2014 
Fritillaria ussuriensis 
Fu7 
Sipeimine antitussive and expectorant Yin and Chen, 
2008 
Fusarium 
chlamydosporum 
Kaempferol antioxidant, anticancer Chaturvedi et al. 
2014 
Fusarium oxysporum Vinca alkaloids anticancer Selvakumar et al. 
2018 
Fusarium proliferatum 
(MTCC 9690) 
Rohitukine antiinflammatory, 
immunomodulatory, 
anticancer 
Kumara et al. 2012 
Fusarium solani Berberine anticancer Selvakumar et al. 
2018 
Fusarium solani 
LCPANCF01 
Taxol anticancer Selvakumar et al. 
2018 
Fusarium solani R13 Rhein antitumor, anti-
inflammatory, antimicrobial 
and hemostatic 
You et al. 2013 
Fusarium subglutinans Subglutinols A and B immune-suppressants Lee et al. 1995 
Phoma glomerata D14 
 
Fusidikactones antifungal activity Selvakumar et al. 
2018 
Penicillium oxalicum Gymnemagenin antidiabetic Parthasarathy and 
Sathiyabama, 2014 
Penicillium sp. Gh01 Quercetin glycoside anti-hypertensive, 
anticancer, 
antiinflammatory, 
antioxidant 
Padmavathy, 2014 
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Endophytic fungi  Bioactive compound Bioactivity Reference 
Periconia sp. Piperine antimicrobial, 
antidepressant, 
antiinflammatory, 
antioxidative, anticancer 
Verma et al. 2011 
Rhinocladiella sp. Cytochalasins anticancer, antibiotic Strobel and Daisy 
2003 
Thielavia 
subthermophila 
Hypericin antidepressant, 
antiinflammatory, 
antimicrobial, antioxidant, 
antiviral 
Zhao et al. 2010 
T. subthermophila Emodin antidiabetic, antiviral, 
anticancer 
Zhao et al. 2010 
3.4.2 Secondary metabolites of endophytic fungi as antimicrobial compounds 
 With the emergence of new infectious diseases and multidrug resistant strains, the 
requirement of new antimicrobial agents is increasing, and scientific efforts have been aimed at 
finding metabolites with antimicrobial activities from endophytes. A diverse array of endophytic 
metabolites exhibited antimicrobial activity against various pathogenic microflora, and these can 
be used in pharmaceuticals, medicine, and agriculture (Gunatilaka et al. 2006). Terpenes are one of 
the largest group of compounds produced by EF which possesses antibacterial activity as 
guanancastepene A, guanacastepene, periconicin A, and periconicin B diterpenoids produced by an 
unidentified endophytic fungus isolated from Daphnopsis americana. Furthermore, colletotric acid 
produced by Colletotrichum sp. isolated from Artemisia annua showed both antibacterial and 
antifungal activity (Yu, et al. 2010). Furthermore, phomol, a novel antimicrobial compound has 
been isolated also from an endophytic fungus (Phomopsis sp.) isolated from the medicinal plant 
Erythrina crista. The structure of this compound was elucidated by spectroscopic methods and it 
proved to be a polyketide lactone (Guo et al. 2000). In endophytes, alkaloids are quite typical 
secondary metabolites and some of them have been shown antibacterial activity. Chaetoglobosins 
A and C were determined from the culture of an endophytic C. globosum derived from the leaves 
of Ginkgo biloba, while 3-O-methylalaternin and altersolanol, produced by the endophyte 
Ampelomyces sp. isolated from the medicinal plant Urospermum picroides - showed antibacterial 
activity against gram-positive pathogens Staphylococcus aureus, S. epidermidis and Enterococcus 
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faecalis (Aly et al. 2008). Cryptocandin A is a unique peptide, which has been considered for 
treatment against fungal infection in humans (Strobel, 2003). It was isolated and characterized from 
an endophyte Cryptosporiopsis quercina of Tripterigeum wilfordii, a medicinal plant, which is 
native to Eurasia (Strobel et al. 2003). In addition, jesterone and hydroxyjesterone from 
Pestalotiopsis sp. were also shown to possess antibacterial activity (Li et al. 2001). 
 Endophytic metabolites also possess antiviral activity, which is exemplified by cytonic 
acids A and B. These compounds were isolated from the culture of the endophytic fungus 
Cytonaema sp. isolated from a Quercus sp. and were reported as human cytomegalovirus protease 
inhibitors (Guo et al. 2000). Other fungal metabolites with promising antiviral activity are the novel 
quinone-related metabolites, xanthoviridicatins E and F, produced by an endophytic Penicillium 
chrysogenum, which inhibited the activity of HIV-1 integrase (Singh et al. 2003). 
3.4.3 Endophytic fungi producing host plant secondary metabolites 
 As EF occupy literally millions of unique biological niches (higher plants) growing in 
numerous unusual environments, exciting possibilities exist as engaging in the discovery and their 
potential use in pharmaceuticals. Over a long period, the coexistence and evolution of endophytes 
with their host plants have established a special relationship significantly influencing the 
production of bioactive metabolites in plants (Jia et al. 2016). The communication of endophytic 
communities with the host plant significantly influences physiological processes of the plant. It is 
important to mention that some endophytic microorganisms isolated from medicinal plants produce 
the same metabolites as their hosts (Table 2). This observed phenomenon leaded to the isolation of 
several EF producing important medicinal agents including digoxin originally described from 
Digitalis lanata (Kaul et al. 2013), ginkgolides from Ginkgo biloba (Cui et al. 2012), 
podophyllotoxin and deoxypodophyllotoxin from Juniperus communis (Kusari et al. 2009a), and 
also vincamine and vinpocetine from Vinca minor (Yin and Sun 2011). The endophytic fungus, 
Thielavia subthermofila strain was able to produce hypericin and emodin in vitro (Kusari et al. 
2008).  
 Bioprospecting EF for host associated metabolites would not only reduce the need to 
harvest slow growing and possibly rare plants, but also preserve the world's ever-diminishing 
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biodiversity. Furthermore, it is recognized that a microbial source of a valued product may be easier 
and more economical to produce, effectively reducing its market price (Strobel, 2003; Kusari et al. 
2009a). 
Table 2. Host medicinal plants and their EF producing host metabolites. 
Host plant Endophytic fungi Compound Reference 
Catharantus roseus Fusarium oxysporum vinblastin and 
vincristine 
Palemp et al. 2015 
Huperzia selago Penicillium griseofulvum, 
Aspergillus flavus, 
Shiraia sp., 
huperzine Higgin et al. 2017 
Taxus baccata 
 
 
Fusarium redolens 
E. nigrum 
Monochaetia sp.,  
Pestalotia bicilia 
 
Paclitaxel, 
baccatin 
Garyali et al. 2013 
Salehi et al. 2019 
Vinca minor Unidentified fungi vincamine, 
vinpocetine 
Yin et al. 2011 
Hypericum perforatum T. subthermophilia hypericin Kusari et al. 2009 
Digitalis lanata Alternaria spp, 
Penicillium spp., and 
Aspergillus spp. 
digoxine 
(glycoside) 
Kaul et al. 2013 
Ginkgo biloba L. Fusarium oxysporum 
SY0056 
glinkolide B 
(terpenoid 
lactone) 
Cui et al. 2012 
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Host plant Endophytic fungi Compound Reference 
Solanum nigrum L.  Aspergillus flavus 
 
 solamargine 
(alkaloid)  
 
El-Hawary et al. 2016 
 
3.4.4 Hypericin and emodin, host plant secondary metabolites involved in this study 
Hypericin (4,5,7,4′,5′,7′-hexahydroxy-2,2′-dimethylnaphtodianthrone) is one of the 
medicinally important polyphenolic compounds as it is proved to be possessing antidepressive, 
antitumor and antiviral properties and is also used in photodynamic therapy for the detection and 
treatment of tumor cells (Karioti and Bilia 2010). This medically important phenanthoperylene 
quinone is found in some species of the genus Hypericum, particularly in Hypericum perforatum 
L. commonly called as St. John's wort (Banks et al. 1976). Due to the broad-spectrum 
pharmacological importance of hypericin, it has been intensively studied in recent decades (Wölfle 
et al. 2014). However, besides Hypericum species, hypericin has also been found in certain 
basidiomycetes belonging to the Dermocybe genus (Garnica et al. 2003; Dewick, 2009) as well as 
in a filamentous fungus (Table 2), which was isolated as the endophyte of H. perforatum (Kusari 
et al. 2008).  
Emodin is a well-known medicinal herb product possess antibacterial and anti-cancer 
activity (Dong et al. 2016), however, according to previous studies emodin has been identified 
firstly from Cortinarius sanguineus (formerly known as Dermocybe sanguinens) as a pigmented 
metabolite in 1925 (Kögl and Postowsky, 1925). This compound has since been detected as a 
product of Cladosporium fulvum (Agosti et al. 1962) and Aspergillus species including Aspergillus 
wentii (Wells et al. 1975), Aspergillus ochraceus (Lu et al. 2010) as well as T. subthermophila 
(Kusari et al. 2008). 
The biosynthesis of hypericin is not yet clarified experimentally in plants, but it is presumed 
to follow the polyketide pathway containing subsequent reactions started with the condensation of 
seven molecules of malonyl-CoA with an acetyl-CoA (Figure 2).  After that, the resulted octaketide 
chain undergoes both cyclization and decarboxylation reactions to form emodin anthrone, which is 
oxidized to emodin probably by the enzyme emodinanthrone-oxygenase and then, a condensation 
24 
 
reaction yields a dianthrone leading to the formation of protohypericin and finally of hypericin 
(Karioti and Bilia, 2010). This biosynthetic pathway is generally accepted and genes encoding the 
corresponding enzymes were already analysed via next generation sequencing technology (Soták 
et al. 2016).  Bais et al. (2003) described an enzyme, hyp-1, in H. perforatum cell cultures, which 
seems to be specifically involved in the direct conversion of the emodin to hypericin in vitro. Few 
years later, Michalska et al. (2010) failed to dimerize emodin to hypericin using hyp-1 as the 
biocatalyst, suggesting that hyp-1 does not participate in hypericin synthesis, but it might act as a 
transporter. Furthermore, studies proved that hyp-1 gene is expressed in all investigated Hypericum 
species regardless of their hypericin production, hence proposed that hyp-1 gene is not a limiting 
factor in the hypericin production in Hypericum species (Kosuth et al. 2011).  
The spatial distribution of the chemical members of the biosynthetic pathway in planta was 
determined with desorption electrospray ionization mass spectrometry imaging, (Thunig et al. 
2011) and matrix free UV-laser desorption/ionization mass spectrometric imaging (Hölscher et al. 
2009) as well as by matrix-assisted laser desorption/ionization high-resolution mass spectrometry 
(MALDI-HRMS) techniques (Kusari et al. 2015). In these examinations, hypericin was localized 
in the dark glands on the leaves of H. perforatum, but the proposed precursor, emodin anthrone, 
could not be visualized. Due to its high reactivity, emodin anthrone can be instantaneously 
converted to emodin by oxidation. However, the other main proposed precursor, emodin was not 
only accumulated in the dark glands, but was also detected in significant amounts outside the glands 
suggesting that the presumed site of hypericin biosynthesis is in the cells adjacent to these gland 
structures from emodin (Kusari et al. 2015). 
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Figure 2. The proposed biosynthetic pathway of hypericin (Revuru et al. 2020). 
Another study proposed a different biosynthetic pathway in Hypericum species, which 
involves skyrin as an intermediate (Kimáková et al. 2018). The same group, in different study found 
that most of the EF isolated from Hypericum species are synthesizing skyrin apart from emodin 
(Figure 2) (Revuru et al. 2020). 
Recently, the same research group established this hypothesis by reporting the spatial 
distribution of skyrin and also localized other compounds skyrin-6-O-β-glucopyranoside, 1,2,4,5-
tetrahydroxy-7-methyl-9,10-anthraquinone-2-O-β-glucopyranoside and 1,2,4,5-tetrahydroxy-7-
(hydroxymethyl)-9,10-anthraquinone, which are considered as the precursors of skyrin in the 
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leaves of Hypericum species using MALDI-HRMS imaging (Revuru et al. 2020). Finally, it can be 
concluded that detailed genetic studies are further required to identify the candidate genes correctly 
and corroborate the exact biosynthesis of hypericin in plants.  
3.5 Plants selected in the current study and their reported fungal endophytes 
 Hungary is located in central Europe and belongs to the eco-region of Pannonian mixed 
forests and has a promising phyto-geographical condition. Yet there is a lack of data on the 
endophytic fungal communities in this region. Only a few studies have been carried out enlisting 
the endophytic community in Hungary (Knapp et al. 2012) 
 In our study 4 plants were selected to investigate EF producing novel bioactive metabolites. 
3.5.1 Hypericum perforatum 
 The genus Hypericum includes almost 500 species among which Hypericum perforatum is 
the best known for its traditional medicinal value. Hypericum perforatum L. (common St. John’s 
wort) is a widely distributed medicinal herb, which has been used over the past 2000 years for its 
diverse healing properties (Butterweck, 2003). The genus Hypericum belongs to the Hypericaceae 
family involving almost five hundred species (Crockett and Robson, 2011). Most of them are able 
to synthetize metabolites possessing antioxidant (Silva et al. 2005), anticancer (Agostinis et al. 
2002), antidepressive (Butterweck, 2003) and antiviral (Birt et al. 2009) as well as antifungal and 
antibacterial effects (Kusari et al. 2008). 
 Studies have reported that Hypericum species constitute several napthodianthrones, which 
include naphthodianthrone derivative hypericin (2,2'-dimethyl-4,4',5,5',7,7'-hexahydroxy-
mesonaphtodianthrone), that is a potential lead candidate molecule for future therapeutics (Karioti 
and Bilia, 2010).  
 Kusari et al. (2008) first isolated EF from H. perforatum and found the host metabolite 
producing ability of one strain. Later Zhang et al (2014) isolated 21 EF species from H. perforatum 
in China. The dominant species were found to be Fusarium sp., Mucor sp., Aspergillus sp., Xylaria 
sp. and Hypocrea sp., and they also reported the antimicrobial effect of these strains.  
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3.5.2  Juniperus communis 
 Juniperus communis is a bush or small evergreen tree which has been commonly referred 
to as herbal medicine in ancient times. Juniperus communis L., which is known as the ‘common 
juniper’, This is one of the most prevalent species of European conifers and is native to Europe, 
South Asia, and North America (Farjon and Filer, 2013). It belongs to the Cupressaceae family. 
The main chemical constituents of J. communis L. are 𝛽-pinene, apigenin, sabinene, 𝛽-sitosterol, 
campesterol, limonene and cupressuflavone. 
 It contains various chemical constituents including flavonoids, volatile oil, coumarins and 
therapeutically important anticancer lignans, podophyllotoxin and deoxypodophyllotoxin 
(Hartwell et al. 1953). Many essential extracts from its twigs, leaves, and berries (the blue-black 
seed cones) have been used as anti-diarrheal, anti-inflammatory, astringent, disinfectant 
gastrointestinal agents, or against urinary tract infections, dermatitis, or as a diuretic. The wood has 
even been shown to be suitable for artificial bone implants (Gross and Ezerietis. 2003). The twigs, 
leaves, and especially the berries represent an important food source for several small and large 
animals and even humans for culinary purposes and preparation of alcoholic drinks (Vichi et al. 
2008) 
  Generally, the dried needles called savin, or the derived oil of Juniperus species have been 
used by native people to cure leprosy, ulcer and also uterine polyps (Bais et al. 2014).  
 Previous studies had been carried out to isolate and characterize EF harboured in Juniperus 
plants sampled from the natural populations in Dortmund and Haltern, Germany, and Jammu and 
Kashmir, India. This resulted in the discovery of a deoxypodophyllotoxin-producing endophytic 
fungus harboured in J. communis (Kusari et al. 2009a). The lignans podophyllotoxin and 
deoxypodophyllotoxin are secondary metabolites with a wide variety of biological activities and 
show efficient pharmaceutical applications in cancer therapy (Kusari et al. 2012). The EF isolated 
from Juniperus trees such as Penicillium, Aspergillus were also found to be exhibiting 
antimicrobial activity (Gherbawy and Elhariry, 2016). 
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3.5.3 Artemisia asiatica 
 The Artemisia genus consists of around 400 species and these are one of the most important 
sources of medicinal compounds. A review on the chemical compounds of 15 Artemisia, reported 
839 compounds, which mainly consists of terpenoids, flavonoids, coumarins, caffeoylquinic acids, 
sterols, and acetylenes (koul et al. 2018).  
 Among the Artemisia species, A. annua is the most known due to its artemisinin content, 
which is an important antimalarial drug (Weathers et al. 2011). Liu et al. identified 14 fungal 
endophytes in A. annua (Liu et al. 2001), which produced antagonistic compounds against four 
phytopathogens. Another study showed the bioactive potential of A. annua EF such as Aspergillus 
sp. and Cephalosporium sp. that were proved to be having the highest antibacterial activity (Zhang 
et al. 2017). 
  Most of the EF isolated from A. annua were investigated for their role as an elicitor in the 
production of artemisinin. There have been limited studies conducted on bioprospection of EF of 
Artemisia species and its EF communities have been proved as a source of 27 novel compounds 
and 22 have already been characterized (Cosoveanu and Cabrera 2018). 
 A. asiatica is also known as mug wort. This is a perennial plant and abundantly found in 
the northern temperate regions of Asia, Europe and North America. This species is widely known 
for its medicinal properties and their essential oil is commonly used in medicine and food products. 
A. asiatica has been proven to be effective against diseases such as hanol and indomethacin-
induced gastric injury (Oh et al. 2005), acetaminophen- and carbon tetrachloride-liver dysfunction 
(Ryu et al. 1998) and cerulein-induced pancreatitis (Ahuja et al. 2018). There are 22 known 
phytochemical compounds that have been identified from A. asiatica including flavonoids, 
coumarins, terpenes, sesquiterpene lactones, monoterpenes, guaianolidem secoguianolide, lignans, 
phenylpropanoids and steroids (Hajdu et al. 2014). Eupatilin and jaceosidin flavonoids are also 
identified from this plant and are known to possess wide bioactivities such as anticancer, anti-
microbial, anti-inflammatory and antioxidative effects (Cheong et al. 2011; Choi et al. 2011a; Choi 
et al 2011b.; Lee et al. 2008). A recent study shows that the ethanolic extract of A. asiatica could 
have skin-protective remedy with anti-photoaging, anti-apoptotic, skin remodelling and anti-
melanogenesis properties (Jeong et al. 2014). Despite the broad-spectrum bioactivity of A. asiatica, 
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and the fact that its EF community has not been investigated, we have chosen this plant for our 
investigations.  
3.5.4 Mosses 
 Most of the studies on endophytes have been focused on vascular plants. Despite the wide 
diversity and significance of non-vascular plants especially in boreal forests, they remain under 
investigated in terms of their endophytic community. Mosses are non-vascular plants, that belong 
to the division of Bryophyta. They are small non-flowering plants, which absorb essential nutrients 
through their leaves (MacKinnon et al. 2004). We chose mosses for our investigations based on the 
rationale that they are most distinct in their physiology and ecology (Cox et al. 2014; Wickett et al. 
2014).  
 Mosses mostly flourish in a vast variety of habitats that range from the cold arctic 
environment to hot deserts, sea-levels and alpines (Higgins et al. 2007.); Malcolm and Malcolm, 
2000).They are ubiquitous and play an important role in regulating moisture and temperature in 
ecosystems. They are also known as microhabitats of microbes and small arthropods (Staddon et 
al. 2010). Although approximately 14,000 moss species exist, they have not been well studied for 
their microbiome population. 
  Mosses have been investigated for their endophytic bacterial community and a study 
reports that mosses are habited by with nitrogen-fixing, phosphorus-solubilizing and IAA-secreting 
bacteria that play a key role in promoting their growth (Lan et al. 2020). There are several studies 
about its endophytic bacterial community (Lan et al. 2020; Shcherbakov, 2013) and it has also been 
reported that the endophytic bacterial community differs in four mosses collected from the same 
soil crusts. 
 In addition, a great phylogenetic diversity of endophytes has been found in bryophytes such 
as liverworts, moss in boreal, temperate and tropical forests (Davis et al 2003; Davis and Shaw, 
2008; Kauserud et al. 2008; U’Ren et al. 2010). In addition to this study bryophytes in the 
Antarctica have been investigated for their endophytic fungal community. This study shows the 
cold adaptation of EF from three different bryophytes (Zhang et al. 2013). Due to the limited 
investigation regarding the EF of mosses, these plants were also selected for our study. 
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4 OBJECTIVES 
  
 The aim of this work was to isolate, identify as well as evaluate and compare the 
bioprospects of fungal endophytes harboured in Hungarian plants. Furthermore, to provide 
fundamental insights into the host metabolite producing abilities of EF and reveal the antimicrobial 
activity of the secondary metabolites produced by the examined endophytic community. 
The main objectives are, 
1. Screening for host metabolite producing EF from the H. perforatum.  
2. In the case of finding host metabolite producer strains, detailed investigation of the host 
metabolite producing EF regarding the taxonomy, yield of the metabolites and dependence 
of the production on certain cultivation conditions. 
3. Isolation and identification of EF from J. communis, A. asiatica and several mosses and 
evaluation of their biodiversity. 
4. Determination of antimicrobial activities of metabolites extracted with different organic 
solvents from the ferment broth and mycelia of isolated EF. 
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5 MATERIALS AND METHODS 
5.1 Culture media used in this study  
Potato Dextrose Agar – PDA (VWR International Ltd., Debrecen) 
Potato Dextrose Broth– PDB (VWR International Ltd., Debrecen) 
Defined Medium (Velmurugan et al 2010) – DM (for 1L): 
 30 g glucose, 1.0 g (NH4)2SO4, 0.5 g MgSO4∙7H2O, 1.4 g K2HPO4, 0.6 g KH2PO4, 0.8 
 mg ZnSO4∙7H2O, 0.8 mg FeCl3∙6H2O, 0.8 mg NaMoO4∙2H2O, 0.4 mg MnSO4∙2H2O, 0.08 
 mg CuSO4∙5H2O (pH=5.6) 
Czapek-Dox Broth (Me´ndez et al. 2011) – CDB (for 1L): 
 30 g sucrose, 3.0 g NaNO3, 1 g K2HPO4, 0.5 g MgSO4∙7H2O, 0.010 g FeSO4 (pH=7.3) 
Malt extract broth (Mapari et al. 2008) – MEB (for 1L): 
 17 g malt extract, 3 g mycological peptone (pH=5.4) 
Luria-Bertani broth – LB (for 1L): 
   10 g tryptone, 5 g yeast extract, 5 g NaCl   
Yeast extract peptone dextrose broth – YPD (for 1L): 
 20 g peptone, 10 g yeast extract, 20 g glucose 
Nutrient broth – NB (for 1L): 1 g peptone, 15 g NaCl, 6 g yeast extract 
5.2 Collection of plant samples 
Fresh, healthy aerial parts of the selected plants were collected in late Autumn in 2015, 2016 and 
in 2017, where GPS coordinates were recorded (Table S1).The collected plants were Hypericum 
perforatum and Juniperus communis. Artemisia asiatica and different mosses were provided by 
the Department of Pharmacognosy, University of Szeged. All plant specimens have been identified 
and authenticated by experts. Collected specimen was placed in a sealed plastic bag and was 
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labelled with the number and date of collection and stored at 4 °C until processing. 
5.3 Isolation of plant endophytes 
   Isolation of EF from plant parts was done according to the method described by Gariyali 
with minor modifications (Garyali, 2013). The plant materials were rinsed in running tap water to 
remove dust and debris and the specimens were cut into small segments of about 0.5 to 1 cm in 
length using a sterile blade. In the case of J. communis, the leaf, twig, root and cone parts were 
separated, and these parts were examined for their fungal endophyte content.  
  The plant segments were surface sterilized to kill the epiphytic microorganisms by 
sequentially immersing the plant material in 70% ethanol for 60 s, washing with sterile distilled 
water and then, steeping in 0.01% mercuric chloride (VWR International Ltd., Hungary) for 30 sec. 
Finally, the specimens were washed again with sterile distilled water 2-3 times and then allowed to 
dry on a sterile blotting paper. Each segment was placed onto the surface of PDA medium 
supplemented with ampicillin (50 µg/mL, Merck Ltd., Hungary) in a Petri dish. All plates were 
incubated at 25 °C for 5-10 days and were checked daily for the growth of fungal colonies. Pure 
isolates were obtained by picking up individual colonies from the plates and transferring them onto 
a fresh PDA medium, where they were incubated at 25 °C for 10 days. Each fungal culture was 
checked again for purity and transferred separately to PDA slants and maintained at 4 °C and this 
generation (3rd) of the isolates were deposited into the Szeged Microbiological Collection (SZMC, 
Hungary, http://szmc.hu/). 
5.4 Molecular identification of endophytic fungi 
 For DNA isolation, fungal isolates were grown in PDB for 5 days at 25 ̊C. Isolation of the 
genomic DNA from the mycelia was performed using E.Z.N.A. Fungal DNA Kit (Omega Bio-tek) 
according to the manufacturer’s instructions. The internal transcribed spacer (ITS) region of the 
rDNA was amplified using the primers ITS1 and ITS4 as described previously (White et al. 1990). 
Sequencing of the amplified DNA fragments was performed on an ABI 373A DNA sequencer 
(Applied Biosystems Inc., USA) using dye dideoxy terminator reaction chemistry. The sequences 
were first analyzed by BLAST similarity search at the website of the National Center for 
Biotechnology Information (http://www.ncbi.nlm.nih.gov/BLAST) and the species were identified 
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based on their identity values (>97%).  Identification of the SZMC 23773 strain was also reinforced 
using the online software (www.isth.info) TrichOkey 2.0 (Druzhinina et al. 2005). 
5.5  Targeted screening of host metabolite production of H. perforatum isolates 
5.5.1 Preparation of metabolite extracts 
 Isolated EF were cultured for 7 days at 25°C in 50 mL PDB medium. The extraction was 
carried out according to a description by Kusari et al. with minor modifications (Kusari et al. 2008). 
The mycelia were separated from the broth by filtration through a cheese cloth and overnight dried 
in an oven until constant weight, which was recorded. Then 25 mL distilled water was added to the 
dry material, which was then sonicated for 20 min after the addition of an aliquot of liquid nitrogen 
to maintain the chilled condition. This aqueous solution was extracted then three times, first, with 
25 mL ethyl acetate (EtOAc) and then, with 25 mL chloroform-methanol (4:1), and the extracts 
obtained with the same solvent were pooled. Fifty mL of the ferment broth was also extracted three 
times sequentially with 50–50 mL of EtOAc and chloroform-methanol (4:1), respectively, and the 
extracts were also pooled. The organic solvents from each pooled extract were removed by a rotary 
evaporator (IKA HB10 basic, VWR International Ltd., Hungary) in vacuum at 30°C. The resulted 
four dry samples per each isolate were stored at -20°C and resuspended in 1 mL of HPLC grade 
methanol (VWR International Ltd., Hungary) prior to use. 
5.5.2 HPLC-UV analysis 
 The applied analytical method was based on the description of Li and Fitzloff, with slight 
modifications (Li and Fitzloff, 2001). The extracts were analyzed by modular HPLC system 
(Shimadzu, Japan) equipped with a CBM-20A system controller, a DGU-14A degasser, an LC-
20AD binary pump, a SIL-20A autosampler, a CTO-10ASvp column thermostat and an SPD-
10Avp UV-VIS detector, which was controlled by ClassVP 6.2 software. The peaks were detected 
at a wavelength of 436 nm. The mobile phase consisted of water containing 20% methanol (A, 
WVR International Ltd., Hungary) and acetonitrile (WVR International Ltd., Hungary) containing 
10% methanol (B) and both were supplemented with 0.5% trifluoroacetic acid (Merck Ltd., 
Hungary). Separations were performed on a Phenomenex Gemini 250 × 4.6 mm, 5 μm reversed 
phase column (GenLab Ltd., Hungary) coupled with Phenomenex C18 guard column (GenLab 
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Ltd., Hungary) with a flow rate of 1 mL/min using a gradient program started with 10% B, and 
reached to 70% B until 10 min, to 90% until 15 min and to 25 min until 100%, which was kept 
until 60 min and reduced to initial eluent ratio and held to pressure stabilization. The total analysis 
time was 65 min. The injection volume was 5 μL. The calibration was done with serial dilution of 
hypericin and emodin standards (Merck Ltd. Hungary) in the range of 250 μg/mL to 7.8 μg/mL 
based on the retention times of hypericin (32.8 min) and emodin (16.9 min). The quantity of 
hypericin and emodin present in the samples were quantified using the equations y = 0.000142788 
x—5.07 and y = 0.0000808111 x—4.66, respectively, while the r values were 0.998 and 0.999 for 
hypericin and emodin, respectively. 
5.5.3 HPLC-HRMS and HRMS/MS analysis 
 The identity of hypericin and emodin was confirmed by a Thermo QExactive Plus high-
resolution mass spectrometer (Thermo Scientific, USA), which was coupled to a Waters UPLC I-
Class System (Waters, USA) consisting of a binary pump, a column manager and a fixed loop auto 
sampler. The separations were performed by using a Phenomenex Kinetex XB-C18 column (2.6 
μm, 2.1 × 50 mm, 100 Å) (GenLab Ltd., Hungary) with water (A) and acetonitrile (B) eluents 
containing 0.1% formic acid with a flow rate of 0.5 mL/min at 40°C. Samples and standards were 
analyzed using a gradient program as follows: from 5% B linear gradient to 95% B over 10 min 
and after 95% B isocratic for 2.5 min, the system returned to its initial condition (5% B) within 0.1 
min and was equilibrated for 2.4 min. The  mass spectrometer was operated in data dependent 
MS2 mode with negative electrospray ionization (ESI) (number of precursors: Top 5; scan range 
100–1500; dynamic exclusion: 10 sec; 1 exclude isotopes: on; stepped NCE: 30, 50, 80) with 
nominal mass resolving power of 60 000 at m/z 200 with a scan rate of 1 Hz with automatic gain 
control to provide high-accuracy mass measurements within 2 ppm. Nitrogen was used as sheath 
gas, and as the collision gas. The source parameters were the followings: spray voltage (-): 
2500.00V, capillary temperature (-): 300.00°C °C, sheath gas (-): 55.00 arbitrary units, auxillary 
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gas (-): 15.00 arbitrary units, spare gas (-): 5.00 arbitrary units, max spray current (-): 100.00 µA, 
probe heater temp. (-): 450.00 °C, S-lens RF level: 50.00 arbitrary units. 
5.5.4 Antibacterial assay 
 The standard compounds, hypericin and emodin (100 µg/µL) and the methanolic solution 
of the extracted samples of both mycelia and ferment broth were tested using the microdilution 
method based on the guideline of the Clinical and Laboratory Standards Institute (Clinical and 
Laboratory Standards Institute (CLSI) 2015) against bacterial strains including Escherichia coli 
(SZMC 0582), Pseudomonas aeruginosa (SZMC 21886), Staphylococcus aureus (SZMC 14532), 
Bacillus subtilis (SZMC 14624) Micrococcus luteus (SZMC 6207) and Streptomyces albus (SZMC 
0282), which were obtained from the Szeged Microbiological Collection (SZMC, 
http://www.wfcc.info/ccinfo/collection/by_id/987, Szeged, Hungary). The suspensions of each 
bacterium were prepared from overnight broth cultures cultivated in NB broth at 37 °C and the 
concentrations of the suspensions were adjusted to 4 x 105 cells/mL. The extracts resuspended in 
methanol were diluted with water to reach the methanol content up to 10%. The 96-well plates 
were prepared by dispensing into each well 100 μL of NB containing the bacterial cells and 100 
μL of extracts and incubated for 24 h at 37 °C. The mixture of 100 μL NB and 100 μL extracts were 
used as the blank sample for the background correction, while 100 μL of bacterial cultures 
supplemented with 100 μL of 10% methanolic solvent or 100 μg/mL ampicillin (Merck Ltd., 
Hungary) solution was applied as the positive and the negative controls, respectively. Absorbances 
were measured at 620 nm after 1 and 24 hours of incubation and inhibition (%) was calculated as 
the percentage of the positive control after the blank correction. 
5.5.5 Phylogenetic Analysis of Producer strains 
 In the case of Alternaria, the ITS sequences of the producer strains were aligned to those 
of the ex-type and representative strains (Woudenberg et al. 2013; Chen et al. 2017). The table of 
the used species and the GenBank identifier of the applied sequences are given in Online Resource 
1. The CLUSTAL_X software (Thompson et al. 1997) was applied to perform the alignment. The 
phylogenetic tree was constructed with the neighbor-joining method using 1,000 bootstrap 
replicates (Saitou and Nei, 1987). The percentage of replicate trees, in which the associated taxa 
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clustered together in the bootstrap test (1000 replicates), were positioned next to the branches 
(Felsenstein, 1985). The evolutionary distances were computed using the p-distance method (Nei 
and Kumar, 2000) and were given in the units of the number of base differences per site. The 
phylogenetic analysis of Alternaria species involved altogether 64 nucleotide sequences using the 
outgroup rooting method, with strain Stemphylium herbarum CBS 191.86 (KC584239) designated 
as the outgroup. All ambiguous positions were removed for each sequence pair and there were 368 
positions in the final dataset. The phylogenetic analyses and the tree construction were conducted 
in MEGA7 (Kumar et al. 2016). 
5.5.6 Statistical analysis 
 The statistical analysis was performed using the GraphPad Prism version 7.0 for Windows 
(GraphPad Software). To compare the inhibition effects of hypericin, emodin and the fungal 
extracts on the bacterial strains, the one-way analysis of variance (ANOVA) was used and p<0.05 
was accepted as statistically significant. 
5.6 Effect of different cultivation parameters on the production of hypericin and emodin 
5.6.1 Hypericin and emodin production under dark and light conditions 
  The fungi Epicoccum nigrum (SZMC 23769) and Alternaria sp. (SZMC 23771) were 
inoculated into 100 mL Erlenmeyer flask containing 50mL of PDB from the parent axenic culture. 
These flasks were completely covered by aluminium foil and incubated at 28 ± 2°C with shaking 
(120 rpm) on a rotary shaker for 7 days in dark condition. A similar set of cultivations was prepared 
simultaneously and processed parallelly in the same way, but under complete light condition. Three 
replicates of each experiment set were performed.   
5.6.2 Hypericin and emodin production on different media 
 To investigate the effects of the media on the host metabolite production, the producer 
strains were cultivated in 100 mL Erlenmeyer flasks containing 50 mL of PDB, MEB, DM and 
CDB. Each flask was inoculated with one mycelial plug cut from the edge of 1-week-old fungal 
colonies and incubations were carried out for 7 days at 150 rpm under light condition. Biomass 
production in each medium was investigated and the samples were prepared according to the 5.5.1 
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chapter and host metabolite content was measured as described in 5.6.5 in triplicates and mean 
values were calculated. All experiments were performed in triplicates. 
5.6.3  Sub-cultivation studies on the production of host metabolites 
 Seven generations of one mycelial plug cut from the edge of 1-week-old fungal colonies of 
E. nigrum (SZMC 23769) and Alternaria sp.  (SZMC 23771) were inoculated in 50 mL of PDB, 
MEB, CDB and DM and cultivated for 7 days at 28 ± 2°C with shaking (120 rpm). The samples 
were then prepared according to 5.5.1 chapter and measured as described in 5.6.5 to quantify the 
hypericin and emodin amount.  All experiments were performed in triplicates.  
5.6.4 Testing the effects of elicitors on hypericin production 
To the test the influence of different elicitors on the hypericin production the following 
experimental setups were applied: 
a) Two grams of H. perforatum tea leaves were mixed with 100 mL of sterile distilled water and 
steeped overnight. Then 25 mL of the filtered tea was added to 25 mL of PDB.  
b) Two grams of H. perforatum tea leaves were mixed with 100 mL of sterile distilled water, 
steeped overnight and filtered. The PDB medium was then prepared 50 mL of this tea instead 
of water. 
c) A hundred milligrams of sterilized and crushed leaves and stems were added directly to 50 mL 
of PDB. 
d) The fermentation medium was supplemented with emodin in 50 µg/mL, 100 µg/mL 
concentration levels. 
e) Aliquots of filtered broth medium (1 mL and 2 mL) of SZMC 23769 inoculated with the 3rd 
fungal generation were made up to 50 mL with PDB.  
 In the case of each setup the mycelial plug of 7th Sub-cultivation of SZMC 23769 was 
inoculated into the medium and cultivated for 7 days at 28 °C with shaking (120 rpm). After 7 
days the mycelia were sub cultured into the fresh PDB medium for 7 days at 28 °C with shaking 
(120 rpm). Then the extraction was done according to 5.5.1 chapter and the hypericin quantity was 
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measured as described in 5.6.5. All the experiments were performed in triplicates. 
5.6.5 HPLC-MS/MS analysis 
 The metabolite extraction was carried out like the aforementioned method described in 
5.5.1. The identity of hypericin and emodin was confirmed by a LC-MS system (Shimadzu, Japan) 
equipped with LC-20ADXR pump, DGU-20A5R degasser, SIL-20AXR autosampler, CTO-
10ASVP oven and a TSQ Quantum Access (Thermo Scientific, USA) mass spectrometer. The 
separations were performed by using a Phenomenex Gemini-NX C18, 50 mm x 2mm, 3µm 
(GenLab Ltd., Hungary) column. The mobile phase consists of A and B eluents, where A contained 
MeOH (VWR International Ltd., Hungary), MeCN (VWR International Ltd., Hungary) and water 
in the ratio of 1: 1: 8 with 0.1% acetic acid and 5 mM of ammonium acetate, while B constituted 
of MeOH and MeCN in the ratio of 1:1 containing 0.1% acetic acid and 5 mM ammonium acetate. 
The flow rate was 0.3 mL/min at 40°C. Samples and standards were analyzed using a gradient 
program, which started at 50 % B, and it rose linearly to 87% in 3 min and then to 95% in 0.1 min 
and held for 3.6 minutes. In 0.3 minutes, B solvent rose to 98% and was held for 2.5 min. The 
mobile phase composition returned to the initial conditions in 0.2 min and was held for 5 min for 
re-equilibration resulting in a total runtime of 13.7 minutes. Mass spectrometric analysis was 
conducted using TSQ Quantum Access (Thermo) mass spectrometer in multiple reaction 
monitoring mode. The instrument was equipped with a heated electrospray ionization (HESI) 
source which operated in negative ionization mode. The operating conditions were as follows: 
electrospray voltage 4000 V, sheath gas pressure 60 arbitrary units, ion sweep gas pressure 2 
arbitrary units, auxiliary gas Pressure 15 arbitrary units, vaporizer temperature 379 °C, capillary 
temperature was maintained at 250°C and collision pressure was continuously regulated at 2.6 m 
Torr (Ar). The target ion and collision energy were m/z 269.87→226.15, 28 V and m/z 
503.20→405.620, 56 V for emodin and hypericin respectively.MS/MS transition and collision 
energy for confirmation were m/z 269.87→242.14 28 V for emodin and m/z 503.20→433.54, 56 
V. for hypericin. The total scan time was 0.015 sec. 
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5.7 Biodiversity mapping of endophytic fungi of A. asiatica, J. communis and mosses 
5.7.1 Calculating Isolation rate and diversity index 
 The Isolation rate (IR) of EF was calculated as the total number of tissue segments infected 
by fungi divided by the total number of tissue segments incubated (Kumar and Hyde, 2004) The 
relative abundance was calculated as the number of isolates of a taxon divided by the total number 
of isolates of all taxa, and the fungal richness was defined as the number of fungal species in a 
sample. 
 The diversity of EF isolated from three plants were evaluated using the Shannon–Weiner 
Index (H′), Simpson’s Dominance D), evenness Index (J), and Margalef richness index (Hoffman 
et al. 2008; Suryanarayanand et al. 2000; Kusari et al. 2012). All the diversity indexes were 
calculated plant wise and also tissue wise to analyse the host and tissue specificity of EF. 
5.7.2 Statistical analysis 
 Statistical analyses for biodiversity calculations were carried out in R 3.5.2. The diversity 
indexes were calculated using Vegan package from R 3.5.2. One-way analysis of variance 
(ANOVA) was carried out to test the effect of plant species or tissue type (stem and root and leaf) 
on the species richness of EF.  Post hoc Tukey’s Honest Significant Difference tests were performed 
to observe the significant differences among the plant species or tissue types at P < 0.05 level. 
5.8 Screening of bioactive metabolite producing endophytic fungi 
5.8.1 Secondary metabolite extraction 
 Isolated EF were cultured for 7 days at 25°C in 50 mL PDB medium. Then the mycelia 
were separated from the broth by filtration through a cheese cloth and overnight dried in an oven 
until constant weight, which was determined. Then 25 mL distilled water was added to the dry 
material, which was then sonicated for 20 min after the addition of an aliquot of liquid nitrogen to 
maintain the chilled condition. After that the extraction of the aqueous samples was done with the 
mixture of 25 mL of chloroform and MeOH (4:1) and extraction was repeated for three times. The 
ferment broths were extracted three times sequentially with 50–50 mL of hexane, EtOAc and 
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chloroform, respectively, and both extract series were pooled. The organic solvents were removed 
by a rotary evaporator (IKA HB10 basic, VWR International Ltd., Hungary) in vacuum at 30°C 
from each pooled extract including EtOAc, chloroform as well as chloroform and MeOH (4:1) 
fractions. The resulted four dry samples per each isolate were stored at -20°C prior to use. 
5.8.2 Antimicrobial activity assay 
 For testing the antibacterial potential of the crude extracts, 400 μL of the methanolic 
extracts were transferred into new Eppendorf tubes and were dissolved in 1 mL 10% MeOH after 
the evaporation. These extracts were tested against two Gram-negative bacteria E. coli (SZMC 
6271) and P. aeruoginosa (SZMC 23290) and two Gram-positive bacteria S. aureus (SZMC 14611) 
and B. subtilis (SZMC 0209) and two yeasts C. albicans (SZMC 1533) and C. krusei (SZMC 1352), 
all of which were obtained from the SZMC, Szeged, Hungary. For the assay, the suspensions of the 
microbes were prepared from overnight cultures that were cultivated in a ferment broth (bacteria-
LB; yeast-YPD) at 37°C, and their concentrations were set to 4×105cells/mL with sterile media. 
Then, 96-well plates were prepared by dispensing 100μL of suspension containing the bacterial or 
yeast cells, 100μL of the extract which is dissolved in 10% of MeOH added into each well, which 
were then incubated for 24 h at 37°C. The mixture of 100μL of broth and 100μL of 10% MeOH 
was used as the blank sample for background correction, while 100μL of the microbial suspension 
supplemented with 100μL of 10% MeOH was applied as the negative control. The positive control 
contained ampicillin (100 μg/mL, Merck Ltd., Hungary) for bacteria and nystatin (10 μg/mL, 
Merck Ltd., Hungary) for fungi. The inhibitory effects of each derivative were 
spectrophotometrically determined at 620 nm after incubation, and the inhibition rate was 
calculated as the percentage of the positive control after blank correction.  
5.8.3 Antifungal activity against phytopathogenic fungi 
To determine the potential antifungal activity of the fungal extracts against plant pathogenic 
fungi, agar well diffusion assay was carried out. Evaporated samples of crude extracts were 
dissolved in 1 ml 10% MeOH. four holes were bored into PDA plates in diameter of 8 mm same 
distances around to centre of the plate. Then precultured (25 °C, 7 days) Fusarium culmorum 
(SZMC 11039) and Rhizoctonia solani (SZMC 21048) strains were placed in the centre of plates 
41 
 
with agar plugs. After that, 100 µl of samples was applied into each well. As solvent control, 10% 
MeOH was used. The mycelial plug inoculated without any extracts was used as a control. 
Antifungal activity of the samples was determined by the size of the inhibition zone. 
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6 RESULTS AND DISCUSSIONS 
6.1 Selection of plants 
 The medicinal plants were collected from the southern Hungarian areas. This set of plants 
comprises of 1) species obtained from different geographical regions (H. perforatum, J. communis) 
with known active ingredients, that are already in use in pharmaceutical products and their 
endophytes that have already been reported to produce these metabolites; 2) species with active 
substances that are also used as medicine, but their endophytes were not reported as producers of 
host’s metabolites and species with proved biological activities, but the secondary metabolites of 
their endophytes are completely unknown (A. asiatica).  The mosses were selected because, despite 
their possible importance, the cultivatable endophytes of mosses in Hungary have not been widely 
examined. 
6.2 Screening for host metabolite producing endophytic fungi from H. perforatum. 
6.2.1 Identification of isolated endophytes 
 H. perforatum plants were collected from the Botanical Garden of the University of Szeged 
in autumn. The leaf, stem, root and flower parts were separated, and these parts were examined for 
their fungal endophyte content. Altogether 48 parts were tested involving 12-12 leaf, stem, root 
and flower cuttings, respectively. Then due to the intensive surface sterilization procedure a total 
of eight fungal strains were isolated after 7 days of incubation at 25 °C from the samples (Table 3). 
Three strains were isolated from the leaves and two fungi from both stems and flowers as well as 
one strain from the root representing the genus Alternaria (6), Epicoccum (1) and Trichoderma (1) 
(Table 3). The latest proved to be Trichoderma harzianum, which was confirmed after the NCBI 
BLAST search by the barcode identification system of this genus due to the 5 genus-specific 
hallmarks found in its sequence. According to the NCBI hits both the SZMC 23771 and 23772 
strains were identified as members of the Alternaria genus (Table 3). These isolates were also 
investigated phylogenetically in detail due to their host metabolite production described later 
(6.2.2).  
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Figure 3. Phylogenetic analysis of the Alternaria strains proved to be the producer of emodin. 
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Based on the phylogenetic analysis of the ITS sequences of these two strains (Figure 3) as 
well as those of the ex-type and representative strains of the species available in the GenBank 
(Table S 15) our Alternaria isolates belong to the section Alternata.  
 Table 3. List of isolated and identified endophytic fungi from H. perforatum. 
Genbank ID Species Collection 
code 
Blast hitsa Plant 
part 
KY613791 Epicoccum nigrum SZMC 23769 510/512(99%) Flower 
KY613792 Alternaria sp. SZMC 23770 536/537(99%) Stem 
KY613793 Alternaria sp. SZMC 23775 499/501(99%) Flower 
KY613794 Alternaria sp. SZMC 23776 521/523(99%) Stem 
KY613795 Alternaria sp. SZMC 23774 491/524(94%) Root 
KY613796 Alternaria sp. SZMC 23771 458/48, 96% Leaf 
KY613797 Alternaria sp. SZMC 23772 520/520(100%) Leaf. 
KY613798 Trichoderma harzianum SZMC 23773 551/553(99%) Leaf. 
aThe first blast hit at 29 May 2018 
The Alternaria isolates were identified only at the genus level due to the highly variable 
phylogenetic loci have found a lack of support between the earlier described phylogenetic clades 
and morphologically described species (Andrew et al. 2009). Numerous morphological species 
have been described within this genus representing same species or discrete evolutionary taxa 
(Armitage et al. 2015), in which eight phylogenetic lineages were identified assigning them the 
taxonomic rank of section (Lawrence et al. 2015). However, the commonly isolated 
morphologically described species as in our cases belonging mainly to the Alternaria genus - are 
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usually within the A. alternata species group including A. tenuissima, A. arborescens, and A. 
alternata (Andrew et al. 2009). Based on the recent classification approach of this genus, the 
support values (Bayesian posterior probabilities, RAxML bootstrap) of the section Alternata were 
high enough for the discrimination using the ITS sequences (Woudenberg et al. 2013). This clade 
involves species that are commonly referred to as small spored Alternaria in the literature 
(Lawrence et al. 2015). Members of the Alternaria genus were most frequently identified within 
the sample set based on the ITS sequences. 
 The fungus producing both of the examined host metabolites hypericin and emodin 
(6.2.2) was identified as E. nigrum via BLAST search of the NCBI GenBank. This species is an 
anamorphic ascomycete distributed worldwide colonizing different types of soils as well as host 
plants as an endophyte (Mims and Richardson, 2005) E. nigrum is considered to be a saprophytic 
fungus, although members of the corresponding taxon have also been described with an endophytic 
lifestyle (Arnold, 2007) and are isolated generally from the inner tissues of several plant species 
(Stuart et al. 2010).  
6.2.2 Confirmation of host metabolite production of certain isolates 
 After the cultivation of the isolated endophytes, the ethyl acetate and chloroform-methanol 
extracts of both fungal mycelia and ferment broths were examined for the presence of hypericin 
and emodin. For the identification, HPLC-UV analysis was applied. The retention times of 
hypericin and emodin were 32.8 min and 16.9 min respectively. 
 Altogether, 32 extracts were checked for the production of both metabolites and in certain 
cases the observed peaks detected in the extracts fitted well to the retention time of the standard 
compounds (Figure 4).  
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Figure 4. HPLC-UV chromatogram of the producer strains. The standard mixture of hypericin and 
emodin (A) as well as the mycelial extract of SZMC23771 (B), SZMC23769 (C) and SZMC23772 
(D) extracted with chloroform-methanol. 
 It could be concluded that none of the EtOAc extracts contained the examined analytes in 
a measurable amount including mycelial and broth ones. However, it seemed that the chloroform-
methanol extract of SZMC 23772 and SZMC 23771 mycelia contained emodin, and both hypericin 
and emodin was detected from the SZMC 23769 mycelial extract. It is important to consider that 
the host metabolites were only observed in the mycelial extracts suggesting that the compounds 
may be produced either intracellularly or associated to the surface of the fungal cell wall. Both 
strains belonging to the Alternaria genus (SZMC 23771 and SZMC 23772) produced emodin at 
similar levels, although the E. nigrum isolate secreted this compound more than 20 times higher 
quantity (over 2 µg) in broth cultured within the applied conditions. Furthermore, the yield of 
hypericin in the ferment broth of SZMC 23769 was approximately three quarters of emodin 
produced also by this strain (Table 4). 
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Table 4. List of the strains producing hypericin and emodin and their detected amounts in the 
extracts of the mycelia. 
Strain number 
Emodin 
(ng/mg) 
Hypericin 
(ng/mg) 
Emodin 
(ng/ml) 
Hypericin 
(ng/ml) 
related to the mycelial weight related to the cultivation volume 
SZMC 23771 19.9 (4.1) BDL 87.7 (5.0) BDL 
SZMC 23772 20.8 (20.5) BDL 71.5 (33.8) BDL 
SZMC 23769 427.9 (37.4) 320.4 (25.0) 2312.6 (19.9) 1752.0 (6.9) 
BDL - below detection limit, SD values are given in brackets  
 The confirmation of the presence as well as the comprehensive identification of hypericin 
and emodin in the extracts detected by the HPLC-UV analysis was achieved by comparison with 
authentic reference standards using LC-HRMS and LC-HRMS/MS techniques. Suitable ionization 
properties were obtained in negative ESI mode for both hypericin and emodin during the MS 
optimization procedures, which was used later to record the high-resolution full scan ESI-MS 
spectra of both the standard and the fungal compounds. The retention times of the fungal hypericin 
and emodin were also equivalent with the standard compound as in the case of HPLC-UV 
measurement in all cases (Figure 5).  
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Figure 5. Full scan MS spectra of emodin (C15H9O5) and hypericin (C30H15O8) (A) and 
chromatograms of the standard hypericin and emodin (B), as well as the mycelial extract of 
SZMC 23769 (C), SZMC 23771 (D) and SZMC 23772 (E) extracted at the m/z values of 
hypericin (m/z 503.0732-503.0812) and emodin (m/z 269.0433-269.0477). 
 Moreover, the molecular formulas of the compounds were also served by the high mass 
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resolution of the applied instrument, which proved to be C15H10O5 ([M-H]-, 269.0456) for emodin 
in the case of each producer and C30H16O8 ([M-H]-, 503.0770) for hypericin in the case of SZMC 
23769, and the full scan spectra were identical to the data obtained for the authentic standards 
(Figure 3). Within data dependent MS2 mode, the resulted patterns of the fragments after the 
collision of the above-mentioned ions as precursor ions in the HCD cell - also corresponded to the 
standard hypericin and emodin compounds (Figure 6 and Figure 7). 
 
 
  
Figure 6. The MS2 spectra of emodin (C15H9O5) standard (A) and the mycelial extract of SZMC 
23769 (B), SZMC 23771 (C) and SZMC 23772 (D) recorded at the retention time of 5.07 min. 
 It was already proven that Alternaria species associated to plants could produce host 
metabolites including methyl-eugenol, capsaicin (Devari et al. 2014) and paclitaxel (Ismaiel et al. 
2017), although according to our knowledge their emodin production has not been reported yet. 
Previously, emodin isolated from Rhamnus triquetra bark was found to be an efficient antifungal 
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toxin showing high efficiency against spore germination of 17 tested fungal species including seven 
species of Alternaria (Singh et al. 1992).  
 The association between plants and Epicoccum species also led to the production of plant 
metabolites by the fungi such as taxol (Somjaipeng et al. 2015) and other unique bioactive 
metabolites (Fatima et al. 2016) involving antimicrobial compounds such as epicorazins A–B 
(Baute et al. 1978), epicoccins A–D (Zhang et al. 2007), epicoccarines A–B and epipyridone 
(Kemami and Hertweck, 2007), flavipin (Bamford et al. 1961) and epirodins (Ikawa et al. 1978). 
However, our study gives the first report of their abilities to produce hypericin and emodin.  
 
 
Figure 7. The MS2 spectra of hypericin (C30H15O8) standard (A) and the mycelial extract of 
SZMC 23769 (B) recorded at the retention time of 10.23 min. 
 Previously, it has been reported that endophytic E. nigrum produces quinizarin, which is 
also an anthraquinone compound (Dzoyem et al. 2017). Furthermore, recent investigations 
presented the plausible explanations for being another compound, skyrin involved in the 
anthraquinone biosynthesis pathway of fungi (Revuru et al. 2020). Therefore, further investigations 
on testing the presence of this compounds in E. nigrum could shed some light on the actual pathway 
involved in the synthesis of hypericin and it will be interesting to investigate whether all producer 
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strains follow the same pathway, or if it is a strain specific phenomenon. 
 Generally, in the literature there is no available data about the amount of hypericin or 
emodin produced by microbes.  However, for the last fungal strain isolated from H. perforatum 
producing both hypericin and emodin compounds under shake flask condition, the produced 
amounts were already quantitated as 0.35 ng/mg hypericin and 1.13 ng/mg emodin DW of fungal 
mycelia (Kusari et al. 2008). In the case of plants, the average amount of 3330 ng/mg DW of 1 and 
190 ng/mg DW of emodin could be measured from H. perforatum, which could be reduced 
significantly with the application of a cold acclimation period and remained unchanged after the 
exposure of plants to dehydration and exogenous abscisic acid treatment (Bruňáková et al. 2015). 
Furthermore, the determinable amount varies between taxonomic categories (Kitanov, 2001), 
seasons (Southwell and Bourke, 2001) and different plant structures (Ayan and Çirak, 2008) as 
well as ontogenetic phases (Mártonfi et al. 2006), which could decrease the robustness of the 
production of these natural products.  It is interesting that the amount of emodin is higher than that 
of hypericin in the case of fungi, while the opposite could be observed in plants. 
 In our study, we detected higher quantities of both hypericin and emodin produced by E. 
nigrum than the T. subthermophila related to the DW of the fungal mycelia, but the observed 
amounts of both compounds were lower than the contents reported of H. perforatum. Furthermore, 
according to the literature the hereby produced amounts were higher than what has been reported 
in case of other Hypericum species (Ayan and Çirak, 2008).  
6.2.3 Antibacterial activity 
 The reference standards of hypericin and emodin were tested against six bacteria at the 100 
µg/mL level of concentration. Both examined compounds showed moderate to high inhibitions 
against each bacterium in the range of 65% – 92% and 60% – 78% for hypericin and emodin, 
respectively (Figure 8).  
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Figure 8. Antibacterial activities of the standard solutions of hypericin and emodin and the three 
selected fungal extracts against all test bacteria. There was a significant difference between the 
inhibitory values of the different extracts and the solution of both hypericin and emodin against 
the test bacteria (p<0.05). 
 In the case of hypericin, the highest antimicrobial activity was against B. subtilis and the 
lowest was against E. coli. Emodin showed the highest inhibitory activity against P. aeruginosa 
and the lowest against Strep. albus. It could also be concluded that the antibacterial effect of 
hypericin is generally higher than that of emodin except for E. coli (Figure 8). The antimicrobial 
effects of extracts of producer strains were higher than standards except the extracts of SZMC 
23771 against Staph. aureus and Strep. albus. The antibacterial efficacy of emodin has been 
evaluated previously and proved to be exhibiting strong antibacterial activity against MRSA strains 
(Lee et al. 2010). The mode of inhibitory action of emodin isolated from the Aspergillus awamori 
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strain has been explained as follows: emodin induces deleterious morphological alterations such as 
swelling and elongation of bacterial cells and conidiation decrease and cytoplasmic retraction of 
fungal cells, thereby inhibiting the growth of pathogenic strains (Ismaiel et al. 2016) 
6.2.4 Effect of different cultivation parameters on the host metabolite production  
 Two of the producer strains, SZMC 23769 and SZMC 23771 were selected to examine the 
dependence of host metabolite production on certain cultivation conditions including lighting and 
cultivation media.  
6.2.4.1 Effect of dark and light conditions on the host metabolite production 
 Cultivation of the producer strains under dark and light conditions results in variations in 
the production of these compounds.  
Table 5 . Production of hypericin and emodin of SZMC 23769 in dark and light conditions in 
terms of their mycelial DW, values of SD is given in brackets 
Collection 
ID 
Light Dark 
DW of 
mycelia 
(mg) 
Emodin 
(ng/mg) 
Hypericin 
(ng/mg) 
DW of 
mycelia 
(mg) 
Emodin 
(ng/mg) 
Hypericin 
(ng/mg) 
SZMC 23771 278.65  
(21.61) 
23.38 
(12.76) 
BDL 167.31 
(14.78) 
10.84 
(6.91) 
BDL 
SZMC 23769 301.49  
(18.62) 
343.71 
(19.65) 
310.4  
(25.0) 
155.84 
(11.94) 
165.37  
(20.14) 
28.62 
(18.23) 
 
 These results suggest that light facilitated the growth of SZMC 23769 and the production 
of hypericin and emodin. Although their production was lower under dark conditions, the fungi did 
not lose their ability to produce these metabolites. In the case of SZMC 23771, the same effect was 
observed, thus the amount of emodin was also lower when grown in the dark (Table 5).  
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 In H. perforatum, the production of hypericin is light dependent. The metabolite is localized 
in the dark glands of leaves and the synthesis of hypericin takes place in presence of light. Although 
in case of T. subthermophila, the production of hypericin and emodin are light independent (Kusari 
et al. 2009b). On the contrary, E. nigrum produces a higher amount of hypericin and emodin in the 
presence of light than in dark related to the amount of biomass (Table 5). This suggests that the 
production ability and the required parameters is species specific. Considering the lower mycelial 
weight in the dark, it is noteworthy to mention that light is also required for the growth of E. nigrum 
SZMC 23769. A similar case was observed in Alternaria sp. SZMC 23771, where the biomass 
obtained in dark condition was considerably lower than that of mycelia obtained in illumination. 
Light showed a remarkable effect on the mycelial growth of Alternaria sp. (SZMC 23771) and the 
production of emodin. Previous literatures show that a 12-hour day light period is beneficial for 
the growth of Alternaria, while continuous light and dark conditions are not favourable for growth 
(Igbalajobi et al. 2019).  
6.2.4.2  Effect of different types of cultivation medium on the host metabolite production 
Various culturing conditions are often tested to optimize the production of specific compounds, 
such as medically important active metabolites (Zou and Hu 2017) or drug-producing microbes 
(Pu et al. 2013). For this purpose, the effect of cultivation medium on the host metabolite 
production of both SZMC 23769 and SZMC 23771 was tested using different media. For SZMC 
23769, the highest yields of both hypericin and emodin were observed on PDB (Figure 9). The 
yield of both metabolites was moderate on MEB, while their production on CDB and on DM was 
substantially low. For emodin production approximately 7 times lower amount was measured on 
both CDB and DM than on PDB. This result supports the findings of Rabbani et al. (2011) that 
media conditions have varying effects on the production of fungal secondary metabolites (Rabbani 
et al. 2011). Similarly, in the case of SZMC 23771, the quantity of emodin was also the highest on 
PDB, followed by MEB/DM and CDB.  
55 
 
 
Figure 9. Hypericin (A) and emodin (B) production of SZMC 23769 in different media.  
 (P values - ****P<0.0001, ***P<0.001, **P<0.01, *P<0.05) 
 The media components like carbon source, nitrogen source, micronutrients significantly 
impact the growth and production of metabolites in fungi. Therefore, optimization of culturing 
conditions using different growth media is necessary to increase the production of a compound of 
interest (VanderMolen et al. 2013). PDB contains potato starch, which supports growth and 
pigment production in many filamentous fungi. Previous results also support that naphthoquinone 
production is also higher in PDB (Kaur et al. 2015). When complex nitrogen sources are used such 
as peptone and yeast extract, it stimulates pigment formation (Carels and Shepherd, 1977). The 
presence of inorganic nitrogen sources also lowers the production of pigments (Kaur et al. 2015). 
These might be the reason why in CDB and DM fungi produced both emodin and hypericin in low 
quantities MEB and PDB contain lots of organic nutrients such as malt extract, peptone and starch, 
all of which influence gene expression regulation and may activate the respective metabolic 
pathways (Pradeep et al. 2013).  
56 
 
 
 
Figure 10. Emodin production of SZMC 23771 in different media. 
(P values - ****P<0.0001, ***P<0.001, **P<0.01, *P<0.05) 
The presence of organic nitrogen source is essential for optimal growth and metabolite production 
(Carels and Shepherd, 1977). These results suggest that PDB would be the most suitable media to 
produce hypericin and emodin by SZMC 23769 and emodin by SZMC 23771 in larger quantities 
in the future (Figure 9, Figure 10). 
6.2.5 Attenuation of host metabolite production during sub-cultivations 
The production of a bioactive compound by an EF can be stimulated in the host plant or by 
a host plant extract. When grown in vitro, an endophyte may continue to produce a bioactive 
material, or this may cease after a certain time (Kusari et al. 2012). Therefore, in certain cases, 
additional examinations are needed to discover what factors could stimulate endophytes to continue 
host metabolite synthesis in vitro (Owen and Hundley, 2004). To investigate whether host 
metabolite production either persists or ceases during repeated sub-cultivations, a detailed study of 
metabolite production was undertaken over several generations in four different media. In shake-
flask fermentation of the producer strains (SZMC 23769 and SZMC 23771), a clear decrease in the 
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production of both host metabolites was observed from the third to the tenth-generation subculture 
(Figure 11, Figure 12).  
 
Figure 11. Host metabolite production of SZMC 23769 during Sub-cultivations: (A) 
hypericin production (B) emodin production. 
In the case of SZMC 23769 the hypericin production ceased in the ninth generation in PDB 
and MEB and the production of emodin ceased  in the tenth generation in PDB and IXth generation 
in MEB, (Figure 11) but the production ability stopped two generations earlier in the other two 
mediums. The amount of emodin ceased also completely from the tenth generation in SZMC 23771 
(Figure 12). One of the major limitations in bioprospecting of EF is the problem of attenuation 
during sub-cultivation (Ansari and Butt, 2011) and we observed a similar challenge regarding 
hypericin and emodin production. These gradual losses in the production ability of host metabolites 
during subsequent generation suggests that the expression of the background genes is decreased in 
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the isolates during the sub-cultivations. This phenomenon has also been reported in case of 
camptothecin production by Fusarium solani, where its production gradually decreased during sub-
cultivations (Kusari et al. 2009a). Another study also showed the reduction of host plant derived 
compound production in an endophytic Aspergillus flavus over 11 generations (El-Hawary et al. 
2020). Similarly, in other cases, the sustainable production of camptothecin and Taxol in EF up to 
10 generations were observed (Ma et al. 2011) It is presumable that the endophytic fungus might 
have acquired BGCs from the plant either by co-evolution or LGT initially and in the absence of 
host plants the acquired genes might get silenced due to the lack of host stimuli (Kusari et al. 2009a; 
El-Hawary et al. 2020). Various factors could be responsible for the attenuation process in hypericin 
production. It might be due to the difference in environmental factors outside the host (Shwab and 
Keller, 2008), Absence of cross activation signals from the plants or biosynthetic precursors within 
the plant or the presence of coexisting endophytes (Jamwal and Gandhi, 2019). Due to the lack of 
information about the host selection and interaction of the endophytes, it is impossible to elucidate 
the exact mechanism of attenuation (Jamwal and Gandhi, 2019). Kusari et al. (2009b) proposed 
that the biosynthetic pathway of hypericin and emodin in fungi is different from that of plants, and 
based on our results it seems that the presence of the plant partner is needed to activate the specific 
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gene clusters in our isolates for persistent metabolite production.  
 
Figure 12. Emodin production of SZMC 23771 during sub-cultivations. 
The exact mechanism of why fungi produce host metabolites is still not experimentally 
proved yet. It is arguable, whether the fungus acquired the specific gene clusters through 
coevolution, if yes then it also raises the question why members of a diverse group of fungi present 
in the same plant produce the same compound. For example, 19 different fungal genera are found 
to be producing Taxol (Mousa and Raizada, 2013). If endophytes are considering as an alternative 
source for the production of these metabolites, further research is required to unravel this 
mechanism. 
6.2.6 Effect of different elicitors on the attenuated strains 
As the biosynthesis of certain compounds outside the host is difficult for EF, elicitation is 
proved to be an effective strategy to induce the secondary metabolism. This approach has been 
predominantly used in microbial systems. Elicitors are signalling molecules, which induce the 
synthesis of secondary metabolites during the fermentation process (Venugopalan and Srivastava, 
2015, Zhao et al. 2010). Compounds like serine and silver nitrate were used to enhance Taxol 
biosynthesis in Nodulisporium sylviforme (Zhao et al. 2011), and salicyclic acid was used to induce 
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camptothecin production in Trichoderma atroviride (Pu et al. 2013). 
To restore the production of hypericin in SZMC 23769, the fermentation medium was 
supplemented with different kinds of elicitors (Table 6). Our results suggest that the ferment broth 
of the producer strains did not have any positive impact on the production of hypericin and emodin 
in attenuated strains. This proves that the spent broth does not contain any element that can 
stimulate the biosynthetic pathway of hypericin or emodin. However, when emodin was added in 
the fermentation medium in two different concentrations as an elicitor, small quantities of hypericin 
was detected in the mycelial extract, however there were no traces of emodin in the ferment broth 
extract.  
Table 6. Effect of different elicitors in production of hypericin in attenuated strain of SZMC 23769. 
 
Elicitors  Experimental setup 
Effect on the production (ng/mg) 
Hypericin Emodin 
Tea solution of H. 
perforatum 
1:1 solution of tea and PDB 
as a growth medium 
BDL 
 
BDLa 
 
1.2 g of PDB dissolved in 50 
mL of tea as a growth 
medium 
8 .812 ng/mg BDL 
Fresh tissues of 
leaves and stems of 
H. perforatum 
0.1 g/L of crushed stem and 
leaves supplemented in PDB  
10.24 ng/mg BDL 
Emodin addition 50 µg/mL 
100 µg/mL 
54.90 ng/mg 
95.93 ng/mg 
BDL 
BDL 
 
Ferment broth of 
SZMC 23769 
producer strain 
1:50 supplementation in 
PDB 
2:50 supplementation 
BDL 
BDL 
BDL 
BDL 
 
 
a
BDL: Below Detection Limit 
 The effect of tea solution of H. perforatum were also tested in two concentrations, where 
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the applied higher tea amount could restore the production of hypericin in low amount, but no 
traces of emodin were observed (Table 6) This suggests that the fresh and dried plants might have 
provided certain elicitors that stimulated the biosynthetic pathway, however detailed investigation 
is needed to elucidate the exact mechanism. Previously, it has been illustrated in the case of EF 
producing camptothecin that the reason of attenuation is due to the absence of the host plant 
enzyme, strictosidine synthase (Kusari et al. 2011). Hence, the addition of the host plants will be 
one of the solutions to re-activate the biosynthetic mechanism of this fungus in axenic culture 
outside the host.   
6.3 Investigation of endophytic fungi isolated from J. communis, A. asiatica and several 
mosses. 
Altogether 240 parts were tested involving 60 cuttings of leaf, stem, root and cone from 12 
different plant samples of J. communis. For A. asiatica, a total of 126 segments (Leaf-63, Stem-
63) were examined for the presence of EF from 21 different plants, while for mosses, the whole 
plant of 40 different species were used and one plant was considered as one segment for endophytic 
isolation. 
 
  
Figure 13. Distribution of EF isolated from J. communis into classes (A) and orders (B). 
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6.3.1 Investigation of fungal endophytes isolated from J. communis 
6.3.1.1 Biodiversity of endophytic fungi isolated from J. communis  
Altogether 75 EF were isolated from J. communis distributed into 3 main classes and 8 
main orders (Figure 13). The predominant class was found to be Sordariomycetes, which were 
similar to the previous studies in Juniperus endophytes (Kusari et al. 2009a). Most of the isolates 
belonged to Hypocreales, and the rest of the isolates were members of the taxa Pleosporales and 
Eurotiales. 
6.3.1.2 Isolation rate and fungal richness, host and tissue specificity of fungi isolated from 
J. communis 
To characterize the biodiversity of A. asiatica EF, the Shannon diversity index (H′) 
Simpson’s Dominance (D), and Margalef’s richness (D mg) have been calculated The Shannon-
index revealed higher certainty of endophytic fungal species consistency in the stem compared to 
that of the other parts in J.  communis. Moreover, the Simpson’s-index clearly showed that the stem 
harbored highly diverse fungal endophytes compared to those harbored by other parts. Finally, 
based on Margalef’s-index the stems have high taxonomic richness and cone had the lowest 
compared to the other tissues in J. communis (Table 7). 
Table 7. Biodiversity parameters of EF isolated from J.  communis. 
 
 
 
The stems of J. communis harbored 11 unique fungi, whereas 4 and 2 were found in leaf 
and cone (Figure 14). Interestingly, the roots of J. communis did not harbor any unique fungi. This 
shows that some species seem to be tissue specific. Xylaria species were found only in cone, while 
Pestalitiopsis and Bipolaris were found only in leaf, whereas Curvularia, Aspergillus, Didymella 
Diversity index Stem Root Leaf Cone Total 
Simpson’s Dominance (D) 0.912 0.775 0.788 0.666 0.92 
Shannon (H’) 2.582 1.630 1.950 1.214 2.85 
Pielou’s evenness (J) 0.931 0.910 0.847 0.48 0.89 
Margeref richness 4.218 1.894 3.176 1.365 5.32 
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and Purpureocillium species were specifically found in stems. The biodiversity parameters 
revealed higher diversity of endophytic fungal species in the stem compared to that of the other 
parts in J. communis (Figure 15). Fusarium strains were more abundant in roots than in other 
tissues. 
 
Figure 14. Venn diagram showing the common and unique fungi along the tissues of J. 
communis. 
 
 
Figure 15. Distribution of EF of J. communis at genus level. 
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6.3.1.3 Antimicrobial effects of fungal extracts of J. communis endophytes  
Gram-positive bacteria were found to be more susceptible against the extracted endophytic 
metabolites than Gram-negative bacteria due to the higher number of highly active (>90%) extracts 
(Figure 16, Table S 2, Table S 3, Table S 4, Table S 5). For B. subtilis, the highest number of highly 
active extract were recorded from the EtOAc extracts of ferment broth (55), while the lowest 
amount of effective extracts (22) was obtained from the hexane based solvent partitions. Against 
E. coli the mycelial and chloroform extracts proved to be the most effective.  
 
 
 
 Figure 16. Summary of the antibacterial effects of endophytic extracts isolated from J. 
communis (C:M - chloroform: MeOH (4:1) extract of mycelia) 
In the case of S. aureus, the highest number of effective extracts were obtained from the 
EtOAc extracts (43) followed by chloroform partitioned ferment broth samples (37). It is important 
to highlight that the SZMC  27155 was highly active against all bacteria, but it was not active 
against the tested yeast and plant pathogens. The EtOAc, CHCl3 extracts of SZMC 27164 and 
SZMC 27031 isolates showed remarkable inhibitory effects against all tested bacteria and the 
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mycelial extracts of these isolates were also active against phytopathogens and yeasts. The 
Trichoderma isolates of this plant showed activity at least against one test microbe. The extracts of 
SZMC 27205 strain showed significant inhibitory activity against both Gram-positive and Gram-
negative bacteria. With respect to taxa, Fusarium, Pestalotiopsis, Trichoderma, A. fumigatus and 
Purpureocillium lilacinum strains showed significantly high bioactivity and will be suitable for 
further investigations. 
   
 
 
Figure 17. Summary of the antifungal effects of endophytic extracts isolated from J. communis 
(C:M - chloroform: MeOH (4:1) extract of mycelia). 
Altogether, 27 extracts showed inhibitory effects against yeasts, which is over 90% (Figure 
17). Interestingly, both chloroform and mycelial extracts of the ferment broth inhibited C. albicans, 
while C. krusei was mainly susceptible to the EtOAc and mycelial extracts (Table S 2, Table S 3, 
Table S 4).   
 Previous works showed that the EF of J. communis were excellent sources of antimicrobial 
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compounds (Elhariry and Gherbawy, 2014). In our study at least one solvent partition of 58 isolates 
were active against B. subtilis, S. aureus and C. albicans.  However, only a few extracts, particularly 
the mycelial extracts were found to be active against the tested phytopathogens, Specifically 
mycelial extracts of Trichoderma and Purp. lilacinum were active against both of the tested fungi. 
F. culmorum was found to be more resistant than R. solani (Table S 14). 
6.3.2 Investigation of fungal endophytes isolated from A. asiatica 
6.3.2.1 Biodiversity of endophytic fungi isolated from A. asiatica 
 Altogether, 83 EF isolated from A. asiatica (Figure 18). The EF were distributed into 3 
classes and 5 orders, where the members of Sordariomycetes were the most abundant.  
  
  
Figure 18. Distribution of EF isolated from A. asiatica into classes (A) and orders (B). 
6.3.2.2 Isolation rate and fungal richness, host and tissue specificity of fungi isolated from 
A. asiatica 
 There was no significant difference between the diversity index of J. communis and A.asiatica, 
although, the sampling tissue segments were different (Table 8). The IR was recorded as 0.75 and 
the fungal richness of EF was 17.  
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Table 8. Biodiversity parameters of EF isolated from A. asiatica. 
Diversity index Stem Leaves Total 
Simpson’s Dominance (D) 0.9 0.87 0.93 
Shannon (H’) 2.62 2.36 2.96 
Pielou’s evenness (J) 0.89 0.87 0.9 
Margeref richness 4.72 3.82 5.86 
 
Although the number of fungi in the stem was higher than leaves in case of A. asiatica, the notable 
difference was comparatively low (Figure 19).  
 The number of fungi in the stem was higher than leaves, but this difference was 
comparatively low. Curvularia, Phomopsis and Simplicillium species were found only in leaves, 
while Aspergillus, Trichoderma and Stemphylium species were isolated only from the stem. (Figure 
19, Table S 1). Therefore, these species could be even tissue specific in A. asiatica, but to clarify 
this statement larger sample set would be favorable. It should also be considered that the host 
specificity of EF can change the prevalence of their taxa in a particular plant and the divergence in 
the EF community might be harbored in specific host tissues due to the histological difference and 
nutritional availability (Arnold et al. 2007).   
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Figure 19. Distribution of EF isolated from A. asiatica at genus level. 
6.3.2.3 Antimicrobial effects of fungal extracts of A. asiatica endophytes  
 Altogether, 328 extracts were tested against both four bacteria and two yeasts and two 
phytopathogenic fungi (Table S 6, Table S 7, Table S 8, Table S 9, Table S 14). Our results revealed 
that altogether 54 hexane-, 78 EtOAc-,73 CHCl3- and 78 mycelial extracts were active against at 
least one test strains. Remarkable high number of extracts (53) were active against B. subtilis, and 
50% of the extracts were active against S. aureus (Figure 20). But low percentage of extracts were 
active against Gram-negative bacteria including E. coli (31%) and P. aeruginosa (28%). D.  
glomerata (SZMC 27102) exhibited higher activity against all of the tested microbes the SZMC 
27125 and SZMC 27126 strains showed a remarkable activity against Gram-positive bacteria and 
the mycelial extract of these EF showed high activity against Gram-negative bacteria, but they did 
not show any activity against yeasts and phytopathogens. Most of the extracts of Fusarium species 
exhibited remarkable antimicrobial activities against yeasts, but none of them were active against 
the two phytopathogen isolates (Table S10). The EtOAc extracts of Aspergillus isolates (SZMC 
27077, SZMC 27078) showed a significant activity (>90%) against B. subtilis, S. aureus, P. 
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aeruginosa and C. albicans. 
 
 
Figure 20. Summary of antibacterial effects of endophytic extracts isolated from A. asiatica 
(C:M - Chloroform: MeOH (4:1) extract of mycelia). 
During the antifungal activity testing, C. krusei was found to be more resistant against the 
extracts than C. albicans (Table S 6, Table S 7, Table S 8, Table S 9). In total 46 strains were found 
to be possessing more than 90% inhibition against at least one test pathogen (Figure 21). Taxa wise, 
Aspergillus, Penicillium, Fusarium were found to have metabolites with effective antifungal 
activity. Moreover, similarly to the EF of J. communis, chloroform and mycelial extracts of 
Trichoderma species were active against R. solani and F. culmorum 
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Figure 21. Summary of antifungal effects of endophytic extracts isolated from A. asiatica (C:M - 
chloroform: MeOH (4:1) extract of mycelia). 
6.3.3 Investigation of fungal endophytes isolated from mosses 
6.3.3.1 Biodiversity of endophytic fungi isolated from mosses 
 To date, most of the studies are focused on the endophytic community of seed plants to 
completely understand the dynamics of endophytic biodiversity, investigating different clades of 
plants is necessary. This study was undertaken to investigate the biodiversity of EF also in mosses. 
 Altogether, 40 EF were isolated from 126 plant segments of 42 different mosses, which is 
distributed into 3 classes and 7 orders. Similarly, to J. communis and A. asiatica, Sordariomycetes 
was the predominant class followed by classes of Dothideomycetes and Eurotiomycetes, while the 
dominant order was Hypocreales (Figure 22). The dominant taxa found in mosses were 
Trichoderma and Alternaria (Figure 22). 
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Figure 22. Distribution of EF isolated from mosses into classes (A) and orders (B). 
Besides the dominant Trichoderma and Alternaria genera, the Aspergillus, Phoma and Fusarium 
genera were also presented. The presence of Dothiorella gregaria (SZMC 27238 and SZMC 
27239) as moss endophyte was only observed in this study. Two isolated species were identified 
only at the order level as Pleosporales. 
6.3.3.2 Isolation rate and fungal richness, host and tissue specificity of fungi isolated from 
mosses 
 The IR of mosses was 0.37. Such low IR was previously reported in isolation from the 
Antarctic region (Bradner et al. 2000; Tosi et al. 2002). Totally, 40 EF were isolated and the fungal 
richness was calculated to be 10. The genera isolated from mosses were different compared to the 
previous studies (Bradner et al. 2000; Tosi et al. 2002). This implies that the diversity of EF also 
differs based on the geographical region. Shannon index shows that the diversity index is moderate 
despite of the low IR (Table 9) 
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Table 9. Biodiversity parameters of EF isolated from mosses. 
Diversity index Parameter value 
Simpson’s Dominance (D) 0.85 
Shannon (H’) 2.43 
Pielou’s evenness (J) 0.82 
Margeref richness 4.67 
  
The comparison of biodiversity indexes of all three plants shows that the fungal endophytes isolated 
from A. asiatica and J. communis are highly diverse compared to mosses (Table 7, 
Table 8,Table 9) The overall diversity of the fungal endophyte population inhabiting three plant 
species, represented by Shannon index H′ were 2.96, 2.85, 2,43 for A. asiatica, J. communis, and 
mosses respectively. This shows that the species richness and evenness is lower in moss samples 
than in the other two plants. The relative diversity (J) also reveals that A. asiatica had the highest 
‘J’ value of 0.90, followed by J. communis and mosses with a ‘J’ value of 0.89 and 0.82, 
respectively. The results clearly corroborate that mosses harbour the least diverse endophytic 
community comparing to other two plants. 
6.3.3.3 Antimicrobial effects of fungal extracts of moss endophytes 
 Totally, 160 extracts (120 broth and 40 mycelial) were tested against four bacteria and two 
yeasts (Table S 10, Table S 11, Table S 12, Table S 13). Our results showed that 136/160 (85%) of 
the extracts showed inhibitory activity against at least one test bacterium. Among 40 EF, almost 
50% were bioactive against at least one bacterium (Figure 23). 54 % of the EtOAc extracts showed 
inhibition against Gram-negative bacteria, which was 52% in the case of mycelial extracts. 
Similarly, to the EF of the other two plants, hexane extracts of moss isolates in certain cases showed 
inhibitory activities (Figure 23). 
 It can be highlighted that Trichoderma isolates were found to be active against most of the 
tested pathogens, including C. albicans. 
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Figure 23. Summary of antibacterial effects of endophytic extracts isolated from 
mosses (C:M - chloroform: MeOH (4:1) extract of mycelia). 
 None of the extracts exhibited > 90% inhibitions against C. albicans, while a few EtOAc 
extracts exhibited >90% activity against C. krusei. None of the Previous studies reported about 
antibacterial activity of moss endophytic bacteria (Lan et al. 2020). But this is the first report 
regarding the bioactive effects of EF from mosses.  There were no significant differences in the 
number of active extracts partitioned with solvents. The metabolites of the SZMC 27257 strain 
were found to be active against all of the tested bacteria and the metabolites of Alternaria SZMC 
27228 strain presented >90% inhibitory activity against B. subtilis and S. aureus. However, only 
three EtOAc extracts showed >90% inhibition against C. krusei and none of the extracts were 
showing remarkable activity against C. albicans. Comparing to the other two hosts, mosses 
harboured fewer bioactive EF against bacteria and yeasts.  
 Interestingly the mycelial extracts of 20 isolates inhibited the growth of the plant pathogen 
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R. solani (Table S 14). Regarding the inhibition of plant pathogens, similarly to our results, it was 
reported that endophytic bacteria from mosses are active against plant pathogenic bacteria and also 
promote the plant’s growth (Shcherbakov et al. 2013; Lan et al. 2020). 
      
 
Figure 24. Summary of antifungal effects of endophytic extracts isolated from 
mosses (C:M - chloroform: MeOH (4:1) extract of mycelia). 
6.3.4 Summary of investigations regarding the endophytic fungi isolated from J. communis, 
A. asiatica and mosses. 
 EF are highly diverse, and their investigation is very important from different plants to 
understand the biodiversity of the endophytic fungal community (Arnold et al. 2007). Given the 
high biodiversity of plants in Hungary, examining their fungal endophytes could lead to the 
discovery of novel metabolites. It is considered that biodiversity and structure of the endophytic 
fungal community mostly depends on the plant physiology, bio-geographical factors and their 
interplay with other pathogenic microbes associated with their host plant (Arnold et al. 2007).  
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 The molecular identification was performed and a list of the identification results of EF 
isolates with their isolation source, collection code and GenBank accession number in NCBI, are 
summarized in Table S 1. In our study, the culture dependent method was followed for the 
molecular identification of fungi, which was carried out using ITS sequences. Although numerous 
studies reported that ITS is sufficient for species delimitation, it has several disadvantages in 
demonstrating intra-specific distances and at present, it is difficult to unify the ITS divergence for 
distinct fungal species (Raja et al. 2017). The availability of only a limited reference sequences in 
the databases and misidentifications of published sequences represents another difficulty restricting 
the identification of EF using ITS (Vilgalys, 2003). However, Arnold et al. reported delimited 
species of 72 Ascomycota and Basidiomycota, based on 90% sequence similarity of ITS genotype 
groups and showed that these sequences were concordant with 28S rDNA (Arnold et al. 2007).  
Based on the ITS sequences, the isolates were characterized into 1 phylum, 3 classes, 10 
orders and 2 isolates were identified only at the order level and 1 at family level. All of the isolated 
fungi belonged to the taxon Ascomycota, which includes three classes, Dothideomycetes and 
Sordariomycetes and Eurotiomycetes. In all three plants, Sordariomycetes was the dominant class 
followed by Dothideomycetes and Eurotiomycetes. Such dominance of Sordariomycetes as 
endophytes has also been reported from several plants eg. Phragmites (Sim et al. 2018) and lichens 
(U’Ren et al. 2016) indicating that Sordariomycetes are ubiquitous among the plant kingdoms.   
 Totally, 22 genera were identified involving Alternaria, Aspergillus, Bipolaris, 
Cladosporium, Colletotrichum, Curvularia, Diaporthe,  Dothiorella , Didymella, Clonostachys, 
Fusarium,  Glomerella, Stemphylium, Simplicillium  Purpureocillium, Phomopsis, Phoma, 
Penicillium, Pestalotiopsis, Trichoderma and Xylaria  (Figure 25, Table S 1). The relative 
abundance (RA) of all genera was analyzed in all three plants (Figure 25) and Fusarium, Alternaria 
and Trichoderma were most abundant in all cases.  
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Figure 25. Relative abundance of EF from A. asiatica, J. communis and moss samples. 
During the biodiversity examinations, Bipolaris sp. and Purp. lilacinum proved to be host 
specific within the examined sample set in J. communis. Previously the occurrence of Purp. 
lilacinum has been reported as endophyte in cotton aphids (Castillo et al. 2014). 
 Our findings revealed that the leaves and stem parts of the plants are excellent reservoirs 
for EF, where the most abundant were Fusarium and Alternaria and Trichoderma genera. Although, 
Alternaria and Fuasrium fungi are considered as plant pathogens, they might be latent, when they 
are inside the living tissues until the environmental conditions are favourable and might have 
evolved to endophytic lifestyle due to loss of virulence (Freeman and Rodrigues, 1993). These EF 
are gaining a lot of attention recently for their bioactive compounds (Toghueo et al. 2019; Hellwig 
et al. 2002; Kaushik et al. 2020). 
 In this work, Phoma strains could be identified only at the genus level and identified in all 
the three plants. The genus Phoma is ubiquitous and inhabits a diverse range of hosts, from soil to 
air, plants to animals (Aveskamp et al. 2010). Previously, extensive studies were carried to clarify 
the significant generic boundaries in Didymellaceae, however, due to the lack of phylogenetic 
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support of nearly 70 Phoma species belonging to Didymellaceae could not be assigned to definite 
genera (Aveskamp et al. 2010; de Gruyter et al. 2013; Chen et al. 2017). Pestalotiopsis species are 
the beneficial members of foliar endophytes as they have the capability to switch their nutritional-
mode either by staying as an endophyte or becoming a saprobe (Maharachchikumbura et al. 2012; 
Douanla-Meli et al. 2013). In our study Pestalotiopsis species were identified only in J. communis. 
Although, Pestalotiopsis species are the most commonly found EF, it only represents 1.4 % in our 
study showing region specificity of this species. The members of the Trichoderma genus are found 
also dominant in our study. However, Trichoderma strains colonized abundantly in stems and cones 
of A. asiatica and J. communis and were not isolated from roots and leaves. In the literature, most 
of the studies reported the tissue specification of Trichoderma species to roots and leaves. In 
addition, the colonization mechanism of Trichoderma sp. was also reported through systemic 
infection, which proved that after the infection of roots the fungus could be re-isolated from stems 
rather than leaves and roots (Rosemana et al. 2018).  
 IR and RA of EF vary from plant to plant. In our cases, the IR of EF were found to be 
highest in stem, followed by leaf, whereas similar studies in other plants showed higher IR values 
in the leaf compared to stems (Alurappa and Chowdappa, 2018). The tissue and host specificity are 
also affected by different environmental conditions. Previous studies show that certain fungi such 
as Aspergillus (El-hawry et al. 2020) and Penicillium (Devi et al. 2012) did not exhibit host and 
tissue specificity, which was also found in our study.  
Most of the pathogenic strains have become resistant to antibiotics and multi drug resistant 
strains have become a serious global health concern. Therefore, an intensive research is required 
for effective antimicrobial drugs. EF have been identified as an abundant reservoir of novel 
antimicrobial compounds (Strobel, 2003). One of the most important properties of EF is that they 
produce a wide variety of compounds that protect themselves from plant pathogens (Tan and Zou, 
2001; Strobel, 2003). Secondary metabolites synthesized by EF have been reported as inhibitors of 
many animal and plant pathogens (Wiyakrutta et al. 2004; Gunatilaka, 2006; Zhao et al. 2011).  
From 2001 to 2019, there is a gradual increase in the number of patents registered related to EF. It 
has been reported that 224 patents were registered for secondary metabolites and 21 patents were 
related to biotransformation using EF. Aspergillus, Fusarium, Trichoderma and Penicillium are the 
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predominant genera with a higher number of patents for their bioactivity (Torres-Mendoza et al. 
2020). In the present work 201 endophytic strains were isolated from medicinal plants and the 
antimicrobial activity of their metabolites was evaluated. A total of 112 (52%) strains showed 
antibacterial activity against at least one test strains. Altogether 23.11% of the isolates have 
antimicrobial effects with wide spectrum. Twelve strains showed remarkably high inhibitory 
percentage (>90%) against all of the tested strains. 
 Among the three solvents applied for the ferment broth extraction, EtOAC extracts were 
found to be more active. The EtOAC is by far the most common solvent used to extract bioactive 
compounds from EF (Selva kumar et al. 2018) and several studies showed that the EtOAC extracts 
showed higher antimicrobial activities in comparison to other solvent extracts (Thomas et al. 2011; 
Toghueo et al. 2020). However, using more than one different solvent, the extraction of different 
chemical profiles can be achieved. Thus, although, EtOAC extracts usually showed higher activity, 
certainly CHCl3 extracts showed inhibition rates over them. Specifically, the CHCl3 extracts of 
Aspergillus (SZMC 27164) isolated from J. communis showed higher activity against both Gram-
positive bacteria and yeast, whereas the EtOAC extracts of the same strain showed no inhibition 
against those microorganisms. This suggests that the use of more than one solvent is important for 
screening bioactive metabolites produced by EF.  
 Furthermore, another significant observation in our study is that the bioactivity of fungal 
mycelial extracts could be comparably high as the ferment broth extracts and occasionally the 
inhibitory percentage is even higher than ferment broth extracts. Regarding the antifungal activity, 
22 mycelial extracts were active against C. albicans, while 18 against C. krusei. Although there are 
numerous studies describing the antibacterial activity of extracellular metabolites (Meenupriya and 
Thangaraj, 2010) few studies have reported the bioactivity of intracellular compounds (Synytsya 
et al. 2017; Meenupriya and Thangaraj, 2010).  
The extracts of A. asiatica endophytes were found to be possessing higher antimicrobial activity 
(Figure 20,Figure 21Table S 6, Table S 8, Table S 7, Table S 8, Table S 9).The antibacterial activity 
was higher than the antifungal activity. 43% of the extracts were active against bacteria, whereas 
only 12% were active against yeasts. C. krusei was found to be more susceptible than C. albicans, 
and regarding Gram-negative bacteria, especially E. coli, was highly sensitive to the extracts. The 
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Fusarium were the most predominant genus found to be exhibiting higher antibacterial activity 
than other isolates. Five out of 30 Fusarium strains had inhibitory activity against all the test 
organisms. Twenty, out of 30 Fusarium isolates were active against at least one of test organisms.  
Particularly, Fusarium oxysporum (SZMC 27185) and Fusarium sp. (SZMC 27188) isolated from 
J. communis showed more than 90% inhibitory activity against all test bacteria. Several studies 
have reported the antimicrobial potential of Fusarium sp. (Gherbawy and Elhariry, 2016; Liu et 
al.2012).  It was isolated from Tripterygium wilfordii and produced the antimicrobial compounds 
subglutinol A and B (Liu, Wu, and Xu, 2007). It was also isolated from the bark of Cinnamomum 
kanehirae and produced beauvericin, which showed a strong inhibitory activity against methicillin-
resistant S. aureus and B. subtilis (Wang et al. 2011). Furthermore, a Fusarium sp. isolated from 
Selaginella pallescens produced a pentaketide compound (2-methylbutyraldehyde-substituted-α-
pyrone), which significantly suppressed the growth of C. albicans (Brady and Clardy, 2000). 
Besides Fusarium species, the metabolites of Penicillium, Aspergillus, Pestalotiopsis, Trichoderma 
and Purpureocillium species also showed strong activity against all the test pathogens. Metabolites 
of Phoma and Didymella exhibited higher antibacterial activity than antifungal activity. 
Trichoderma is another predominant genus producing metabolites, which exhibit high inhibitory 
activity. The important classes of secondary metabolites such as terpenes, anthraquinones, 
peptaibols and diketopiperazine like metabolites have been previously reported as Trichoderma 
products (Leylaie and Safari, 2018). It could be also observed that the isolated EF belonging in the 
same taxa could show different degrees of inhibition against test microorganisms. In the case of 
Fusarium oxysporum, F. oxysporum (SZMC 27184) showed no inhibition, whereas the SZMC 
27185, SZMC 27186 strain of F. oxysporum exhibited inhibitory effect against all tested pathogens. 
This result strongly recommends that different strains from the same species cannot be ignored in 
examining their bioactivities. 
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7 CONCLUSIONS 
 
 In the present study, fungal endophytes were isolated from Hungarian medicinal plants (H. 
perforatum, J. communis and A. asiatica) and mosses. In the case of H. perforatum a 
chromatographic based screening was carried out to find host metabolite producing EF. Based on 
the results of analytical examinations (HPLC-UV) certain endophytes were able to produce the 
same metabolites as their plant hosts and thus, they can serve as novel microbial sources of 
bioactive plant metabolites. These metabolites were the hypericin, which is a medicinally important 
polyphenolic compound, and emodin, which is a biosynthetic precursor of hypericin in plants. The 
producer EF were the members of the genus Alternaria (producing emodin only) and a member of 
the genus Epicoccum (producing both emodin and hypericin). The Alternaria isolates were 
identified only at the section level, because members of the A. alternata species group including 
A. tenuissima, A. arborescens, and A. alternata cannot be discerned based either on the ITS 
sequence or on multigene approach. Furthermore, E. nigrum is anamorphic ascomycete distributed 
worldwide and considered to be a saprophytic fungus. Although it can also show an endophytic 
lifestyle and can be frequently isolated from the inner tissues of various plants. The identities of 
the host metabolites were confirmed via HPLC-HRMS technique based on the exact masses and 
MS2 fragmentation patterns and yield of the produced metabolites were determined in several 
cultivation conditions including illumination and cultivation media. In the case of the E. nigrum 
strain hypericin and emodin production ceased in the nineth generation and in the tenth generation, 
respectively, while the amount of emodin ceased completely from the tenth generation in the 
examined Alternaria strains. The addition of dried and fresh plant parts as an elicitor enhanced the 
biosynthesis of hypericin in the attenuated strains.  
 EF produce a plethora of secondary metabolites, which may open new avenues to study 
their applicability in pharmaceuticals. Despite the biotechnological potential of EF, the basic 
ecology about their relationship with the host plants is poorly understood. Therefore, in our study 
the fungal endophytic communities of J. communis, A. asiatica and several mosses were examined. 
The culturable EF were identified using molecular techniques and related to each plant group their 
biodiversity, richness, host and tissue specificity were described. As EF have been generally 
identified as an abundant reservoir of novel antimicrobial compounds, the antimicrobial activities 
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(antibacterial and antifungal) of the metabolites produced by the isolated fungi were extensively 
studied. Several extracts containing the endophytic metabolites proved to be active against the 
applied microorganisms. These isolates will be examined in detail in the future and the chemical 
nature of the active metabolites will be determined that may possibly lead to novel compounds for 
the pharmaceutical applications.    
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8  SUMMARY  
Medicinal plants have been used in therapies for various illnesses from time immemorial. The 
use of natural sources for the prevention of illnesses is evident in many ancient cultures such as 
those of Indians, Chinese and North Africans, and was also recorded in Sumerian archeological 
remains (Phillipson 2001). Today, we are threatened with the extinction of many wild medicinal 
plant species due to the destruction of their anthropogenic habitat and to harvesting due to an 
increasing demand for plant metabolites. Besides, it is challenging to obtain bioactive compounds 
from plants due to technical difficulties such as long growth period, low yield and low level of 
accumulation (Chen et al. 2016). For instance, the accumulation of Taxol in Taxus brevifolia is 
0.001–0.05% and to produce 1 kg of taxol, 15 kg of Taxus bark is needed (Malik et al. 2011). 
Therefore, it is important to find alternative approaches to produce medicinal plant-derived 
biologically active compounds, in particular, those derived from endangered or difficult-to-
cultivate plant species to meet the medical demand. In this study we identified an endophytic 
fungus E. nigrum as an alternative source of the widely used antidepressant hypericin and also 
screened bioactive EF isolated from three different medicinal plants based on their antimicrobial 
activity. 
This study was established to investigate the EF of Hungarian medicinal plants: H. 
perforatum, A. asiatica, J. communis and mosses. Results of this study were divided into 3 parts, 
isolation and molecular identification of EF, host metabolite producing ability of fungal endophytes 
from H. perforatum and screening of EF from other three plants for their bioactive potential. 
In the targeted approach, the alternative source for the medically important compounds 
hypericin and emodin was the endophytic E. nigrum, and for emodin alone Alternaria sp. There 
are various challenges in exploiting EF for commercial utilization. To overcome the challenges; 
different parameters were employed to optimize the production of host metabolites in the producer 
strains. The strains were cultivated in different media including PDB, MEB, DM and CDB. The 
results revealed that PDB medium was found to be superior when compared to the other ones in 
terms of both biomass accumulation and host metabolite production in case of both SZMC 23769 
and SZMC 23771. In order to check the stability of production for later commercial purposes, the 
strains were sub cultivated in different media. Our results on generation studies clearly indicated 
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that the strains SZMC 23769 and SZMC 23771 lost their ability to produce host metabolites during 
subsequent culturing. This is also dependent on the type of media used for the fermentation. In this 
case, DM and CDB were not suitable for increasing the production of metabolites over Sub-
cultivations. Different strategies were employed to check whether the production ability of the 
attenuated strains could be restored and we found that the addition of dried and fresh plant parts of 
H. perforatum to the fermentation medium as an elicitor enhanced the synthesis of hypericin in an 
attenuated strain. It was also found that emodin could be used as an effective elicitor to stimulate 
the biosynthetic pathway of hypericin in our producer strain. It would be interesting to investigate 
the actual mechanism of biosynthesis in the future and to apply genomic and epigenomic strategies 
to stimulate the pathway in EF, which could provide opportunities for using our strain as a 
sustainable cell factory for hypericin synthesis.  
In our work, altogether 254 strains from 406 plant fragments of A. asiatica (95), J. 
communis (132) and mosses (44) were isolated. The strains were selected for further investigations 
based on their culturable ability. The species, which showed slow growth and were not culturable 
under laboratory conditions were omitted and finally 82, 75 and 40 fungi were chosen from A. 
asiatica, J. communis and mosses, respectively for further investigations. Trichoderma, Fusarium 
and Alternaria species were found to be dominant in all three plants used for our investigation. 
However, by combining metagenomic approaches with traditional culture dependent isolation, the 
exact biodiversity of EF could be determined. 
Regarding bioactivity, a total of 788 extracts were tested and 481 (61%) were found to be 
effective against at least one tested microorganism including 367 against B. subtilis, 341 against S. 
aureus, 221 against E. coli and 262 against P. aeruginosa. In the case of yeasts, C. albicans was 
susceptible to 92 extracts, and 63 extracts inhibited the growth of C. krusei. Interestingly, 36 
extracts exerted antimicrobial activity against all bacteria and yeasts (>90%). However, none of 
the extracts did not show a remarkable activity against R. solani and F. culmorum, but few inhibited 
the growth of both phytopathogens, especially, Purp. Lilacinum (SZMC 27031) and T. atroviride 
(SZMC 27261). The detailed investigations of biocontrol metabolites of these fungi will be planned 
in the future. Pestalotiopsis sp. D. glomerata, Aspergillus sp. and Purp. lilacinum presented high 
inhibition against yeasts and further metabolomic investigation of these fungi could lead to the 
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identification of novel compounds with high therapeutic relevance. Summarizing the importance 
of the antimicrobial investigations, our work could serve as a base to explore the presence of novel 
bioactive compounds or even alternative sources for the existing ones.  
 As EF are a source of high bioactive compounds and phytochemicals, their bioprospecting 
could result in the discovery of a huge variety of novel therapeutic compounds. For the feasibility 
of using EF in commercial scale, it is essential to study the production kinetics of the active 
metabolites and to characterize the parameters effecting the production. Although, addition of 
plant-based elicitors and precursors was proved to restore the production ability, other approaches 
such as reversing the epigenetic silencing, metabolic reprogramming, and genome mining 
techniques would lead to overcome the problem of attenuation, which has been experienced also 
in our examinations.  
 In summary, our results corroborate, that the isolated and deposited fungal endophytes are 
excellent reservoirs of bioactive secondary metabolites, however further studies are needed to 
isolate the pure compounds from the screened strains. The presented results offer a proper 
framework of utilizing our isolates for their medical purposes. 
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9 ÖSSZEFOGLALÓ 
 
A gyógynövények szerepe a különböző betegségek kezelésében nagy múltra tekint vissza. A 
természetes forrásból származó különleges vegyületek preventív és gyógyító hatását már a 
tradicionális gyógyászati rendszerekben is alkalmazták, melynek legkorábbi írott emléke a sumér 
homokkőtáblákon található, de ezen alapszik az indiai, kínai és észak-afrikai tradicionális orvoslás 
is (Phillipson 2001). Napjainkban számos vadon élő gyógynövényfaj kihalásával kell számolni 
egyrészt az antropogén hatások következtében kialakuló élőhely pusztulás miatt, másrészt pedig a 
növényi metabolitok iránti megnövekedett keresletet kielégítését célzó túlzó kitermelések 
következtében. További probléma a jelenkori gyógynövény hatóanyagokat tekintve, amely már a 
termesztett gyógynövények esetében is felmerülhet, hogy az utánpótlást biztosító növények 
gyakran hosszú növekedési ciklussal rendelkeznek, valamint, hogy kis mennyiségben tartalmazzák 
az egyes hatóanyagokat (Chen et al. 2016). A Taxus brevifolia esetében például a Taxol kihozatal 
0.001–0.05%-os, azaz 1 kg hatóanyag előállításához 15 kg tiszafa kéreg szükséges (Malik et al. 
2011). Ezért a gyógyszeriperi igényeknek megfelelve kiemelten fontos az új alternatív források 
felkutatása a növényi eredetű biológiailag aktív vegyületek előállításához, különösen olyan 
hatóanyagok esetében, melyek veszélyeztetett vagy nehezen termeszthető gyógynövényekből 
nyerhetők csak ki jelenleg. A munkánk során megoldást keresve a fenti kihívásokra, sikerrel 
izoláltunk egy Epicoccum nigrum endofiton gomba törzset, amely kutatásaink alapján új forrása 
lehet a széleskörben alkalmazott, antidepresszáns hatású hypericin vegyületnek, valamint 
feltérképeztük több endofiton gomba antimikrobiális hatású metabolit-termelő képességét.   
A vizsgálatok alapját képező endofiton gombatörzsek izolálásához a Hypericum perforatum, 
Artemisia asiatica, Juniperus communis gyógynövényeket és különböző mohákat választottunk ki. 
A munka során elért eredményeket három fő részre lehet osztani, az első részben számoltunk be a 
H. perforatum növényből izolált, a növényi hatóanyagot termelni képes törzs felfedezéséről és a 
hatóanyag-termelés jellemzéséről. A második részben jellemeztük az A. asiatica, J. communis 
gyógynövényekből és mohákból izolált endofiton gombák biodiverzitását, valamint a harmadik 
részben áttekintést adtunk az izolátumok antimikrobiális metabolit termelő képességéről. 
A célzott hatóanyag-vizsgálatok során azonosítottunk egy E. nigrum (SZMC 23769) törzset, 
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amely mind a hipericint, mind pedig a bioszintetikus előanyagát az emodint képes volt termelni, 
valamint két Alternaria (SZMC 23771, SZMC 23772) törzset melyek az emodint termelték. Az 
endofiton mikroorganizmusok alkalmazása a hatóanyag-termelésben azonban a termelés 
instabilitása miatt sokszor nehézségekbe ütközik, ezért megvizsgáltuk, hogy a törzseknél a 
tenyésztési paraméterek változtatása milyen hatással van a metabolitok hozamára. Az izolátumokat 
tenyésztettük burgonya-glükóz- (PDB), maláta kivonatos- (MEB), Czapek-Dox- (CDB) valamint 
szintetikus (DM) tápoldatokban, mely során mind a biomassza mennyiség mind pedig a hatóanyag 
kihozatal szempontjából a PDB tápközeg bizonyult a legelőnyösebb választásnak a vizsgált SZMC 
23769 és SZMC 23771 izolátumok esetében. Ezt követően megvizsgáltuk, hogy a törzsek a 
különböző tápközegekben az egymást követő átoltások következtében elveszítik-e a metabolitok 
termelési képességét, vagy az stabilan fenntartható. Az egymást követő generációk termelési 
képesége fokozatosan csökkent mindkét vizsgált izolátumnál, mindkét vegyület esetében. A 
képesség elvesztésének kinetikája azonban jelentős függést mutatott a fermentáció során 
alkalmazott tápközeg minőségétől. Az SZMC 23769 törzs nem termelő generációjának 
felhasználásával különböző kísérleti beállításokat terveztünk a termelőképesség re-aktiválására. A 
vizsgálatban az előfermentációs közeghez adott szárított és frissen előkészített H. perforatum 
részek eredményesen indukálták a hipericin termelését, amely mérhető mennyiségben volt jelen az 
adott generáció, inducert nem tartalmazó környezetben fermentált tápközegében is. Hasonló 
indukciós hatás volt tapasztaltható, ha az emodint adalékoltuk az előtenyésztés során. A termelt 
hipericin mennyisége azonban mindkét esetben alacsonyabbnak bizonyult, mint a kiindulási 
generáció által termelt mennyiség. Kísérleteink alapján kijelenthető, hogy a termelés teljeskörű 
stabilizálásához további vizsgálatok szükségesek és valószínűleg a végső megoldást a bioszintézis 
mechanizmusának feltérképezése fogja jelenteni a jövőben, mely alapján tervezhetővé válik, hogy 
milyen genetikai és/vagy epigenetikai stratégiákat érdemes alkalmazni majd a stimulálás 
érdekében.  
A kutatásaink második részében összesen 254 törzset izoláltunk A. asiatica (95), J. 
communis (132) és különböző mohák (44) 406 db növényi szegmenséből. Az izolálásokat 
táptalajon végeztük, így csak az úgynevezett „tenyészthető” endofiton gombák kerültek 
begyűjtésre, melyek közül kizártuk azokat a törzseket is, melyek növekedése túl lassú volt az 
alkalmazott körülmények között. Így végül 82 törzset izoláltunk az A. asiatica szegmensekről, míg 
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75-öt a J. communis növényi részekről és 40-et a mohnövényekről. Az ITS alapú molekuláris 
taxonómiai vizsgálatok alapján feltártuk a növényeket kolonizáló endofiton gombák 
biodiverzitását és meghatároztuk az egyes közösségek szerkezetét. A legdominánsabb fajoknak 
mindhárom növény esetében a Trichoderma, Fusarium és Alternaria nemzetség képviselői 
bizonyultak.  A metagenomikai megközelítést az általunk is alkalmazott hagyományos tenyésztéses 
módszerrel kombinálva az endofiton gombák biodiverzitásáról részletesebb képet kaphattunk 
volna, azonban munkánk során arra törekedtünk, hogy azon gombák biodiverzitását mérjük fel, 
melyeknek a gyakorlat szempontjából is jelentőségük lehet. A nem tenyészthető endofitonok 
jelentősége vitathatatlan, azonban bioaktív képeségeik a tesztelhetőség hiányában jelenleg 
felfeddhetetlenek. 
A bioaktivitási kísérletekben 788 extraktum antimikrobiális hatásait vizsgáltuk, mely során 481 
extraktum (61%) bizonyult hatásosnak legalább egy tesztelt mikroorganizmussal szemben. A tesz-
tek során 367 extraktum mutatott gátló hatást Bacillus subtilis, 341 Staphylococcus aureus, 221 
Escherichia coli és 262 kivonat Pseudomonas aeruginosa baktériummal szemben. Az élesztők ese-
tében 92 extraktum gátolta az alkalmazott Candida albicans törzset, míg 63 kivonat bizonyult ak-
tívnak a C. krusei törzzsel szemben. Kiemelkedően magas antimikrobiális hatást (>90%) 36 kivo-
nat tesztelése során tapasztaltunk, melyek egyaránt aktivak voltak a baktériumok és az élesztők 
gátlása során is. Azonban az is elmondható, hogy a fitopatogén gombákkal, a tesztekben alkalma-
zott Rhizoctonia solani és Fusarium culmorum törzsekkel szemben általában az extraktumoknál 
nem detektáltunk erőteljes gátló hatásokat. Ez alól csak néhány izolátum extraktuma volt kivétel, 
melyek közül kiemelkedtek a Purpureocillium lilacinum (SZMC 27031) és egy Trichoderma at-
roviride (SZMC 27031) izolátum aktivitásai. Klinikai jelentőségükre való tekintettel szintén érde-
mes megemlíteni négy izolátumot, melyek a Pestalotiopsis, Didymella, és Aspergillus nemzetség 
képviselői, valamint az előbb említett Purp. lilacinum törzs, mert extraktumaik mindkét élesztő 
esetében jelentős gátlóhatást mutattak. A hatástesztek során számos ígéretes, antimikrobiális meta-
bolitot vagy metabolitokat termelni képes törzs került regisztrálásra, amely utat nyitott azok elvá-
lasztástechnikai vizsgálata felé, mely során új bioaktív vegyületek felfedezése vagy a már leírt 
vegyületek új forrásainak feltárása a cél. 
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13 SUPPLEMENTARY MATERIAL 
 
Table S 1. EFs isolated in this study 
Plant 
GPS coordinates 
if available 
Plant part Species 
Collection 
code 
Genbank 
ID 
A. asiatica 
 
Leaf Alternaria sp SZMC 27067   MT879608 
A. asiatica 
 
Leaf Alternaria sp SZMC 27068   MT879609 
A. asiatica 
 
Leaf Alternaria sp SZMC 27069   MT879610 
A. asiatica 
 
Leaf Alternaria sp SZMC 27070   MT879611 
A. asiatica 
 
Leaf Alternaria sp SZMC 27071   MT879612 
A. asiatica 
 
Leaf Alternaria sp SZMC 27072   MT879613 
A. asiatica 
 
Leaf Alternaria sp SZMC 27073   MT879614 
A. asiatica 
 
Leaf Alternaria sp SZMC 27074   MT879615 
A. asiatica 
 
Leaf Alternaria sp SZMC 27075   MT879616 
A. asiatica 
 
Stem Aspergillus sp SZMC 27076  MT994591 
A. asiatica 
 
Stem Aspergillus sp SZMC 27077  MT994592 
A. asiatica 
 
Leaf Aspergillus sp SZMC 27078  MT994593 
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Plant 
GPS coordinates 
if available 
Plant part Species 
Collection 
code 
Genbank 
ID 
A. asiatica 
 
Stem Aspergillus flavus SZMC 27079  MT994594 
A. asiatica 
 
Stem Aspergillus fumigatus SZMC 27080  MT994595 
A. asiatica 
 
Stem Aspergillus sp SZMC 27081  MT994596 
A. asiatica 
 
Stem Aspergillus sp SZMC 27082  MT994597 
A. asiatica 
 
Stem Aspergillus sp SZMC 27083  MT994598 
A. asiatica 
 
Stem Clonostachys rosea SZMC 27084 MT883288 
A. asiatica 
 
Stem Cladosporium sp SZMC 27085 MT883289 
A. asiatica 
 
Stem Cladosporium sp SZMC 27086 MT883290 
A. asiatica 
 
Stem Cladosporium sp SZMC 27087 MT883291 
A. asiatica 
 
Stem Cladosporium sp SZMC 27088 MT883292 
A. asiatica 
 
Stem Cladosporium sp SZMC 27089 MT883293 
A. asiatica 
 
Leaf Penicillium sp SZMC 27090 MT994617 
A. asiatica 
 
Stem Clonostachys rosea SZMC 27091 MT940229 
A. asiatica 
 
Leaf Clonostachys rosea SZMC 27092 MT940230 
A. asiatica 
 
Leaf Curvularia lunata SZMC 27093 MT994617 
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Plant 
GPS coordinates 
if available 
Plant part Species 
Collection 
code 
Genbank 
ID 
A. asiatica 
 
Leaf Curvularia lunata SZMC 27094 MT994617 
A. asiatica 
 
Leaf Diaporthe sp SZMC 27095 MT940231 
A. asiatica 
 
Leaf Diaporthe sp SZMC 27096 MT940232 
A. asiatica 
 
Leaf Diaporthe sp SZMC 27097 MT940233 
A. asiatica 
 
Leaf Didymella sp SZMC 27098 MT940234 
A. asiatica 
 
Leaf Didymella sp SZMC 27099 MT940235 
A. asiatica 
 
Leaf Didymella sp SZMC 27100 MT940236 
A. asiatica 
 
Leaf Didymella glomerata SZMC 27101 MT940237 
A. asiatica 
 
Leaf Didymella glomerata SZMC 27102 MT940238 
A. asiatica 
 
Leaf Didymella glomerata SZMC 27103 MT994617 
A. asiatica 
 
Stem Alternaria sp SZMC 27104 MT997192 
A. asiatica 
 
Stem Alternaria sp SZMC 27105 MT997193 
A. asiatica 
 
Stem Fusarium circinatum SZMC 27106 MT997194 
A. asiatica 
 
Stem Fusarium circinatum SZMC 27107 MT997195 
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Plant 
GPS coordinates 
if available 
Plant part Species 
Collection 
code 
Genbank 
ID 
A. asiatica 
 
Leaf Fusarium oxysporum SZMC 27108 MT997196 
A. asiatica 
 
Leaf Fusarium oxysporum SZMC 27109 MT997197 
A. asiatica 
 
Leaf Fusarium oxysporum SZMC 27110 MT997198 
A. asiatica 
 
Stem Fusarium sp SZMC 27111 MT881636 
A. asiatica 
 
Stem Fusarium sp SZMC 27112 MT881637 
A. asiatica 
 
Leaf Fusarium sp SZMC 27113 MT881638 
A. asiatica 
 
Stem Fusarium sp SZMC 27114 MT881639 
A. asiatica 
 
Leaf Fusarium sp SZMC 27115 MT997199 
A. asiatica 
 
Leaf Penicillium 
chrysogenum 
SZMC 27116 MT997200 
A. asiatica 
 
Leaf Penicillium hordeii SZMC 27117 MT997201 
A. asiatica 
 
Leaf Penicillum sp SZMC 27118 MT997202 
A. asiatica 
 
Leaf Penicillum sp SZMC 27119 MT994761 
A. asiatica 
 
Leaf Penicillum sp SZMC 27120 MT994762 
A. asiatica 
 
Stem Penicillum sp SZMC 27121 MT994763 
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Plant 
GPS coordinates 
if available 
Plant part Species 
Collection 
code 
Genbank 
ID 
A. asiatica 
 
Leaf Penicillum sp SZMC 27122 MT994764 
A. asiatica 
 
Leaf Penicillum sp SZMC 27123 MT994765 
A. asiatica 
 
Leaf Phomopsis sp SZMC 27124 MT994766 
A. asiatica 
 
Leaf Phoma sp SZMC 27125 MT994650 
A. asiatica 
 
Leaf Phoma sp SZMC 27126  MT994651 
A. asiatica 
 
Leaf Phomopsis sp SZMC 27127  MT994652 
A. asiatica 
 
Stem Phomopsis sp SZMC 27128  MT994653 
A. asiatica 
 
Leaf Pleosporales sp SZMC 27129  MT994654 
A. asiatica 
 
Leaf Simplicillium sp SZMC 27130  MT994655 
A. asiatica 
 
Stem Stemphylium sp SZMC 27131  MT994656 
A. asiatica 
 
Stem Trichoderma sp SZMC 27132 MT881591 
A. asiatica 
 
Stem Trichoderma 
harzianum 
SZMC 27133 MT881592 
A. asiatica 
 
Stem Trichoderma sp SZMC 27134 MT994657 
A. asiatica 
 
Stem Trichoderma sp SZMC 27135 MT881593 
A. asiatica 
 
Stem Trichoderma sp SZMC 27136 MT881594 
A. asiatica 
 
Stem Trichoderma 
atroviride 
SZMC 27137 MT881595 
A. asiatica 
 
Stem Trichoderma sp SZMC 27138 MT881596 
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Plant 
GPS coordinates 
if available 
Plant part Species 
Collection 
code 
Genbank 
ID 
A. asiatica 
 
Leaf Trichoderma sp SZMC 27139 MT881597 
A. asiatica 
 
Stem Trichoderma sp SZMC 27140 MT881598 
A. asiatica 
 
Stem Trichoderma sp SZMC 27141 MT881599 
A. asiatica 
 
Stem Trichoderma sp SZMC 27142 MT881600 
A. asiatica 
 
Stem Phoma sp SZMC 27143 MT994658 
A. asiatica 
 
Stem Phoma sp SZMC 27144 MT994659 
A. asiatica 
 
Stem Phoma sp SZMC 27145 MT994660 
A. asiatica 
 
Stem Pleosporales sp SZMC 27146 MT994661 
A. asiatica 
 
Stem Fusarium lateritium SZMC 27147 MT994662 
A. asiatica 
 
Stem Fusarium 
sporotrichiodes 
SZMC 27148 MT994661 
A. asiatica N 46°53.338'  E 019°24.483' Stem Alternaria sp SZMC 27149 MT940776 
J. communis N 46°53.340'  E 019°24.528' Stem Alternaria sp /SZMC 27150 MT940777 
J. communis N 46°53.340'  E 019°24.528' Stem Alternaria sp SZMC 27151 MT940778 
 J. 
communis 
N 46°53.338'  E 019°24.483' Stem Alternaria sp SZMC 27152 MT940779 
J. communis N 46°53.345'  E 019°24.501' Stem Alternaria sp SZMC 27153 MT940780 
J. communis N 46°53.345'  E 019°24.501' Stem Alternaria sp SZMC 27154 MT940781 
J. communis N 46°53.345'  E 019°24.501' Leaf Alternaria sp SZMC 27155 MT940782 
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Plant 
GPS coordinates 
if available 
Plant part Species 
Collection 
code 
Genbank 
ID 
J. communis N 46°53.345'  E 019°24.501' Stem Alternaria sp SZMC 27156 MT940783 
J. communis N 46°53.345'  E 019°24.501' Stem Alternaria sp SZMC 27157 MT940784 
J. communis N 46°53.338'  E 019°24.483' Leaf Alternaria sp SZMC 27158 MT940785 
J. communis N 46°53.345'  E 019°24.501' Stem Alternaria sp SZMC 27159 MT940786 
J. communis N 46°53.345'  E 019°24.501' Stem Alternaria sp SZMC 27160 MT940787 
J. communis N 46°53.345'  E 019°24.501' Stem Alternaria sp SZMC 27161 MT940788 
J. communis N 46°53.345'  E 019°24.501' Stem Alternaria sp SZMC 27162 MT940789 
J. communis N 46°53.338'  E 019°24.483' Stem Alternaria sp SZMC 27163 MT940790 
J. communis N 46°53.345'  E 019°24.501' Stem Aspergillus fumigatus SZMC 27164 MT993364 
J. communis N 46°53.345'  E 019°24.501' Stem Aspergillus sp SZMC 27165 MT993365 
J. communis N 46°53.338'  E 019°24.483' Stem Aspergillus sp SZMC 27166 MT993366 
J. communis N 46°53.345'  E 019°24.501' Stem Aspergillus sp SZMC 27167 MT993367 
J. communis N 46°53.345'  E 019°24.501' Stem Aspergillus sp SZMC 27168 MT993368 
J. communis N 46°53.330'  E 019°24.478' Stem Cladosporium sp SZMC 27169 MT993369 
J. communis N 46°53.330'  E 019°24.478' Stem Cladosporium sp SZMC 27170 MT993370 
J. communis N 46°53.330'  E 019°24.478' Stem Cladosporium sp SZMC 27171 MT993371 
J. communis N 46°53.338'  E 019°24.483' Stem Cladosporium sp SZMC 27172 MT993372 
J. communis N 46°53.330'  E 019°24.478' Root Cladosporium sp SZMC 27173 MT994503 
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Plant 
GPS coordinates 
if available 
Plant part Species 
Collection 
code 
Genbank 
ID 
J. communis N 46°53.330'  E 019°24.478' Stem Colletotrichum sp SZMC 27174 MT994504 
J. communis N 46°53.330'  E 019°24.478' Leaf Colletotrichum sp SZMC 27175 MT994505 
J. communis N 46°53.330'  E 019°24.478' Stem Colletotrichum sp SZMC 27176 MT994506 
J. communis N 46°53.342'  E 019°24.474' Stem Curvularia lunata SZMC 27177 MT994507 
J. communis N 46°53.330'  E 019°24.478' Stem Curvularia lunata SZMC 27178 MT994508 
J. communis N 46°53.330'  E 019°24.478' Stem Didymella glomerata SZMC 27179 MT994509 
J. communis N 46°53.338'  E 019°24.483' Stem Fusarium 
accuminatum 
SZMC 27180 MT994510 
J. communis N 46°53.342'  E 019°24.474' Stem Fusarium 
accuminatum 
SZMC 27181 MT994511 
J. communis N 46°53.340'  E 019°24.528' Stem Fusarium 
accuminatum 
SZMC 27182 MT994512 
J. communis N 46°53.338'  E 019°24.483' Leaf Fusarium 
accuminatum 
SZMC 27183 MT994513 
J. communis N 46°53.342'  E 019°24.474' Root Fusarium oxysporum SZMC 27184 MT982177 
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Plant 
GPS coordinates 
if available 
Plant part Species 
Collection 
code 
Genbank 
ID 
J. communis N 46°53.340'  E 019°24.528' Root Fusarium oxysporum SZMC 27185 MT982178 
J. communis N 46°53.338'  E 019°24.483' Root Fusarium oxysporum SZMC 27186 MT982179 
J. communis N 46°53.340'  E 019°24.528' Root Fusarium oxysporum SZMC 27187 MT982180 
J. communis N 46°53.340'  E 019°24.528' Root Fusarium sp SZMC 27188 MT982181 
J. communis N 46°53.340'  E 019°24.528' Root Fusarium sp SZMC 27189 MT982182 
J. communis N 46°53.338'  E 019°24.483' Root Fusarium sp SZMC 27190 MT982183 
J. communis N 46°53.340'  E 019°24.528' Root Fusarium sp SZMC 27191 MT982184 
J. communis N 46°53.340'  E 019°24.528' Root Fusarium sp SZMC 27192 MT982185 
J. communis N 46°53.340'  E 019°24.528' Root Fusarium sp SZMC 27193 MT982186 
J. communis N 46°53.342'  E 019°24.474' Root Fusarium sp SZMC 27194 MT982187 
J. communis N 46°53.340'  E 019°24.528' Root Fusarium sp SZMC 27195 MT982188 
J. communis N 46°53.340'  E 019°24.528' Root Fusarium sp SZMC 27196 MT982189 
J. communis N 46°53.338'  E 019°24.483' Root Penicillum sp SZMC 27197 MT982190 
J. communis N 46°53.340'  E 019°24.528' Leaf Penicillum sp SZMC 27198 MT982191 
J. communis N 46°53.342'  E 019°24.474' Leaf Penicillium citrinum SZMC 27199 MT982192 
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Plant 
GPS coordinates 
if available 
Plant part Species 
Collection 
code 
Genbank 
ID 
J. communis N 46°53.340'  E 019°24.528' Leaf Penicillium citrinum SZMC 27200 MT982193 
J. communis N 46°53.338'  E 019°24.483' Leaf Penicillium 
chrysogenum 
SZMC 27201 MT982194 
J. communis N 46°53.342'  E 019°24.474' Leaf Penicillum sp SZMC 27202 MT982195 
J. communis N 46°53.340'  E 019°24.528' Leaf Penicillum sp SZMC 27203 MT982196 
J. communis N 46°53.340'  E 019°24.528' Leaf Pestalotiopsis sp SZMC 27204 MT982197 
J. communis N 46°53.340'  E 019°24.528' Leaf Pestalotiopsis sp SZMC 27205 MT982198 
J. communis N 46°53.338'  E 019°24.483' Leaf Pestalotiopsis sp SZMC 27206 MT982199 
J. communis N 46°53.340'  E 019°24.528' Leaf Bipolaris sp SZMC 27207 MT982200 
J. communis N 46°53.340'  E 019°24.528' Leaf Bipolaris sp SZMC 27208 MT982201 
J. communis N 46°53.338'  E 019°24.483' Leaf Phomopsis sp SZMC 27209 MT982202 
J. communis N 46°53.340'  E 019°24.528' Leaf Trichoderma sp SZMC 27210 MT997192 
J. communis N 46°53.342'  E 019°24.474' Leaf Trichoderma sp SZMC 27211 MT997193 
J. communis N 46°53.342'  E 019°24.474' Cone Trichoderma sp SZMC 27212 MT997194 
J. communis N 46°53.342'  E 019°24.474' Cone Trichoderma sp SZMC 27213 MT997195 
J. communis N 46°53.342'  E 019°24.474' Cone Trichoderma sp SZMC 27214 MT997196 
J. communis N 46°53.342'  E 019°24.474' Cone Trichoderma sp SZMC 27215 MT997197 
J. communis N 46°53.338'  E 019°24.483' Cone Trichoderma sp SZMC 27216 MT997198 
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Plant 
GPS coordinates 
if available 
Plant part Species 
Collection 
code 
Genbank 
ID 
J. communis N 46°53.342'  E 019°24.474' Cone Trichoderma sp SZMC 27217 MT997199 
J. communis N 46°53.342'  E 019°24.474' Cone Trichoderma sp SZMC 27218 MT997200 
J. communis N 46°53.340'  E 019°24.528' Cone Trichoderma sp SZMC 27219 MT997201 
J. communis N 46°53.340'  E 019°24.528' Cone Xyaria digitata SZMC 27220 MT997202 
J. communis N 46°53.338'  E 019°24.483' Cone Xyaria digitata SZMC 27221 MT997203 
J. communis N 46°53.338'  E 019°24.483' Cone Xyaria sp SZMC 27222 MT997204 
J. communis N 46°53.338'  E 019°24.483' Stem Purpureocillium 
lilacinum 
SZMC 27031 MT997205 
J. communis N 46°53.340'  E 019°24.528' 
 
Alternaria sp SZMC 27223 MT872076 
Mosses 
  
Alternaria sp SZMC 27224 MT872077 
Mosses 
  
Alternaria sp SZMC 27225 MT994749 
Mosses 
  
Alternaria sp SZMC 27226 MT873032 
Mosses 
  
Alternaria sp SZMC 27227 MT873033 
Mosses 
  
Alternaria sp SZMC 27228 MT873034 
Mosses 
  
Alternaria sp SZMC 27229 MT873035 
Mosses 
  
Alternaria sp SZMC 27230 MT873036 
Mosses 
  
Alternaria sp SZMC 27231 MT873037 
Mosses 
  
Alternaria sp SZMC 27232 MT872025 
Mosses 
  
Alternaria sp SZMC 27233 MT873038 
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Plant 
GPS coordinates 
if available 
Plant part Species 
Collection 
code 
Genbank 
ID 
Mosses 
  
Aspergillus sp SZMC 27234   MT874055 
Mosses 
  
Aspergillus sydowii SZMC 27235   MT874056 
Mosses 
  
Phoma sp SZMC 27236 MT994750 
Mosses 
  
Cladosporium sp SZMC 27237 MT994751 
Mosses 
  
Dothiorella gregaria SZMC 27238   MT874057 
Mosses 
  
Dothiorella gregaria SZMC 27239   MT874058 
Mosses 
  
Fusarium sp SZMC 27240 MT994752 
Mosses 
  
Fusarium cerealis SZMC 27241   MT874059 
Mosses 
  
Fusarium cerealis SZMC 27242   MT874060 
Mosses 
  
Fusarium sp SZMC 27243 MT994753 
Mosses 
  
Fusarium oxysporum SZMC 27244 MT994754 
Mosses 
  
Fusarium sp SZMC 27245 MT994755 
Mosses 
  
Fusarium sp SZMC 27246 MT994756 
Mosses 
  
Glomerellaceae SZMC 27247 MT994757 
Mosses 
  
Phoma sp SZMC 27248 MT994758 
128 
 
Plant 
GPS coordinates 
if available 
Plant part Species 
Collection 
code 
Genbank 
ID 
Mosses 
  
Phoma sp SZMC 27249 MT994759 
Mosses 
  
Pleosporales sp SZMC 27250 MT997891 
Mosses 
  
Pleosporales sp SZMC 27251 MT997892 
Mosses 
  
Trichoderma 
atroviride 
SZMC 27252 MT997893 
Mosses 
  
Trichoderma 
atroviride 
SZMC 27253 MT997894 
Mosses 
  
Trichoderma 
citrinoviride 
SZMC 27254 MT997895 
Mosses 
  
Trichoderma 
longibrachiatum 
SZMC 27255 MT997896 
Mosses 
  
Trichoderma sp SZMC 27256 MT997897 
Mosses 
  
Trichoderma sp SZMC 27257 MT997898 
Mosses 
  
Trichoderma sp SZMC 27258 MT997899 
Mosses 
  
Trichoderma sp SZMC 27259 MT997900 
Mosses 
  
Trichoderma viride SZMC 27260 MT997901 
Mosses 
  
Trichoderma 
atroviride 
SZMC 27261 MT997902 
Mosses 
  
Trichoderma sp SZMC 27262 MT997903 
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Table S 2. Antimicrobial effects of EFs’ metabolites of J. communis extracted with chloroform 
from ferment broth. 
Collection 
code 
Inhibition rates (%) 
B. subtilis S. aureus E. coli 
P. 
aeruginosa 
C. albicans C. krusei 
SZMC 27149 
SZMC 27150 
SZMC 27151 
SZMC 27152 
SZMC 27153 
SZMC 27154 
SZMC 27155 
SZMC 27156 
SZMC 27157 
SZMC 27158 
SZMC 27159 
SZMC 27160 
SZMC 27161 
SZMC 27162 
SZMC 27163 
SZMC 27164 
 95.41±13.2 
15.67±1.6 
99.7±11.2 
76.76±15.6 
65.47±3.9 
66.51±3.4 
79.71±15.1 
77.94±5.1 
51.57±16.2 
67.46±5.3 
77.67±15.9 
46.67±7.1 
6.77±3.6 
79.06±12.1 
97.7±11.7 
96.15±12.2 
16.53±16.2 
49.15±12.4 
49.1±16.1 
86.52±11.4 
76.51±13.1 
81.79±11.7 
99.19±10.2 
91.61±15.6 
86.33±10.7 
42.38±16.3 
77±1.5 
78.67±9.4 
81.67±6.9 
49.72±10.6 
32.01±9.6 
94.04±13.2 
43.45±12.9 
42.64±14.5 
33.93±6.8 
1.12±3.1 
45.36±11 
32.02±3.3 
6.38±14.3 
45.15±5 
25.09±5.5 
43.02±15.2 
31.44±13.7 
45.01±11.2 
24.13±16.4 
8.24±16.2 
9.15±11.7 
90.43±4.6 
25.85±10.5 
11.62±1.6 
30.88±4.4 
47.29±7.5 
15.6±3.3 
44.79±9.6 
21.46±6.1 
10.4±2.5 
21.78±11.4 
32.5±12.7 
20.2±2.2 
5.94±2.1 
36.02±6.7 
8.48±3.3 
29.38±9.1 
90.02±1.2 
24.73±5 
37.98±2.9 
41.31±13.5 
45.2±8.3 
18.39±2.4 
20.67±14.7 
25.37±2.3 
39.59±5.5 
15.99±9.3 
46.66±1.5 
15.56±16.2 
45.9±12.5 
22.81±5.2 
47.54±14.5 
18.46±11.5 
86.53±6.7 
6.3±3.1 
8.95±14.3 
6.59±11.4 
14.97±12.4 
46.96±4.7 
19.13±1.5 
12.63±4.2 
38.7±6.3 
1.39±8.5 
24.39±14.6 
18.84±14.8 
10.61±8 
0.91±6.2 
23.01±11.2 
58.96±14.8 
94.38±15.3 
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Collection 
code 
Inhibition rates (%) 
B. subtilis S. aureus E. coli 
P. 
aeruginosa 
C. albicans C. krusei 
SZMC 27165 
SZMC 27166 
SZMC 27167 
SZMC 27168 
SZMC 27169 
SZMC 27170 
SZMC 27171 
SZMC 27172 
SZMC 27173 
SZMC 27174 
SZMC 27175 
SZMC 27176 
SZMC 27177 
SZMC 27178 
SZMC 27179 
SZMC 27180 
SZMC 27181 
SZMC 27182 
SZMC 27183 
11.91±10.2 
97.7±6.5 
76.4±2.5 
69.76±12 
56.71±3.3 
71.69±2.3 
70.46±3.9 
44.74±8.8 
61.6±11.6 
71.55±3.3 
79.91±7.7 
70.77±4.7 
96.49±14.7 
40.54±6.8 
77.54±13.1 
70.76±11.9 
97.44±10.8 
7.64±14.9 
7.46±11.9 
70.76±2.8 
77.33±7 
85.8±2.6 
13.36±7.1 
62.23±1.1 
49.28±12.4 
85.39±12.6 
77±7.9 
29.21±9.3 
43.38±1.4 
18.16±8.7 
29.09±6.9 
68.21±12 
41.67±5.1 
70.46±5.3 
55.89±8.9 
5.71±6.6 
14.09±14.4 
77.8±7.9 
36.64±1.9 
23.36±11.7 
24.92±10.8 
50.44±14.5 
80.11±6.7 
28.51±15.9 
30.82±3.8 
68.23±10 
35.41±14.4 
60.93±14.4 
41.66±9 
44.64±5.5 
34.43±2.8 
14.44±6.5 
89.3±7.5 
42.53±2.3 
95.59±12.4 
69.14±7.5 
34±5.5 
64.36±8.4 
47.25±15.9 
28.11±15.6 
78.93±8.5 
16.23±2.7 
13.16±13.3 
17.08±7.8 
14.31±5.3 
54.29±9.9 
32.02±3.7 
13.48±4.6 
98.97±15.2 
60.16±1.9 
55.36±10.4 
71.99±7.5 
66.69±8.5 
36.96±13.9 
76.43±5.3 
19.07±8 
94.26±10 
28.39±15.7 
81.22±2.6 
30.2±11.7 
50.93±15.4 
81.96±13 
50.54±6.3 
43.43±11.7 
69.91±10.7 
14.35±2.9 
84.94±2.8 
97.05±10.6 
83.51±13.5 
95.67±15.7 
21.58±11.8 
12.03±13.6 
62.61±5 
71.06±9.1 
16.43±8.4 
52.85±1.1 
28.85±1.4 
82.69±7.4 
97.9±11.3 
26.7±6.6 
14.82±8.3 
74.29±7 
52.24±7.6 
41.32±6.9 
33.81±15 
26.64±2.4 
34.38±3.3 
43.75±5.2 
23.42±11.6 
0.87±5.6 
24.8±13.2 
53.79±9.1 
51.22±11.2 
44.53±8.4 
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Collection 
code 
Inhibition rates (%) 
B. subtilis S. aureus E. coli 
P. 
aeruginosa 
C. albicans C. krusei 
SZMC 27184 
SZMC 27185 
SZMC 27186 
SZMC 27187 
SZMC 27188 
SZMC 27189 
SZMC 27190 
SZMC 27191 
SZMC 27192 
SZMC 27193 
SZMC 27194 
SZMC 27195 
SZMC 27196 
SZMC 27197 
SZMC 27198 
SZMC 27199 
SZMC 27200 
SZMC 27201 
SZMC 27202 
29.57±14.7 
91.6±3.4 
79.77±3.8 
79.97±15.9 
66.76±4.7 
77.79±12 
77.96±8.5 
96.49±15.9 
77.16±9.9 
7.91±11.5 
76.05±16 
65.67±4 
79.17±14.9 
71.17±14.6 
79.66±6.9 
5.4±13.9 
59.57±8.6 
47.55±6.4 
74.19±13.4 
4.92±13.2 
79.51±8.7 
53.77±6.3 
8.98±9.3 
30.93±4.7 
93.43±16 
7.97±3.8 
6.16±9 
11.18±5.2 
80.23±2.4 
22.37±8.5 
53.45±4.2 
27.52±15.5 
32.35±8.5 
32.98±6.3 
46.54±6 
90.11±9 
8.57±12.9 
61.28±2.5 
44.65±12.3 
13.66±14.3 
21.95±13.7 
62.43±3.6 
16.43±9.4 
42.54±12.9 
4.84±11.7 
54.19±6 
43.43±13.8 
43.12±7.7 
66.89±3.1 
61.45±4 
19.88±15.7 
1.35±14.3 
65.18±4.6 
22.83±10.3 
64.81±12.5 
18.68±13.2 
42.69±2.2 
28.45±9.8 
19.87±10.9 
78.08±11.2 
86.34±15.2 
60.41±8.1 
66.26±12.7 
82.22±8.2 
3±3.4 
26.11±13.1 
12.84±14.7 
74.31±7.4 
32.27±3.3 
84.81±1.1 
64.61±14.3 
45.61±6.5 
72.02±14.8 
70.74±3.6 
43.25±6.8 
17.93±6.9 
0.29±2.2 
54.24±6.3 
86.87±11.5 
79.54±5 
46.08±2.4 
44.87±10.8 
82.35±12.4 
80.2±7.9 
3.33±7.8 
37.27±12.1 
33.22±13.8 
66.14±8.4 
39.44±10.2 
12.93±4 
11.49±13.8 
50.66±6.6 
37.03±11.8 
29.39±9 
71.37±2.8 
26.86±2.2 
6.06±10.6 
94.41±13.8 
53.95±7 
61.1±11.7 
76.73±11.6 
35.24±15.2 
16.53±6.3 
25.88±5.1 
64.21±2.7 
92.59±6.4 
53.54±12.4 
16.08±3.1 
38.59±2.6 
31.82±3 
39.63±13.5 
33.34±2.6 
3.66±7.1 
23.87±5.8 
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Collection 
code 
Inhibition rates (%) 
B. subtilis S. aureus E. coli 
P. 
aeruginosa 
C. albicans C. krusei 
SZMC 27203 
SZMC 27204 
SZMC 27205 
SZMC 27206 
SZMC 27207 
SZMC 27208 
SZMC 27209 
SZMC 27210 
SZMC 27211 
SZMC 27212 
SZMC 27213 
SZMC 27214 
SZMC 27215 
SZMC 27216 
SZMC 27217 
SZMC 27218 
SZMC 27219 
SZMC 27220 
SZMC 27221 
6.06±3.9 
6.79±5.8 
96.71±9.5 
56.75±13.9 
57.65±13.5 
49.16±8.3 
44.17±15.2 
36.46±15.7 
56.47±13.7 
65.77±10.5 
67.67±3.5 
70.66±12.8 
6.61±15.1 
27.66±1.6 
66.66±11.9 
76.6±14 
94.65±12.1 
6.46±15.8 
37.75±8.3 
65.15±15.9 
83.72±11.5 
92.12±9.9 
72.13±14.4 
8.28±12.1 
3.61±13.6 
78.14±15.2 
49.21±7.5 
13.33±14.6 
55.78±15.3 
2.41±7.3 
92.07±2.3 
31.95±1.2 
80.21±7.4 
45.03±11.7 
45.65±2.3 
32.87±7 
2.42±5.1 
92.68±11.9 
93.84±6.3 
43.49±9.1 
85.36±4.4 
66.28±16.2 
86.49±9.8 
54.25±6.1 
55±1.5 
13.29±14.9 
24.14±2.5 
9.21±16.2 
63.24±12.5 
61.88±16.4 
40.84±9.8 
44.1±2.7 
2.41±9.6 
49.4±3.9 
96.22±12.1 
58.34±3.4 
46.49±4.1 
3.18±5.2 
46.69±12.2 
92.76±11 
44.43±3 
12.24±5.5 
21.03±3 
26.05±10.1 
59.15±10 
28.28±6 
33.65±8.3 
57.19±4.6 
75.91±15.1 
1.24±9.1 
36.31±14.8 
10.45±9.2 
79.41±8.4 
43.84±13 
62.5±7.5 
68.72±8.1 
29.9±9.6 
9.51±7.2 
96.05±1.2 
61.67±13.8 
35.66±6.8 
23.95±3 
53.59±14.6 
34.76±11.2 
44.95±2.1 
39.51±12.6 
70.24±12 
41.75±3.5 
74.01±14.3 
33.21±2.6 
24.5±10.7 
59.05±6.3 
30.31±11.5 
14.5±15.3 
12.06±6.9 
28.84±14.6 
0.48±9.4 
87.78±11.4 
37.24±12.5 
43.14±8.8 
34.6±11.6 
46.44±14.5 
43.06±9.3 
45.5±4.3 
28.95±13.1 
16.84±2.1 
11.63±6.4 
39.12±4.7 
95.74±14.2 
17.75±7 
29.99±1.2 
36.52±12.4 
43.9±10.8 
4.91±6.8 
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Collection 
code 
Inhibition rates (%) 
B. subtilis S. aureus E. coli 
P. 
aeruginosa 
C. albicans C. krusei 
SZMC 27222 
SZMC 27031 
47.76±12.4 
97.16±1.8 
47.41±5.2 
89.41±9.4 
11.34±15.5 
8.9±1.1 
7.91±11.4 
26.27±4.4 
20.88±7 
53.98±14.3 
37.2±1.5 
12.5±8.2 
 
Table S 3. Antimicrobial effects of EFs’ metabolites of J. communis extracted with ethyl acetate 
from ferment broth. 
Collection 
code 
Inhibition rates (%) 
B. subtilis S. aureus E. coli P. aeruginosa C. albicans C. krusei 
SZMC 27149 
SZMC 27150 
SZMC 27151 
SZMC 27152 
SZMC 27153 
SZMC 27154 
SZMC 27155 
SZMC 27156 
SZMC 27157 
SZMC 27158 
SZMC 27159 
SZMC 27160 
5.6±3.5 
6.59±13.7 
52.7±4.4 
5.21±11 
60.88±8 
56.78±11.9 
68.06±11.4 
77.19±15.4 
2.12±2.3 
72.69±11.3 
75.6±9.7 
18.22±5.9 
77.44±9 
59.56±5.8 
58.19±10 
18.35±10.1 
76.18±3.3 
1.22±12 
95.11±13.3 
87.04±1.3 
7.2±9.4 
37.24±5.3 
37.79±13.3 
78.43±5 
54.35±10.3 
30.54±7.9 
44.44±14.3 
30.36±7.1 
52.4±6 
11.13±2.3 
85.41±10 
54.25±4.5 
0.52±1.3 
15.05±1.1 
15.55±12.7 
55.44±8.8 
54.88±11.3 
46.26±1.4 
42.66±2.9 
24.24±14.4 
46.92±1.7 
96.24±12.1 
1.46±4.5 
12.22±12.9 
6.15±12.5 
51.86±11.8 
15.65±3.2 
24.4±8.4 
25.85±12.8 
51.62±16.3 
30.88±8.7 
47.29±15.9 
15.6±11.6 
44.79±3 
71.46±5.7 
10.4±13.1 
21.78±11.3 
32.5±12.9 
60.2±13.5 
5.94±14.1 
14.5±5.6 
19.44±11.1 
54.35±12.7 
67.3±16 
75.02±15.5 
15.89±2.2 
75.4±11.2 
39.16±10.2 
63.82±12.8 
30.78±1.2 
54.73±12.3 
56.92±9.4 
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Collection 
code 
Inhibition rates (%) 
B. subtilis S. aureus E. coli P. aeruginosa C. albicans C. krusei 
SZMC 27161 
SZMC 27162 
SZMC 27163 
SZMC 27164 
SZMC 27165 
SZMC 27166 
SZMC 27167 
SZMC 27168 
SZMC 27169 
SZMC 27170 
SZMC 27171 
SZMC 27172 
SZMC 27173 
SZMC 27174 
SZMC 27175 
SZMC 27176 
SZMC 27177 
SZMC 27178 
SZMC 27179 
62.68±12.8 
69.05±5.4 
59.16±12.3 
27.86±10.8 
62.5±12.2 
17.62±6.5 
67.79±13.3 
66.57±12.8 
61.2±12.7 
78.89±8.2 
17.26±15.7 
67.28±13.8 
81.69±13.2 
92.89±16.4 
91.15±3.2 
57.66±1.1 
80.79±8.4 
27.86±1.7 
97.15±15 
23.08±11.5 
67.79±11.3 
64.27±4.9 
39.52±8.8 
8.8±10.8 
56.51±15.2 
45.2±12.7 
82.4±13.7 
82.02±4.5 
85.48±7.8 
10.01±9.8 
77.26±3.8 
98.86±13.9 
24.27±3.5 
89.08±3.4 
32.88±3.2 
91.82±10.1 
0.03±3.2 
54.1±16.3 
5.34±13.9 
41.65±13.6 
0.65±9.8 
50.85±14.6 
51.02±1.7 
41.46±15.2 
51.06±4.7 
45.46±2.1 
5.04±15.9 
44.44±1.3 
15.22±3 
55.53±12.4 
44.84±2.5 
45.31±1.6 
45.33±11.7 
48.59±11.3 
24.4±8.7 
34.44±3.5 
42.31±15.4 
84.84±1.2 
30.45±7 
83.03±16.4 
22.69±5.1 
49.32±4.5 
55.49±10.3 
6.01±12.7 
34.06±3.8 
1.93±12.6 
35.15±8.9 
11.34±9.8 
33.91±2.9 
83.42±13.9 
44.31±5.3 
69.83±5.3 
98.59±4.7 
45.6±2.5 
0.16±7.6 
81.55±13.9 
86.02±15.8 
8.48±8.1 
29.38±10.4 
40.02±5.1 
64.36±12.2 
47.25±7.3 
28.11±7.6 
78.93±5.4 
16.23±4.1 
13.16±8.1 
87.08±15.1 
54.31±3.5 
54.29±5.8 
32.02±3.5 
13.48±2.4 
98.97±14.4 
60.16±8 
55.36±14.9 
71.99±8.8 
12.96±7.1 
47.99±9.4 
70.86±5.6 
52.89±4.8 
41.31±9 
78.84±3.4 
46.49±10.1 
52.49±2.9 
59.62±9 
75.26±3.2 
58.49±3.1 
93.94±7.5 
52.93±5.2 
32.14±3.7 
21.94±7.6 
15.72±9.1 
40.2±16.3 
17.56±4.9 
20.62±12 
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Collection 
code 
Inhibition rates (%) 
B. subtilis S. aureus E. coli P. aeruginosa C. albicans C. krusei 
SZMC 27180 
SZMC 27181 
SZMC 27182 
SZMC 27183 
SZMC 27184 
SZMC 27185 
SZMC 27186 
SZMC 27187 
SZMC 27188 
SZMC 27189 
SZMC 27190 
SZMC 27191 
SZMC 27192 
SZMC 27193 
SZMC 27194 
SZMC 27195 
SZMC 27196 
SZMC 27197 
SZMC 27198 
57.91±13 
61.96±10 
27.08±1.1 
96.27±4.3 
6.51±8 
97.01±3.4 
1.72±8 
96.77±6.6 
97.96±3.4 
71.86±3.8 
10.17±4.1 
20.58±2.6 
67.69±2.1 
70.62±13 
72.8±6.6 
56.92±7.5 
51.57±7.1 
1.71±5.4 
67.16±8.9 
12.41±5.8 
66.7±16.3 
53.66±12.8 
25.84±5.2 
72.17±9.9 
94.29±6.6 
39.09±7.6 
95.23±1.9 
97.01±1.1 
65.41±12.4 
0.6±13.6 
90.09±8.2 
65.15±13.4 
28.51±16.3 
62.9±8.7 
95.07±4.6 
6.96±11.7 
3.47±11.1 
0.38±15.9 
94.29±5.9 
94.44±7.9 
14±5.8 
43.42±15.7 
41.24±9.8 
94.05±2.1 
55.45±9.9 
94.42±1.6 
90±14.2 
8.91±12.7 
40.44±5.1 
44.44±15 
34.41±13.8 
25.24±10.8 
50±5.2 
84.48±1.2 
0.82±8.6 
34.21±4.3 
35.3±9.5 
24.09±5.7 
31.64±6 
52.19±9.5 
24.41±5.9 
46.31±5.5 
98.48±1.8 
93.85±4.4 
91.44±6 
96.91±5.6 
24±11.4 
50.42±15.2 
44.19±5.3 
45.32±8.7 
46.24±6.9 
42.41±9.2 
91.46±6.3 
4.42±11 
6.19±11.3 
4.44±5.8 
66.69±3.9 
36.96±9.6 
76.43±12 
19.07±6.8 
28.45±9.7 
91.87±14.6 
78.08±4.6 
86.34±8.5 
90.41±10.5 
96.26±3.7 
82.22±15.7 
3±7.1 
26.11±1.7 
12.84±6.2 
74.31±1.1 
32.27±4.2 
84.81±3.8 
64.61±4.4 
45.61±10 
0.27±11.9 
70.81±7.3 
0.15±14.9 
14.36±9 
45.12±10.9 
91.41±5.5 
52.73±10.5 
80.9±5.2 
96.49±14.8 
73.5±14.2 
3.8±11.3 
43.43±13.6 
48.6±15.4 
37.01±8.5 
20.39±12.1 
30.31±14 
74.62±10.7 
42.92±6.6 
39.01±7.4 
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Collection 
code 
Inhibition rates (%) 
B. subtilis S. aureus E. coli P. aeruginosa C. albicans C. krusei 
SZMC 27199 
SZMC 27200 
SZMC 27201 
SZMC 27202 
SZMC 27203 
SZMC 27204 
SZMC 27205 
SZMC 27206 
SZMC 27207 
SZMC 27208 
SZMC 27209 
SZMC 27210 
SZMC 27211 
SZMC 27212 
SZMC 27213 
SZMC 27214 
SZMC 27215 
SZMC 27216 
SZMC 27217 
67.79±5 
75.26±14.8 
96.25±11.7 
91.78±7.2 
81.96±8.1 
77.06±4.4 
87.51±13.2 
77.02±11.8 
76.08±12.3 
52.12±5.1 
10.78±12.7 
62.56±13.9 
61.1±8.7 
55.21±10.1 
16.71±7.2 
60.7±14.3 
60.69±10.8 
7.16±15.6 
69.7±16.2 
93.25±9.7 
20.37±1.7 
97.62±3.9 
79.05±3.9 
62.06±13.7 
65.26±7.4 
97.29±12.7 
43.35±12.8 
17.35±4.4 
26.61±5.1 
82.49±3 
13.48±1.7 
63.74±3.3 
55.6±7.2 
86.62±16.3 
57.83±14.8 
2.7±14.7 
35.03±7.7 
7.56±12.2 
19.09±7.9 
48.34±1.2 
8.48±2 
44.59±7.1 
10±2.2 
44.33±2.9 
81.29±13.7 
44.14±3.3 
14.81±10.8 
25.22±7.5 
44.43±11.8 
58.8±3 
50.42±6.4 
51.03±12.3 
38.51±13.2 
32.44±2.4 
35.42±7.7 
30.41±4.3 
30.4±10.5 
9.36±1.5 
63.93±10.2 
69.44±1.3 
56.02±6.2 
15.4±9.9 
34.58±11.1 
61.61±8.6 
12.55±1.6 
14.04±12.6 
33.54±1.4 
66.91±2.7 
24.93±11.3 
36.23±16.1 
33.48±1.6 
98.32±15.3 
16.4±6.3 
5.4±14.2 
98.61±15.2 
48.24±11.5 
72.02±16.3 
90.74±13.5 
43.25±10.5 
17.93±11.3 
3.18±7 
46.69±1.4 
12.76±6.9 
44.43±4.3 
12.24±6.1 
21.03±14.7 
66.05±2.1 
59.15±15.6 
28.28±10.3 
33.65±11.2 
57.19±4.2 
75.91±14.5 
1.24±9.7 
56.31±12.1 
60.45±8.3 
64.25±3.8 
11.13±11.1 
1.43±7.2 
42.92±10.8 
55.31±6.7 
37.56±15.3 
11.89±5.4 
55.01±6.7 
30.21±6.8 
6.53±14.5 
29.07±13.1 
38.08±15.4 
46.85±6.8 
23.6±15 
30.97±14.1 
28.02±13.5 
34.57±14.9 
42.21±2.5 
0.26±2.1 
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Collection 
code 
Inhibition rates (%) 
B. subtilis S. aureus E. coli P. aeruginosa C. albicans C. krusei 
SZMC 27218 
SZMC 27219 
SZMC 27220 
SZMC 27221 
SZMC 27222 
SZMC 27031 
7.52±5.2 
70.9±8.6 
1.75±4.5 
50.75±10.6 
57.59±6.1 
93.62±2.1 
41.52±2 
50.77±9.5 
37.85±4.7 
8.49±12.8 
1.18±12 
92.19±2.8 
33.49±15.3 
42.24±11.9 
19.23±10.1 
54.24±8.3 
53.28±8.9 
92.18.98±8.
3 
13.14±3.8 
88.04±6.3 
56.21±5.3 
10.23±5 
45.46±9.7 
93.95±12.2 
79.41±5.6 
43.84±3.2 
62.5±2.5 
98.72±11.6 
7.91±3.5 
96.27±11.7 
53.81±11.3 
47.53±4.3 
41.73±8.6 
70.38±9.3 
53.4±10.1 
97.42±14.7 
 
 
Table S 4. Antimicrobial effects of EFs’ metabolites of J. communis extracted with hexane from 
ferment broth. 
Collection code 
Inhibition rates (%) 
B. subtilis S. aureus E. coli 
P. 
aeruginosa 
C. 
albicans 
C. krusei 
SZMC 27149 
SZMC 27150 
SZMC 27151 
SZMC 27152 
SZMC 27153 
SZMC 27154 
50.71±7.2 
19.43±15.4 
5.49±10.8 
70.24±6.9 
1.37±4.8 
41.96±5.7 
4.15±1.5 
15.79±8.5 
31.93±10 
55.23±2.5 
5.2±7.8 
29.53±12.2 
12.12±7.3 
58.03±1.5 
56.63±13.6 
46±10.8 
34.84±15.7 
62.9±6.6 
96.26±3.6 
26.2±12.6 
45.43±12.4 
11.55±4.9 
88.32±14.8 
51.69±12.5 
14.62±13.5 
71.74±11.8 
77.47±1.9 
4.48±16.3 
90.13±16 
38.12±4.8 
22.51±11.6 
18.41±6.5 
24.03±13.7 
36.95±7.6 
9.11±12.1 
37.54±3.3 
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Collection code 
Inhibition rates (%) 
B. subtilis S. aureus E. coli 
P. 
aeruginosa 
C. 
albicans 
C. krusei 
SZMC 27155 
SZMC 27156 
SZMC 27157 
SZMC 27158 
SZMC 27159 
SZMC 27160 
SZMC 27161 
SZMC 27162 
SZMC 27163 
SZMC 27164 
SZMC 27165 
SZMC 27166 
SZMC 27167 
SZMC 27168 
SZMC 27169 
SZMC 27170 
SZMC 27171 
SZMC 27172 
SZMC 27173 
0±9.7 
5.67±12.1 
31.95±4 
52.39±1.3 
47.25±3.8 
7.64±5.2 
45.91±14.1 
20.65±2.1 
48.61±10.4 
75.09±15.6 
13.93±3.4 
76.08±14.4 
95.5±11.4 
27.29±13.8 
21.47±5.7 
20.15±9.5 
53.78±11.1 
47.25±1.5 
32.65±6.1 
43.12±10.9 
51.94±11.7 
33.93±7.9 
43.21±12.8 
11.35±6.5 
42.45±4.4 
53.3±15.3 
42.17±9.8 
37.39±9.6 
3.35±12.7 
49.9±16.2 
7.11±16.3 
35.21±5 
54.54±15.7 
44.49±3.2 
54.45±10.3 
25.45±16.3 
53.29±11.9 
32.08±3.1 
26.44±3.5 
28.95±2.7 
24.63±7.2 
18.32±1.2 
24.45±9 
8.08±2.9 
62.03±8.4 
44.13±16.2 
52.91±6.7 
20.4±8.1 
40.31±15.9 
84.44±2.7 
33.84±1.7 
50.95±6.5 
35.4±8.9 
1.18±3 
26.14±11.8 
46.92±5 
21.94±5.9 
26.52±5.1 
22.45±2.9 
21.95±13.3 
22.58±6 
22.53±8.3 
23.15±15.8 
92.24±1.5 
64.86±2.2 
8.62±13.5 
25.19±1.5 
22.61±15.6 
20.94±11 
32.51±12.3 
65.24±3 
18.23±14.8 
46.55±1.4 
31.29±3.3 
29.6±6.2 
45.69±11.2 
16.68±1.2 
46.67±10.7 
37.09±13.9 
44.94±13.7 
77.59±1.8 
71.54±6.6 
17.66±6.4 
39.23±9.1 
21.65±12.7 
83.28±9.3 
31.06±5.2 
49.99±1.5 
2.06±6.1 
44.24±13.6 
12.39±10.9 
17.92±7.1 
36.84±12 
6.23±4.9 
25.76±7 
43.11±14.1 
38.85±4.5 
51.49±13.5 
49.86±2.4 
52.27±5.1 
32.73±11.8 
34.59±4.2 
98.34±13.1 
22.64±2.3 
37.75±15.8 
37.27±2 
20.17±5.2 
38.47±4.3 
44.15±11.8 
21.24±2.3 
8.83±8.6 
46.98±3.2 
34.99±11.4 
44.51±15.2 
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Collection code 
Inhibition rates (%) 
B. subtilis S. aureus E. coli 
P. 
aeruginosa 
C. 
albicans 
C. krusei 
SZMC 27174 
SZMC 27175 
SZMC 27176 
SZMC 27177 
SZMC 27178 
SZMC 27179 
SZMC 27180 
SZMC 27181 
SZMC 27182 
SZMC 27183 
SZMC 27184 
SZMC 27185 
SZMC 27186 
SZMC 27187 
SZMC 27188 
SZMC 27189 
SZMC 27190 
SZMC 27191 
SZMC 27192 
30.47±1.1 
43.25±6 
41.11±6.1 
12.96±13.7 
47.24±9.3 
48.62±7.7 
62.68±9.1 
36.86±13.3 
53.45±3.4 
35.98±5.1 
39.31±5.4 
42.01±1.8 
53.13±15.4 
60.37±1.2 
30.93±7.3 
27.05±7.5 
4.79±3.6 
0.24±10.7 
53.32±12.3 
51.55±10.5 
13.2±14.5 
27.75±1.1 
57.35±15.4 
57.9±5.9 
15.11±5.3 
5.73±10.5 
49.5±9.2 
72.71±16.1 
0.03±6.7 
47.39±2.7 
52.49±14.9 
71.25±13.9 
74.54±1.6 
47.2±4.6 
77.57±3.3 
47.51±5.8 
44.1±10.7 
54.9±14.1 
42.96±13.6 
42.45±3.4 
32.41±9.8 
42.32±12.3 
85.84±12 
51.61±2 
42.44±5.9 
23.43±13.5 
40.4±4.8 
0.95±11.4 
31.51±12.9 
36.42±16 
65.4±6.5 
12.14±13 
23.04±2.7 
30.98±3.6 
54.94±15 
50.48±11.8 
34.02±15.8 
4.85±13 
65.06±10 
48.86±4.3 
8±8.7 
36.11±13 
58.04±8.4 
61.25±9.6 
23.32±10.5 
30.3±11.5 
26.89±9.6 
42.5±7.6 
46.24±2.8 
64.26±10.9 
33.05±8.3 
44.45±7.2 
22.46±3.9 
21.4±2.7 
43.29±12.4 
38.92±1.4 
64.94±15.5 
17.25±9 
29.18±15.6 
33.68±12.4 
26.6±6.6 
48.8±15.8 
28.55±2.7 
64.67±15.4 
98±7.8 
97.88±2.1 
9.06±5 
32.36±10 
66.44±16.2 
93.73±2.2 
55.36±4.9 
22.07±12.3 
15.61±5 
45.2±4.6 
44.04±3.1 
38.87±8 
20.12±9.3 
22.41±5.3 
40.09±9.5 
48.59±3.9 
55.89±15.5 
39.36±10.5 
51.6±8.9 
30.06±7.1 
19.6±7.2 
4.87±10.7 
59.18±15.7 
0.98±10.2 
35.77±1.7 
42.93±8.6 
76.74±14.3 
44.25±13.7 
9.7±9.8 
45.15±12 
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Collection code 
Inhibition rates (%) 
B. subtilis S. aureus E. coli 
P. 
aeruginosa 
C. 
albicans 
C. krusei 
SZMC 27193 
SZMC 27194 
SZMC 27195 
SZMC 27196 
SZMC 27197 
SZMC 27198 
SZMC 27199 
SZMC 27200 
SZMC 27201 
SZMC 27202 
SZMC 27203 
SZMC 27204 
SZMC 27205 
SZMC 27206 
SZMC 27207 
SZMC 27208 
SZMC 27209 
SZMC 27210 
SZMC 27211 
17.91±15.3 
27.3±7.5 
25.6±14.6 
13.42±10.6 
32.29±10.1 
46.14±5 
59.91±11.1 
8.32±3.2 
43.31±4.2 
3.64±2.2 
11.63±8.4 
15.93±15.9 
32.52±15.9 
31.27±15.1 
46.78±8.2 
16±10 
59.75±10.4 
39.36±9.2 
28.48±6.6 
73.17±13.4 
45.33±3.4 
53.03±15 
74.01±10.2 
45.17±3.3 
15.91±13.1 
0.4±7 
13.32±4.9 
52.11±7.8 
49.44±15.8 
53.59±10.3 
14.53±7.3 
9.04±3.1 
45.44±9.6 
34.41±4.5 
13.97±6.1 
50.71±8.8 
22.94±2.3 
51.52±2.1 
36±6.1 
34.63±14.2 
12.94±8.5 
62.42±13.7 
62.05±11.3 
50.1±7.7 
26.42±3.2 
31.02±7.5 
24.44±2.8 
53.43±9.6 
36.46±5.5 
4.04±14.1 
58.08±11.8 
24.9±13 
84.88±4.1 
32.18±13.1 
33.46±11.1 
42.8±3.2 
16.62±14.7 
35.46±14.6 
56.26±7 
13.6±7.5 
6.35±6.6 
31.02±12.7 
10.88±10 
0.53±8.1 
59.43±3.8 
42.2±5 
13.4±9.4 
22.63±6.1 
85.32±10.6 
29.16±9 
25.24±3.1 
86.26±13 
63.89±12.6 
29.1±13.6 
56.3±14.7 
59.83±6 
17.48±6.1 
7.46±11.3 
31.42±5.7 
51.52±14.1 
36.57±6.9 
43.2±10.8 
16.68±15.8 
41.66±8.3 
21.17±6.5 
61.31±6.2 
66.78±9.1 
28.79±5.1 
9.25±6.1 
46.76±6.8 
41.15±4.7 
4.26±12.6 
25.9±11.2 
40.1±13.5 
44.24±10.1 
28.37±9.8 
50.52±11 
78.47±1.3 
26.64±2.1 
32.44±10.7 
1.03±15.2 
47.58±5.4 
56±4.6 
44.87±11.2 
36.81±13.8 
73.73±8.9 
9.6±5.5 
14.58±15.2 
5.13±1.3 
33.38±1.1 
3.06±15.8 
14.9±4.7 
5.25±12.9 
57.29±4 
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Collection code 
Inhibition rates (%) 
B. subtilis S. aureus E. coli 
P. 
aeruginosa 
C. 
albicans 
C. krusei 
SZMC 27212 
SZMC 27213 
SZMC 27214 
SZMC 27215 
SZMC 27216 
SZMC 27217 
SZMC 27218 
SZMC 27219 
SZMC 27220 
SZMC 27221 
SZMC 27222 
SZMC 27031 
16.66±8.2 
95.88±10.8 
40.53±2.4 
45.48±6.1 
14±7.2 
9.56±8.6 
34.3±15.7 
67.69±11 
49.34±8.8 
61.97±11.9 
41.42±14.9 
91.84±6 
59.34±11.3 
32.54±5.3 
25.5±14 
35.79±14.4 
14.15±14.9 
52.24±4.6 
14.95±7.9 
40.05±7.5 
31.77±9.3 
25.95±14.4 
25.91±10.6 
84.01±4.1 
26.04±8.3 
48.93±14.6 
44.9±6.8 
38.05±5.7 
41.92±2.5 
12.46±12.5 
18.45±12.9 
48.12±4.9 
46.05±6.3 
42.64±4.2 
34.48±12 
6.44±7 
23.6±6.2 
23.61±9.8 
26.62±9.2 
19.12±7.6 
39.4±16.4 
39.29±15.4 
32.23±8.9 
64.1±9.1 
11.14±1.8 
23.44±8 
9.13±16.3 
16.61±6.7 
46.22±10 
2.8±11 
14.86±7.2 
39.91±2.9 
6.28±3 
38.47±2.2 
26.6±1.2 
18.32±14.8 
4.18±12.8 
6.39±4.4 
17.99±14.5 
7.85±13.5 
44.51±11.2 
57.85±14.9 
86.6±5.6 
53.07±11.7 
45.74±12.2 
4.89±3.3 
45.28±15.1 
17.46±8.4 
44.45±11.6 
58.86±9.1 
45.06±7.1 
32.64±8.7 
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Table S 5. Antimicrobial effects of EFs’ metabolites of J. communis extracted with 
chloroform/methanol from mycelia. 
Collection 
code 
DW (mg) 
Inhibition rates (%) 
B. subtilis S. aureus E. coli P. aeruginosa C. albicans C. krusei 
SZMC 27149 
SZMC 27150 
SZMC 27151 
SZMC 27152 
SZMC 27153 
SZMC 27154 
SZMC 27155 
SZMC 27156 
SZMC 27157 
SZMC 27158 
SZMC 27159 
SZMC 27160 
SZMC 27161 
SZMC 27162 
SZMC 27163 
SZMC 27164 
SZMC 27165 
SZMC 27166 
SZMC 27167 
SZMC 27168 
178.45±11.3 
228±3.7 
163.94±10.2 
222.49±2 
198.23±11.7 
234.67±4.3 
278.45±6.5 
298.11±8.4 
214.81±8.8 
167.98±3.7 
293.92±8.6 
285.39±4.5 
275.51±10 
330.33±6.9 
228.16±15.6 
316.16±5.9 
289.32±4.6 
387.12±13.1 
198.56±11.7 
267.34±15.2 
1.01±1.7 
41.61±15.6 
83.8±15.5 
8.77±5.8 
34.57±8 
45.98±2.8 
29.68±9 
57.96±6.7 
29.44±9 
53.29±12.3 
55.19±5.5 
33.57±10.9 
9.98±2.2 
7.24±2.4 
36.54±15.1 
81.31±3.8 
55.33±13.3 
35.12±7 
31.51±1.6 
52.92±9.8 
77.44±9 
59.56±5.8 
58.19±10 
18.35±10.1 
76.18±3.3 
1.22±12 
95.11±13.3 
87.04±1.3 
7.2±9.4 
37.24±5.3 
37.79±13.3 
78.43±5 
23.08±11.5 
67.79±11.3 
64.27±4.9 
89.52±8.8 
8.8±10.8 
56.51±15.2 
45.2±12.7 
82.4±13.7 
16.53±11.7 
49.15±8.6 
49.1±10.3 
86.52±8 
76.51±3.1 
81.79±6.6 
99.19±5.8 
91.61±7.5 
86.33±2 
42.38±5.1 
77±8.6 
78.67±14.9 
81.67±9.9 
49.72±13.8 
32.01±2.6 
94.04±3.5 
70.76±4.2 
77.33±14 
85.8±7.6 
13.36±3.7 
25.85±4.8 
51.62±11.8 
30.88±5.1 
47.29±9.3 
15.6±13.5 
44.79±3.2 
71.46±6.7 
10.4±6.5 
21.78±7.9 
32.5±14.9 
60.2±14 
5.94±10.7 
86.02±8.4 
8.48±2.4 
29.38±16.4 
90.02±15 
64.36±9.9 
47.25±7.7 
28.11±9.7 
78.93±10.1 
24.73±4.4 
37.98±3.5 
41.31±5 
45.2±7.6 
18.39±5.1 
20.67±10 
65.37±2.8 
39.59±13.6 
85.99±14.9 
46.66±8.5 
15.56±11.5 
45.9±13.2 
82.81±10.8 
47.54±14.4 
18.46±11.6 
86.53±10.7 
94.26±3.1 
28.39±3.3 
81.22±5.9 
30.2±8.7 
56.3±14.4 
86.95±2.7 
68.59±2.3 
54.97±10.6 
46.96±14.7 
19.13±8.9 
52.63±5.9 
98.7±9.3 
1.39±10.6 
24.39±12.9 
58.84±9.1 
10.61±1.7 
70.91±6.1 
64.08±14.1 
58.96±1.9 
94.38±12.2 
52.85±2.6 
28.85±9.7 
82.69±7.8 
97.9±4.7 
143 
 
Collection 
code 
DW (mg) 
Inhibition rates (%) 
B. subtilis S. aureus E. coli P. aeruginosa C. albicans C. krusei 
SZMC 27169 
SZMC 27170 
SZMC 27171 
SZMC 27172 
SZMC 27173 
SZMC 27174 
SZMC 27175 
SZMC 27176 
SZMC 27177 
SZMC 27178 
SZMC 27179 
SZMC 27180 
SZMC 27181 
SZMC 27182 
SZMC 27183 
SZMC 27184 
SZMC 27185 
SZMC 27186 
SZMC 27187 
SZMC 27188 
SZMC 27189 
SZMC 27190 
193.25±12.3 
209.12±3.7 
207.16±12.6 
220.45±2.6 
298.34±4.2 
192.67±9 
144.66±15.8 
288.45±3.9 
298.53±14.3 
265.43±6.5 
285.45±6 
299.38±1.2 
244.32±12.5 
187.32±3.6 
199.36±12 
298.34±9.8 
331.45±8.8 
332.45±1.5 
284.45±13.2 
256.41±11.5 
276.41±5.9 
233,45±1.9 
55.65±11.7 
18.79±8.8 
95.15±6.9 
43.39±9.8 
13.71±8.9 
33.1±7.8 
69.92±15.8 
64.58±9 
61.26±9.5 
43.59±3.2 
65.49±13.9 
60.09±8.2 
20.17±15 
25.63±11.3 
10.36±13.3 
23.74±4.4 
43.44±4.1 
92.4±7.3 
75.32±7.6 
1.16±15.7 
58.92±3.2 
8.23±1.1 
82.02±4.5 
85.48±7.8 
10.01±9.8 
77.26±3.8 
98.86±13.9 
24.27±3.5 
89.08±3.4 
32.88±3.2 
91.82±10.1 
0.03±3.2 
54.1±16.3 
12.41±5.8 
66.7±16.3 
53.66±12.8 
25.84±5.2 
32.17±9.9 
54.29±6.6 
39.09±7.6 
65.23±1.9 
71.01±1.1 
65.41±12.4 
0.6±13.6 
62.23±9.5 
49.28±10.4 
85.39±8 
77±2.5 
29.21±2.5 
43.38±1.4 
18.16±11.9 
29.09±14.8 
68.21±4.7 
41.67±6.8 
70.46±11.9 
55.89±9 
5.71±14.4 
14.09±2.4 
77.8±4.1 
4.92±13.1 
79.51±5.2 
53.77±2.8 
8.98±10.5 
30.93±11.3 
93.43±2.2 
7.97±7.5 
16.23±3.1 
13.16±7.3 
87.08±10 
54.31±8.3 
54.29±5.6 
32.02±13.8 
13.48±16.3 
98.97±16.2 
60.16±1.1 
55.36±3.4 
71.99±9.6 
66.69±8.6 
36.96±11.7 
76.43±15.2 
19.07±2.9 
28.45±3.1 
19.87±5.1 
78.08±7.6 
86.34±3.5 
60.41±9.4 
66.26±5.3 
82.22±5.7 
50.93±4.1 
81.96±7.3 
50.54±1.6 
43.43±11.2 
69.91±14.9 
14.35±15.6 
84.94±8.1 
97.05±2.8 
83.51±1.9 
95.67±2.6 
21.58±7.6 
12.03±16.1 
62.61±7.1 
71.06±8.5 
16.43±13.1 
0.29±15.5 
54.24±11.7 
86.87±3.9 
79.54±6.7 
46.08±11.9 
44.87±5.4 
82.35±15 
26.7±10.7 
14.82±10.4 
74.29±3.9 
52.24±5.8 
41.32±3.5 
33.81±10.8 
26.64±14 
34.38±16 
43.75±2 
23.42±4.8 
0.87±2.6 
24.8±13.6 
53.79±11.3 
51.22±4.3 
44.53±11.4 
26.86±10.2 
6.06±8.3 
94.41±1.9 
53.95±15 
61.1±3.7 
76.73±3.7 
35.24±3.1 
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Collection 
code 
DW (mg) 
Inhibition rates (%) 
B. subtilis S. aureus E. coli P. aeruginosa C. albicans C. krusei 
SZMC 27191 
SZMC 27192 
SZMC 27193 
SZMC 27194 
SZMC 27195 
SZMC 27196 
SZMC 27197 
SZMC 27198 
SZMC 27199 
SZMC 27200 
SZMC 27201 
SZMC 27202 
SZMC 27203 
SZMC 27204 
SZMC 27205 
SZMC 27206 
SZMC 27207 
SZMC 27208 
SZMC 27209 
SZMC 27210 
SZMC 27211 
SZMC 27212 
284.34±11.1 
199.23±12.1 
176.43±7.2 
144.56±13.3 
277.36±2.2 
256.34±1.2 
233.45±10.7 
269.34±8.4 
299.41±11.7 
301.36±4.7 
331.85±5.6 
249.81±11.7 
366.12±5.2 
341.34±13.7 
112.67±9.6 
288.56±6.3 
298.34±8.7 
255.34±9.7 
232.67±10.2 
289.34±4.6 
189±1.5 
213.66±11.9 
64.5±4.9 
42±7.6 
48.81±4.1 
10.3±13.5 
9.2±9.8 
80.4±14.8 
45.35±3.8 
59.94±14.3 
93.18±7.3 
19.89±3.5 
10.24±10.1 
28.89±8.8 
53.56±3.2 
6.91±7.9 
3.62±6.5 
19.98±12.1 
29.55±10.5 
13.5±10.5 
51.55±1.4 
15.55±16 
58.9±12 
46.52±6.2 
90.09±8.2 
65.15±13.4 
28.51±16.3 
62.9±8.7 
95.07±4.6 
6.96±11.7 
3.47±11.1 
0.38±15.9 
93.25±9.7 
20.37±1.7 
97.62±3.9 
79.05±3.9 
62.06±13.7 
65.26±7.4 
97.29±12.7 
43.35±12.8 
17.35±4.4 
26.61±5.1 
82.49±3 
13.48±1.7 
63.74±3.3 
55.6±7.2 
6.16±10.5 
11.18±1.8 
80.23±5.5 
22.37±6.5 
53.45±8.3 
27.52±13.8 
32.35±8 
32.98±2.4 
46.54±4.2 
90.11±1.9 
8.57±14.1 
61.28±12.9 
65.15±5.7 
83.72±8.3 
92.12±1.2 
72.13±3.6 
8.28±16 
3.61±12.8 
78.14±13 
49.21±2.6 
13.33±15 
55.78±11.6 
3±1.8 
26.11±5.5 
12.84±3 
74.31±14.6 
32.27±16.3 
84.81±2.6 
64.61±5 
45.61±5.4 
72.02±2.9 
70.74±16.1 
43.25±15.8 
17.93±8.6 
3.18±11 
46.69±15.7 
12.76±10.5 
44.43±3.9 
12.24±4.9 
21.03±7.5 
66.05±7.8 
59.15±11.8 
28.28±8.5 
33.65±9.5 
80.2±9.5 
3.33±7.9 
37.27±7.9 
33.22±7.1 
66.14±11.6 
39.44±9.1 
12.93±14.6 
51.49±12.7 
50.66±10.8 
37.03±9.6 
59.39±7 
71.37±10 
29.9±1.3 
9.51±15.7 
56.05±2.3 
61.67±4.7 
55.66±6.9 
23.95±15.2 
53.59±12.7 
34.76±15.8 
44.95±4.1 
39.51±12.9 
16.53±11 
25.88±12.8 
64.21±14.4 
92.59±4.1 
53.54±10.3 
16.08±15.8 
38.59±1.9 
31.82±10.5 
39.63±8.2 
33.34±7.5 
3.66±6.1 
23.87±14.4 
28.84±7.6 
60.48±11.9 
50.78±3.4 
37.24±16.4 
43.14±3.6 
74.6±10.3 
46.44±3.4 
43.06±9.5 
45.5±8.2 
28.95±8 
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Collection 
code 
DW (mg) 
Inhibition rates (%) 
B. subtilis S. aureus E. coli P. aeruginosa C. albicans C. krusei 
SZMC 27213 
SZMC 27214 
SZMC 27215 
SZMC 27216 
SZMC 27217 
SZMC 27218 
SZMC 27219 
SZMC 27220 
SZMC 27221 
SZMC 27222 
SZMC 27031 
219.23±3 
298.33±7 
272.45±2.5 
276.11±13.3 
324.56±5.9 
311.9±7.1 
344.23±3.5 
401.89±5.8 
228.67±10.4 
321.73±9.5 
382.12±8.56 
58.15±16.3 
19.05±6.7 
48.3±12.1 
28.81±14.9 
54.44±2.3 
26.16±12.3 
98.42±16.4 
39.41±12.8 
28.14±7.7 
44.55±5.6 
84.99±3.8 
86.62±16.3 
57.83±14.8 
2.7±14.7 
35.03±7.7 
7.56±12.2 
41.52±2 
50.77±9.5 
37.85±4.7 
8.49±12.8 
1.18±12 
92.19±2.8 
2.41±10.2 
92.07±8.5 
31.95±14.7 
80.21±4.7 
45.03±5.2 
45.65±15.8 
32.87±7.4 
2.42±16.2 
92.68±13.6 
47.41±13.1 
79.41±7.9 
57.19±12.5 
75.91±14.7 
1.24±9.6 
66.31±1.9 
60.45±4 
79.41±8.8 
43.84±9.4 
62.5±1.4 
68.72±4.1 
7.91±6.5 
56.27±10.3 
70.24±5.9 
41.75±13.5 
74.01±10.1 
33.21±7.6 
24.5±13.3 
59.05±9 
30.31±11.2 
14.5±5.8 
12.06±5.9 
20.88±13.3 
63.98±7.9 
16.84±8.5 
11.63±5.2 
39.12±3.9 
95.74±14.5 
17.75±14.2 
79.99±9.5 
66.52±3.5 
43.9±2 
4.91±8.4 
37.2±15.7 
82.5±4.6 
 
 
Table S 6. Antimicrobial effects of EFs’ metabolites of A. asiatica extracted with chloroform 
from ferment broth. 
Collection code 
Inhibition rates (%) 
B. subtilis S. aureus E. coli 
P. 
aeruginosa 
C. albicans C. krusei 
SZMC 27067 
SZMC 27068 
SZMC 27069 
54.26±15 
53.35±9 
72.25±1.1 
5.79±12.8 
25.54±4.3 
97.55±7.6 
22.32±6.1 
3.76±6.1 
24.59±8 
24.21±15.1 
94.32±13.3 
53.59±4.7 
22.32±11.3 
3.76±7.9 
24.59±15.7 
24.21±2.6 
24.32±14 
53.52±12.1 
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Collection code 
Inhibition rates (%) 
B. subtilis S. aureus E. coli 
P. 
aeruginosa 
C. albicans C. krusei 
SZMC 27070 
SZMC 27071 
SZMC 27072 
SZMC 27073 
SZMC 27074 
SZMC 27075 
SZMC 27076 
SZMC 27077 
SZMC 27078 
SZMC 27079 
SZMC 27080 
SZMC 27081 
SZMC 27082 
SZMC 27083 
SZMC 27084 
SZMC 27085 
SZMC 27086 
SZMC 27087 
SZMC 27088 
92.18±15.8 
63.18±7.7 
63.95±4.1 
32.59±3.2 
27.52±15.6 
70.06±15.4 
35.94±6.5 
96.41±14.2 
92.34±11.2 
98.14±2.3 
1.55±12 
49.7±12.4 
93.23±7.6 
80.54±16 
34.51±15.7 
21.38±1.5 
66.55±5.9 
76.62±16.2 
6.6±9.8 
90.33±2.6 
33.85±8.8 
84.11±15.2 
87.45±11.5 
38.71±8.1 
71.55±13.4 
84.79±11.9 
91.54±10.2 
44.35±9.8 
90.54±16.4 
90.27±3.9 
74.46±8.9 
78.14±2.2 
64.56±16.3 
7.2±15.5 
5.62±9.6 
40.73±5.6 
45.67±16.2 
83.98±12.5 
87.35±13.5 
8.41±2.9 
69.08±7.5 
32.01±4.6 
30.06±15.9 
58.02±15.8 
5.59±10.7 
62.08±8.9 
48.87±4.2 
69.53±6.3 
34.38±3.3 
26.42±14.3 
33.79±16 
43.41±5.9 
28.48±3.9 
8.56±2.6 
53.84±6.5 
19.14±10.8 
27.3±15.8 
37.27±7.4 
34.59±5.9 
55.64±6.9 
45.47±11.7 
74.47±14 
77.14±3.9 
44.6±9.4 
75.19±8.1 
43.59±9.4 
93.45±6.8 
91.26±4.8 
97.37±2.6 
30.45±5.3 
50.42±8.7 
56.46±9.3 
24.69±3.9 
34±7.9 
25.73±7.9 
56.39±9.5 
87.35±14.1 
8.41±3.9 
69.08±15.5 
32.01±15.3 
30.06±4.1 
58.02±8 
5.59±12.5 
62.08±11.2 
48.87±5.3 
69.53±15 
34.38±12.7 
26.42±12 
33.79±12.6 
43.41±14.9 
28.48±9.6 
8.56±10.4 
53.84±12.9 
19.14±10 
27.3±16.1 
37.27±5.5 
34.52±8.9 
55.64±6.9 
45.47±5.9 
74.47±1.3 
77.14±8.2 
44.6±4.8 
75.12±16 
43.52±2.9 
23.45±1.5 
21.26±11.8 
27.37±8.6 
30.45±8.3 
50.42±13.1 
56.46±8.5 
24.62±11.7 
34±15.4 
25.73±5 
56.32±9 
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Collection code 
Inhibition rates (%) 
B. subtilis S. aureus E. coli 
P. 
aeruginosa 
C. albicans C. krusei 
SZMC 27089 
SZMC 27090 
SZMC 27091 
SZMC 27092 
SZMC 27093 
SZMC 27094 
SZMC 27095 
SZMC 27096 
SZMC 27097 
SZMC 27098 
SZMC 27099 
SZMC 27100 
SZMC 27101 
SZMC 27102 
SZMC 27103 
SZMC 27104 
SZMC 27105 
SZMC 27106 
SZMC 27107 
89.99±16.10 
19.64±13.2 
93.52±12.4 
61.92±8.2 
3.79±5.6 
77.68±8.5 
18.52±5.8 
45.36±7.4 
5.63±5.2 
82.78±3.7 
38±3.2 
5.53±6.2 
54.89±1.5 
69.76±13.9 
40.14±14.6 
80.82±8 
2.93±11.8 
14.55±16.3 
78.86±8.4 
62.78±3.4 
82.88±3.8 
0.68±14.9 
75.42±4.6 
48.15±6.4 
80.42±5.1 
38.27±13.2 
49.04±6.7 
29.88±15.1 
96.35±8.4 
17.73±10 
20.94±12.4 
24.58±9.3 
90.93±2.8 
60.48±4.4 
92.41±11.8 
36.88±15.9 
51.72±16.3 
91.34±12.8 
40.3±11.2 
17.11±15.9 
12.25±13.6 
75.35±1.2 
26.86±11.7 
30.17±2.5 
1.54±2.9 
45.99±15.3 
24.89±2.4 
28.04±7.1 
97.09±8.2 
0.55±8 
24.92±15.7 
67.91±2.4 
15.24±16 
2.01±13.8 
24.14±8.2 
28.53±9.3 
14.8±13.1 
74.45±12 
25.34±3.5 
56.53±11.8 
54.02±6.5 
13.44±13.9 
59.24±2.6 
23.9±7.2 
40.21±10.3 
39.11±9.6 
46.14±8.2 
12±9.8 
37.3±10.3 
16.54±1.6 
75.41±6.5 
90.54±15.4 
73±14.4 
14.22±4.2 
72.64±2.5 
43.49±5.7 
40.3±8.6 
17.11±7.6 
12.25±13.2 
75.35±12.7 
26.86±9.8 
30.17±14.4 
1.54±11 
45.99±9.5 
24.89±13.8 
28.04±8.2 
97.09±10.3 
0.55±6.1 
24.92±7 
17.91±5.8 
15.24±4.4 
2.01±10.3 
34.14±14.9 
28.53±7.9 
14.8±13.2 
74.45±1.7 
25.34±15.3 
56.53±2.5 
54.02±8.3 
13.44±12 
52.24±7.4 
23.2±1.6 
40.21±13.4 
32.11±6.8 
46.14±16.1 
12±5.4 
37.3±16.3 
16.54±2.3 
75.41±13.5 
20.54±10.8 
73±8.6 
14.22±1.9 
72.64±3.6 
43.42±10.1 
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Collection code 
Inhibition rates (%) 
B. subtilis S. aureus E. coli 
P. 
aeruginosa 
C. albicans C. krusei 
SZMC 27108 
SZMC 27109 
SZMC 27110 
SZMC 27111 
SZMC 27112 
SZMC 27113 
SZMC 27114 
SZMC 27115 
SZMC 27116 
SZMC 27117 
SZMC 27118 
SZMC 27119 
SZMC 27120 
SZMC 27121 
SZMC 27122 
SZMC 27123 
SZMC 27124 
SZMC 27125 
SZMC 27126 
53.17±5.9 
47.2±1.6 
28.21±1.3 
24.36±13.5 
24.49±10.6 
22.21±15.1 
34.19±4.3 
88.14±16.4 
47.7±2.6 
51.72±2.4 
63.11±2.3 
57.37±9.7 
55.03±16.2 
34.11±2.8 
26.49±4 
22.01±8.5 
91.67±2.9 
9.33±9.6 
49.73±4 
92.47±2.2 
98.11±12.7 
4.93±5.7 
37.05±10.9 
57.86±12.6 
14.44±10.2 
2.29±4.6 
87.89±13.8 
16.54±6.5 
11.84±2.4 
92.88±14.9 
58.77±10.8 
93.39±6.1 
98.66±7.8 
94.2±8.8 
49.39±2.9 
0.73±6.5 
33.54±15 
98.17±14.3 
22.89±5.1 
46.79±12.6 
18.1±12.8 
32.8±1.7 
55.63±11.7 
13.14±15.8 
34.4±12.3 
4.98±7 
58.83±12.4 
5.62±2.7 
38.41±3.4 
18.51±10.9 
29.84±14.3 
57.85±4.8 
1.84±8.6 
50.2±16.1 
36.19±7.2 
36.23±1.2 
92.26±5 
5.4±15.7 
94.42±14.7 
93.73±5.4 
29.3±7.1 
46.35±4.5 
37.41±2.6 
42.63±7.2 
72.46±12.5 
32.12±14.8 
46.71±2 
1.34±5.8 
67.32±15.2 
44.63±14.9 
47.4±15.9 
14.53±15.6 
36.39±8.6 
41.39±6.2 
33.52±3.3 
46.56±13.2 
22.89±8.1 
46.79±5.5 
18.1±1.4 
32.8±3.3 
55.63±6.3 
13.14±11.6 
34.4±7.6 
4.98±7.9 
58.83±3.6 
5.62±4.3 
38.41±2 
18.51±15.8 
29.84±9.7 
57.85±15.3 
1.84±3.8 
50.2±12.3 
36.19±12.7 
36.23±10.4 
92.26±14.8 
5.4±10.3 
24.42±10 
23.73±3.7 
22.3±10.3 
46.35±6 
37.41±15 
42.63±2.3 
72.46±1.2 
32.12±7.2 
46.71±13.1 
1.34±3.7 
67.32±5.8 
44.63±10.5 
47.4±14.8 
14.53±16.2 
36.32±9.9 
41.32±15 
33.52±1.5 
46.56±15.6 
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Collection code 
Inhibition rates (%) 
B. subtilis S. aureus E. coli 
P. 
aeruginosa 
C. albicans C. krusei 
SZMC 27127 
SZMC 27128 
SZMC 27129 
SZMC 27130 
SZMC 27131 
SZMC 27132 
SZMC 27133 
SZMC 27134 
SZMC 27135 
SZMC 27136 
SZMC 27137 
SZMC 27138 
SZMC 27139 
SZMC 27140 
SZMC 27141 
SZMC 27142 
SZMC 27143 
SZMC 27144 
SZMC 27145 
31.08±10.6 
66.91±3.6 
38.94±8.8 
14.3±14 
10.25±13.3 
45.26±2.5 
76.87±14.8 
9.19±9.5 
95.26±11.7 
28.2±6.5 
92.02±8.8 
97.53±5.7 
56.05±9.7 
17.03±2.9 
30.96±14 
25.43±14.1 
77.9±1.3 
93.48±11.3 
91.01±15.4 
96.41±15.2 
41.64±11.3 
78±13.3 
95.3±5.9 
34.64±1.6 
92.75±15.3 
91.65±2 
17.87±6.7 
12.9±4.7 
30.65±1.6 
71.21±1.1 
8.42±16 
55.16±12 
86.78±4.4 
1.4±1.4 
50.15±13.4 
60.14±11.6 
62.15±15.4 
0.43±5.4 
17.76±16.1 
36.58±3.3 
9.14±6 
49.61±4.9 
50.94±11.8 
50.02±11.2 
58.27±4 
24.48±4.8 
56±12.5 
5.45±9.5 
51.73±14.8 
13.01±14.4 
9.85±2.1 
18.13±6.4 
41.8±9.1 
79.37±11.4 
41.01±10.3 
26.78±1.8 
79.23±3 
15.61±3.3 
24.47±15.3 
67.44±8.4 
79.6±14 
90.61±15.2 
25.34±15.7 
42.36±14 
73.62±5.2 
75.34±11.5 
54.4±14 
34.46±12.3 
65.33±13.1 
35.71±11.1 
27.19±6.1 
75.66±4.9 
11.45±1.2 
13.52±11.1 
46.55±13.9 
7.17±12.8 
17.76±1.5 
36.58±8 
9.14±2.3 
49.61±2.7 
50.94±2.6 
50.02±10 
58.27±3.4 
24.48±7.4 
56±16.1 
5.45±10.8 
51.73±10.3 
13.01±13.5 
9.85±15.7 
18.13±16.4 
41.8±5.5 
79.37±11.4 
41.01±10.3 
26.78±4.2 
79.23±16.2 
15.61±6.5 
24.47±14.7 
67.44±8.5 
72.6±8.3 
20.61±7.7 
25.34±10.2 
42.36±15.8 
73.62±3.3 
75.34±1.4 
54.4±14.7 
34.46±14.4 
65.33±4.3 
35.71±4.9 
27.12±8.8 
25.66±5 
11.45±5.1 
13.52±9.7 
46.55±9.7 
7.17±3.9 
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Collection code 
Inhibition rates (%) 
B. subtilis S. aureus E. coli 
P. 
aeruginosa 
C. albicans C. krusei 
SZMC 27146 
SZMC 27147 
SZMC 27148 
6.95±11.2 
62.12±9.9 
20.98±14.6 
61.49±11.4 
5.27±14.1 
11.72±9.1 
94.66±6.4 
72.46±3.1 
21.27±10.6 
21.42±2.3 
0.54±5.3 
42.14±2.9 
94.66±13.2 
72.46±1.1 
21.27±10.7 
21.42±4.4 
0.54±3.7 
  42.14±15.6 
 
 
Table S 7. Antimicrobial effects of EFs’ metabolites of A. asiatica extracted with ethyl acetate 
from ferment broth. 
Collection 
code 
Inhibition rates (%) 
B. subtilis S. aureus E. coli 
P. 
aeruginosa 
C. albicans C. krusei 
SZMC 27067 
SZMC 27068 
SZMC 27069 
SZMC 27070 
SZMC 27071 
SZMC 27072 
SZMC 27073 
SZMC 27074 
SZMC 27075 
34.36±5.6 
18.43±10.3 
90.24±10.9 
84.98±8.9 
74.28±14.7 
48.22±2.3 
77.84±7.6 
82.43±15.7 
65.46±4.8 
21.84±7.4 
9.53±2.4 
80.99±15.4 
91.77±13.7 
92.48±9.4 
87.46±6.1 
6.45±1.7 
36±2.7 
25.02±10.2 
8.25±2.7 
6.65±15.1 
51.03±14 
71.08±7.7 
5.81±9.3 
89.14±11.8 
25.3±3 
43.29±15.1 
10.23±16.1 
3.11±2.9 
49.43±8.2 
54.34±15.9 
39.55±12.4 
94.9±12.5 
59.49±11.8 
51.26±1.5 
5.53±2.9 
39.45±5.9 
8.25±12.6 
6.65±4.6 
51.03±16 
71.08±13.9 
5.81±14 
89.14±10.5 
25.3±1.6 
43.29±14.1 
10.23±6.8 
3.11±5 
49.43±4.4 
54.34±9.3 
39.55±12.4 
94.9±4.5 
59.49±5.3 
51.26±2.6 
5.53±13.3 
39.45±4.3 
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Collection 
code 
Inhibition rates (%) 
B. subtilis S. aureus E. coli 
P. 
aeruginosa 
C. albicans C. krusei 
SZMC 27076 
SZMC 27077 
SZMC 27078 
SZMC 27079 
SZMC 27080 
SZMC 27081 
SZMC 27082 
SZMC 27083 
SZMC 27084 
SZMC 27085 
SZMC 27086 
SZMC 27087 
SZMC 27088 
SZMC 27089 
SZMC 27090 
SZMC 27091 
SZMC 27092 
SZMC 27093 
SZMC 27094 
74.97±10.7 
96.65±13.2 
93.42±4.9 
74.19±1.3 
41.44±6.7 
91.84±4.6 
94.45±5.1 
50.2±11.9 
1.94±8.6 
53.07±15.8 
97.42±13.1 
72.49±12.1 
35.32±7.5 
22.8±13.50 
81.32±5.7 
87.31±12.7 
52.66±13.3 
35.31±16.3 
11.75±9.2 
72.48±3.3 
90.6±14.7 
76.87±1.3 
92.64±8.1 
97.82±14.4 
52.62±1.5 
78.73±5.9 
36.27±4.4 
78.87±7.2 
53.87±4.4 
25.35±8.8 
10.95±6.4 
94.96±8.2 
53.9±11.5 
95.57±9.3 
33.27±5.2 
2.15±8.5 
92.12±16.3 
91.02±7.2 
95.3±15.8 
93.06±16 
43.91±10.9 
20.32±5.5 
47.83±3.5 
83.65±10.2 
76.98±11.7 
67.36±9.3 
32.04±9.1 
52.29±2.1 
4.45±11.7 
89.78±10.8 
53.96±3.5 
28.3±13.2 
24.2±11.3 
80.31±11.6 
84.31±6.5 
32.54±12.1 
44.43±14.2 
17.11±12.6 
12.52±8.4 
41.25±14.6 
21.52±10.3 
32.66±4.2 
6.44±14 
50.73±5.3 
21.61±15.3 
94.95±14.3 
16.7±12.5 
32.32±1.6 
94.57±9.5 
64.54±10.1 
39.22±8.4 
14.05±5.8 
52.36±12.9 
4.69±13.8 
37.92±8.6 
11.35±8.9 
95.3±1.1 
93.06±5.2 
43.91±11.3 
20.32±5.5 
47.83±14.6 
83.65±5.6 
76.98±4.6 
67.36±14.2 
32.04±14.6 
52.29±14.8 
4.45±12.9 
89.78±1.8 
53.96±2.6 
28.3±5.8 
24.2±2.3 
80.31±2 
84.31±5.6 
32.54±9.7 
44.43±12 
17.11±1.1 
12.52±10.7 
41.25±11.2 
21.52±11.6 
32.66±6.1 
6.44±13.7 
50.73±3.9 
21.61±8 
94.95±15.5 
16.7±1.6 
32.32±10 
94.57±16.2 
64.54±4.6 
39.22±7.6 
14.05±12.9 
52.36±2.1 
4.69±11.6 
37.92±15 
11.35±9.8 
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Collection 
code 
Inhibition rates (%) 
B. subtilis S. aureus E. coli 
P. 
aeruginosa 
C. albicans C. krusei 
SZMC 27095 
SZMC 27096 
SZMC 27097 
SZMC 27098 
SZMC 27099 
SZMC 27100 
SZMC 27101 
SZMC 27102 
SZMC 27103 
SZMC 27104 
SZMC 27105 
SZMC 27106 
SZMC 27107 
SZMC 27108 
SZMC 27109 
SZMC 27110 
SZMC 27111 
SZMC 27112 
SZMC 27113 
3.1±4.9 
92.64±5.8 
72.54±5 
61.71±15.7 
50.45±12.7 
87.78±13.5 
78.04±13.3 
81.35±14.5 
77.99±5.3 
90.72±11.7 
87.94±3.4 
49.91±13 
11.1±12.8 
45.38±4.9 
3.4±8.9 
76.14±15.5 
91.07±6.5 
82.85±5.5 
37.94±13.6 
67.75±6.7 
58.76±9.3 
66.57±5.9 
97.31±2.6 
65.95±4.5 
36.97±4.1 
93.1±14 
92.81±14.7 
15.69±14.5 
89.14±10.9 
4.41±10.7 
10.69±3.3 
53.6±12.4 
14.22±9.9 
99.43±12 
37.68±5.9 
87.49±11.8 
80.15±8.8 
13.42±10 
81.23±7.9 
64.55±9.2 
1.3±5.2 
26.42±13.8 
80.78±16.3 
79.74±6.7 
7.15±12.7 
65.27±3.9 
68.33±16.2 
49.44±4.1 
41.28±3.4 
8.75±6.6 
28.49±2.6 
45.63±3 
44.36±8.6 
95.78±3.8 
35.86±8 
89.89±10.5 
82.5±15.7 
63.95±4.4 
34.04±4.4 
34.05±11.9 
30.34±2.1 
52.59±9.3 
9.37±13.1 
4.33±8.9 
90.02±13.9 
47.09±12.4 
14.34±3.3 
53.55±15.6 
22.22±1.6 
22.76±6.6 
69.46±1.6 
75.32±7.1 
21.31±7.6 
43.41±3.4 
45.66±4.3 
0.95±3.9 
81.23±9.8 
64.55±2.9 
1.3±14.9 
26.42±16.2 
80.78±6 
79.74±12.2 
7.15±11 
65.27±8.3 
68.33±12.8 
49.44±4.8 
41.28±11 
8.75±1.1 
28.49±1.9 
45.63±12.4 
44.36±15.6 
95.78±15.3 
35.86±3 
89.89±14.4 
82.5±6.8 
63.95±2.8 
34.04±11.8 
34.05±3.8 
30.34±1.6 
52.59±5.1 
9.37±15.3 
4.33±9.1 
90.02±9 
47.09±6.8 
14.34±12.5 
53.55±12.3 
22.22±4.6 
22.76±11.3 
69.46±12.4 
75.32±10.2 
21.31±10.8 
43.41±13.1 
45.66±12.6 
0.95±5.6 
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Collection 
code 
Inhibition rates (%) 
B. subtilis S. aureus E. coli 
P. 
aeruginosa 
C. albicans C. krusei 
SZMC 27114 
SZMC 27115 
SZMC 27116 
SZMC 27117 
SZMC 27118 
SZMC 27119 
SZMC 27120 
SZMC 27121 
SZMC 27122 
SZMC 27123 
SZMC 27124 
SZMC 27125 
SZMC 27126 
SZMC 27127 
SZMC 27128 
SZMC 27129 
SZMC 27130 
SZMC 27131 
SZMC 27132 
10.9±12 
78.89±8 
28.4±7.3 
64.81±7.2 
49.17±6.9 
40.3±13.2 
94.21±9 
68.24±2.8 
93.99±15.2 
80.55±9.3 
74.4±16.2 
97.25±4 
95.08±15.7 
94.99±11.3 
79.54±5.4 
26.35±15.9 
20.25±6.5 
0.53±10.6 
57.88±12.2 
78.27±9.6 
23.29±16.3 
13.05±11.1 
73.94±16 
38.9±4.4 
44.97±6.1 
62.5±16.1 
27.39±13.7 
18.57±15.9 
95.27±10.2 
69.93±10.8 
80.49±7.2 
36.51±3.4 
75±14 
52.95±9 
68.68±13.5 
17.08±11.8 
74.94±15.3 
64.71±6.8 
68.37±15.7 
71.07±7.7 
26.31±10.3 
55.46±2.5 
31.36±4.6 
12.67±8.3 
54.26±11.7 
13.25±6 
40.7±8.4 
51.12±9.1 
13.96±3.6 
43.62±3.3 
8.03±1.8 
18.72±10.6 
30.63±13.7 
13.46±6.6 
24.58±8 
57.1±2.2 
2.72±13.5 
43.35±12.5 
63.74±14.7 
42.64±2.7 
56.14±4.5 
32.56±9.3 
4.04±8.4 
33.95±14.8 
29.17±7 
97.42±1.5 
34.26±2 
59.6±13.9 
51.52±13.9 
54.43±8.3 
24.16±13.5 
4.59±11.6 
3.01±9.7 
14.66±7.7 
43.44±3 
74.93±10.2 
68.37±6.3 
71.07±15.9 
26.31±8.9 
55.46±7.1 
31.36±6.9 
12.67±8.4 
54.26±3.9 
13.25±10.2 
40.7±10.7 
51.12±1.8 
13.96±14.1 
43.62±13.4 
8.03±2.5 
18.72±5.7 
30.63±8.5 
13.46±4.3 
24.58±9.7 
57.1±5.8 
2.72±14.2 
43.35±14.9 
63.74±6.5 
42.64±13.6 
56.14±9.4 
32.56±8.4 
4.04±5.8 
33.95±8.8 
29.17±16.1 
97.42±8.2 
34.26±2.2 
59.6±1.8 
51.52±15.1 
54.43±8.4 
24.16±4.4 
4.59±11.8 
3.01±15.4 
14.66±7.5 
43.44±10.1 
74.93±14 
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Collection 
code 
Inhibition rates (%) 
B. subtilis S. aureus E. coli 
P. 
aeruginosa 
C. albicans C. krusei 
SZMC 27133 
SZMC 27134 
SZMC 27135 
SZMC 27136 
SZMC 27137 
SZMC 27138 
SZMC 27139 
SZMC 27140 
SZMC 27141 
SZMC 27142 
SZMC 27143 
SZMC 27144 
SZMC 27145 
SZMC 27146 
SZMC 27147 
SZMC 27148 
73.97±16.2 
68.4±16.4 
96.78±5.7 
71.59±11.9 
93.11±15.1 
93.66±3.7 
97.52±3.7 
70.94±4.3 
68.78±4.3 
70.77±13.7 
93.89±10.7 
99.28±12.8 
96.58±11.7 
25.68±6.6 
72.45±2.9 
90.18±8.6 
71.44±10.8 
98.72±13.9 
11.33±2.7 
38.06±10.6 
95.59±1.7 
45.86±7.5 
93.33±8.9 
37.19±10.3 
43±7.5 
7.02±11.6 
26.57±9 
40.38±2.5 
25.4±5.2 
69.06±4.5 
63.38±10.2 
91.18±14.3 
24.7±13 
6.12±7.5 
19.78±9.7 
26.01±12.3 
42.02±1.3 
80.63±15.4 
40.21±8 
59.69±13.9 
43.79±14.9 
37.73±16.1 
27.33±5.4 
6.98±4.7 
37.75±11.1 
32.32±10.1 
54.28±2.8 
21.56±6.9 
54.44±7.2 
17.44±13.3 
31.73±16.2 
49.69±1.2 
35.47±4.8 
25.64±8.1 
24.44±14.6 
12.7±1.5 
42.51±9.5 
10.7±8.5 
5.36±5.9 
77.44±2.2 
31.07±10.9 
44.99±2.7 
49.56±13.6 
44.05±9.9 
24.7±4.7 
6.12±13.9 
19.78±15.2 
26.01±13.6 
12.02±9.4 
80.63±10.3 
40.21±4.2 
59.69±6 
43.79±11.2 
37.73±10.4 
27.33±13.5 
6.98±13.5 
37.75±12.3 
32.32±4.9 
54.28±12.1 
21.56±5.5 
54.44±15.9 
17.44±1.6 
31.73±2.7 
49.69±3.2 
35.47±14.6 
25.64±16 
24.44±15.9 
12.7±3.3 
42.51±7.5 
10.7±8.4 
5.36±4.5 
77.44±14.7 
31.07±14.6 
44.99±14.4 
49.56±9 
44.05±13.3 
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Table S 8. Antimicrobial effects of EFs’ metabolites of A. asiatica extracted with hexane from 
ferment broth. 
Collection 
code 
Inhibition rates (%) 
B. subtilis S. aureus E. coli 
P. 
aeruginosa 
C. albicans C. krusei 
SZMC 27067 
SZMC 27068 
SZMC 27069 
SZMC 27070 
SZMC 27071 
SZMC 27072 
SZMC 27073 
SZMC 27074 
SZMC 27075 
SZMC 27076 
SZMC 27077 
SZMC 27078 
SZMC 27079 
SZMC 27080 
SZMC 27081 
SZMC 27082 
SZMC 27083 
2.24±14.6 
17.27±15.8 
22.25±14.1 
0.66±9.1 
82.25±11 
28.68±6.5 
76.11±13.8 
68.75±14.4 
31.59±9.2 
29.49±11.2 
47.85±9 
19.31±14 
45.43±11 
26.18±5.5 
1.13±9.4 
32.41±15 
42.25±5.2 
89.15±6.2 
38.25±2.8 
68.4±14.2 
59.81±5.4 
76.15±13.7 
40.05±14.2 
7.11±2.9 
72.37±15.2 
10.3±14.1 
89.1±12.2 
11.57±15.2 
5.68±2.5 
24.15±7.6 
31.87±5.2 
31.9±8.8 
16.05±6 
25.09±2.9 
25.25±15.9 
30.06±6.6 
11.9±10.4 
48.91±15.4 
15.24±5.4 
25.13±4 
20.84±12.8 
31.07±5 
33.05±2.2 
66.13±14.3 
28.81±13.5 
42.86±13.3 
61.87±2.2 
56.8±11.1 
30.47±9.1 
28.16±16.1 
18.15±2.9 
43.38±1.3 
30.3±12.5 
33.38±13.4 
54.03±4.3 
35.84±7.5 
34.33±11.1 
53.03±7.4 
34.55±5.2 
24.32±15 
33.34±12.7 
33.52±14.9 
34.54±8.2 
37.38±15.3 
87±13.2 
43.8±10.2 
53.72±16.1 
25.33±5.4 
25.25±6.3 
30.06±9.8 
11.9±8.4 
48.91±15.7 
15.24±14.5 
25.13±13.9 
20.84±8.4 
31.07±5.6 
33.05±14.4 
66.13±1.4 
28.81±2.3 
42.86±11.1 
61.87±9.4 
56.8±16.3 
30.47±7.7 
28.16±14.3 
18.15±16.4 
43.38±2.2 
30.3±9.6 
33.38±15.8 
54.03±6.2 
35.84±9.8 
34.33±16.3 
53.03±15.7 
34.55±3.3 
24.32±7.9 
33.34±3.7 
33.52±13.6 
34.54±12.7 
37.38±9.2 
87±8.4 
43.8±6.1 
53.72±9.5 
25.33±5.5 
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Collection 
code 
Inhibition rates (%) 
B. subtilis S. aureus E. coli 
P. 
aeruginosa 
C. albicans C. krusei 
SZMC 27084 
SZMC 27085 
SZMC 27086 
SZMC 27087 
SZMC 27088 
SZMC 27089 
SZMC 27090 
SZMC 27091 
SZMC 27092 
SZMC 27093 
SZMC 27094 
SZMC 27095 
SZMC 27096 
SZMC 27097 
SZMC 27098 
SZMC 27099 
SZMC 27100 
SZMC 27101 
SZMC 27102 
25.06±3.5 
16.33±13.9 
54.92±13.5 
32.25±9.2 
46.57±10 
26.07±14.90 
47.41±15.7 
71.94±6.3 
0±9.4 
41.38±2.8 
53.58±2.4 
84.79±4.4 
61.23±6.8 
53.34±16.1 
96.01±7.4 
54.8±5.7 
17.48±3.7 
11.31±13.6 
49.61±12.3 
54.76±13.7 
23.55±2.7 
11.33±4 
25.09±5.4 
16.03±7.3 
38.09±6.10 
44.28±3.8 
16.02±4.8 
4.12±1.6 
32.57±2.7 
82.29±14.6 
59.96±8.5 
39.29±2.4 
34.9±5.2 
57.92±5.1 
46.36±8.9 
14.8±14.3 
84.35±13.1 
45.79±14.5 
2.35±6.4 
47.16±5.1 
49.21±11.4 
10.32±4.9 
51.8±5.2 
56.44±4.7 
68.02±12 
82.52±16 
27.31±10.8 
59.21±1.7 
11.28±4.6 
16.82±16.1 
7.16±4.5 
59.49±2.7 
43.25±6.8 
28.02±6.4 
28.85±14 
18.77±11.9 
56.14±9.2 
53.27±3.9 
41.53±14.2 
53.75±5 
22.43±9.4 
13.02±14.1 
2.81±14.2 
23.05±11.5 
13.22±16.3 
31.85±14.8 
27.33±2.6 
35.04±12.9 
58.34±4.4 
13.53±11 
33.82±8.9 
23.83±6.4 
11.82±13.9 
32.84±16.2 
17.02±7.2 
34.18±4.9 
2.35±12.9 
47.16±7.1 
49.21±1.4 
10.32±7.2 
51.8±1.8 
56.44±3.6 
68.02±5.4 
82.52±1.3 
27.31±7.2 
59.21±3.9 
11.28±12.5 
16.82±8.3 
7.16±4.4 
59.49±5.6 
43.25±10.1 
28.02±8.1 
28.85±3.7 
18.77±10.9 
56.14±14.2 
53.27±2.5 
41.53±4 
53.75±7.7 
22.43±12.6 
13.02±4.1 
2.81±12.5 
23.05±13.3 
13.22±13.8 
31.85±15.8 
27.33±15.7 
35.04±3.3 
58.34±16.3 
13.53±15.3 
33.82±2.2 
23.83±15.2 
11.82±11.4 
32.84±3.6 
17.02±5.3 
34.18±6.2 
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Collection 
code 
Inhibition rates (%) 
B. subtilis S. aureus E. coli 
P. 
aeruginosa 
C. albicans C. krusei 
SZMC 27103 
SZMC 27104 
SZMC 27105 
SZMC 27106 
SZMC 27107 
SZMC 27108 
SZMC 27109 
SZMC 27110 
SZMC 27111 
SZMC 27112 
SZMC 27113 
SZMC 27114 
SZMC 27115 
SZMC 27116 
SZMC 27117 
SZMC 27118 
SZMC 27119 
SZMC 27120 
SZMC 27121 
25.79±1.7 
15.63±8.9 
40.37±15.5 
30.18±13.4 
90.44±1.9 
34.58±6.8 
51.48±10.2 
14.18±8.3 
26.99±8 
81.96±12 
27.46±8.7 
38.13±5.5 
86.89±13.2 
43.07±7.6 
73.57±13.7 
21.54±5.1 
52.02±14.3 
30.57±4.2 
9.64±8.4 
57.57±11.4 
27.12±14.3 
8.17±15.3 
1.03±5.2 
48.99±13.5 
41.83±4.6 
71.86±4.8 
33.55±6.7 
52.24±13.2 
47.78±10.9 
21.45±16.4 
16.06±12.1 
11.35±5.8 
27.91±5.6 
36.09±1.5 
58.22±3.5 
89.04±1.7 
36.47±3 
26.24±7.3 
26.31±5 
46.46±6.1 
38.13±10.4 
15.8±13.6 
5.29±1.5 
7.53±14.4 
28.71±6.4 
94.71±1.7 
3.17±1.1 
28.77±9 
4.4±3.1 
53.98±3.9 
21.66±16.2 
97.5±11 
22.79±9.3 
9.73±1.3 
13.35±4.6 
38.49±12.2 
2.26±15.7 
30.38±13.2 
15.22±8.5 
53.51±5 
23.24±14.1 
30.1±5.3 
14.39±10.3 
33.44±14.8 
19.01±5.2 
70.32±15.6 
12.33±16.3 
18.33±12.6 
25.41±5 
48.33±1.5 
39.35±8.7 
33.81±6.1 
31.13±2 
9.13±13.6 
12.44±9.9 
79.57±13.4 
26.31±3.2 
46.46±6 
38.13±4.1 
15.8±2.4 
5.29±9.4 
7.53±12.1 
28.71±6.2 
94.71±3.5 
3.17±8.6 
28.77±11.3 
4.4±15 
53.98±12.9 
21.66±7.9 
97.5±1.9 
22.79±8 
9.73±15.8 
13.35±15.3 
38.49±15.7 
2.26±8.7 
30.38±3.5 
15.22±4 
53.51±2.3 
23.24±6.1 
30.1±9.2 
14.39±3.6 
33.44±12.7 
19.01±15.1 
70.32±14.4 
12.33±12.2 
18.33±9.6 
25.41±14.1 
48.33±10.2 
39.35±4.7 
33.81±2.8 
31.13±13.6 
9.13±14.6 
12.44±10.3 
79.57±14.1 
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Collection 
code 
Inhibition rates (%) 
B. subtilis S. aureus E. coli 
P. 
aeruginosa 
C. albicans C. krusei 
SZMC 27122 
SZMC 27123 
SZMC 27124 
SZMC 27125 
SZMC 27126 
SZMC 27127 
SZMC 27128 
SZMC 27129 
SZMC 27130 
SZMC 27131 
SZMC 27132 
SZMC 27133 
SZMC 27134 
SZMC 27135 
SZMC 27136 
SZMC 27137 
SZMC 27138 
SZMC 27139 
SZMC 27140 
29.3±9 
69.54±5.7 
15.23±13.8 
41.32±7.5 
49.31±2.7 
35.32±16 
23.71±6.3 
68.44±2.8 
23.07±15.5 
27.04±12.8 
15.11±3.4 
68.78±13 
39.37±9.2 
28.57±8.4 
37.25±1.3 
74.86±7.2 
22.06±3.1 
44.23±15.1 
46.81±6.4 
27.67±9.2 
6.56±6.9 
56.36±13.6 
17.81±14.1 
11.65±7.1 
17.47±15.1 
12.72±3.3 
31.59±1.8 
24.61±9 
56.29±14.3 
38.92±2.2 
66.15±5.8 
41.77±6.3 
26.99±1.1 
6.62±8.2 
77.6±8.9 
64.75±7.2 
45.13±15.1 
32.53±15.1 
46.27±2.8 
26.65±5.3 
8.54±6 
28.66±4 
24.98±15.9 
7.03±4.5 
22.58±9.3 
31.21±8.1 
35.02±13.5 
48.62±4.2 
34.27±15.6 
11.99±9.5 
34.91±3.1 
20.59±12.9 
27.2±2.3 
86.89±6.2 
37.27±6.2 
32±12.4 
48.44±5.1 
39.2±12.2 
57.34±14.3 
38.08±10.4 
43.91±6.7 
33.34±3.3 
53.33±5.6 
24.13±9.1 
20.21±10.7 
47.51±12.5 
42.55±15.1 
73.15±15.9 
23.14±5.6 
51.95±9.5 
34.87±5.7 
52.23±1.7 
83.93±7.3 
47.52±15.4 
33.38±12.9 
28.93±2 
46.27±11.7 
26.65±12.5 
8.54±2.2 
28.66±7.4 
24.98±6.7 
7.03±3.2 
22.58±12.5 
31.21±13.4 
35.02±7.9 
48.62±4.8 
34.27±12.7 
11.99±14.3 
34.91±5.6 
20.59±6.4 
27.2±10 
56.89±6.7 
37.27±12.2 
32±11.2 
48.44±3.3 
39.2±5.4 
57.34±5.4 
38.08±7.2 
43.91±7.9 
33.34±9.7 
53.33±11 
24.13±2.6 
20.21±1.5 
47.51±14.7 
42.55±12.8 
73.15±9.8 
23.14±3.2 
51.95±3.2 
34.87±15.7 
52.23±7.3 
33.93±2.4 
47.52±6.2 
33.38±8.6 
28.93±5.7 
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Collection 
code 
Inhibition rates (%) 
B. subtilis S. aureus E. coli 
P. 
aeruginosa 
C. albicans C. krusei 
SZMC 27141 
SZMC 27142 
SZMC 27143 
SZMC 27144 
SZMC 27145 
SZMC 27146 
SZMC 27147 
SZMC 27148 
49.77±7.8 
32.2±15.9 
15.97±14.1 
16.81±2.4 
82.28±11.8 
38.64±9.5 
76.93±5.1 
58.17±11.7 
46.45±1.7 
32.09±12.5 
52.79±8.5 
29.28±9.6 
4.45±5.2 
15.26±14.5 
18.28±6.1 
58.51±8.2 
23.68±12.6 
48.71±6.8 
20.82±5.1 
47.64±10.8 
20.38±2.3 
37.15±7.9 
26.52±11.2 
37.92±9.5 
52.19±3.9 
37.97±8.4 
44.07±15 
33.32±13.2 
4.28±3.4 
39.88±13.6 
11.58±3.6 
3.35±3.6 
23.68±2.5 
48.71±10.1 
20.82±11.1 
47.64±6.1 
20.38±8.9 
37.15±2.8 
26.52±3.2 
37.92±7.1 
52.19±16.2 
37.97±1.8 
44.07±4.3 
33.32±7.8 
4.28±13.4 
39.88±9.3 
11.58±3 
3.35±5.4 
 
 
 
Table S 9. Antimicrobial effects of EFs’ metabolites of A. asiatica extracted with 
chloroform/methanol from mycelia. 
Collection 
code 
Dry weight 
(mg) 
Inhibition rates (%) 
B. subtilis S. aureus E. coli P. aeruginosa C. albicans C. krusei 
SZMC 27067 
SZMC 27068 
SZMC 27069 
SZMC 27070 
SZMC 27071 
302.22±10.6 
235.02±2.7 
302.53±5.7 
262.52±5 
225.63±13.3 
75.94±8.5 
74.63±1.2 
69±7.7 
90.87±11.4 
68.51±13.2 
34.95±13.3 
53.61±12.9 
33.88±7.4 
83.66±12.6 
33.38±14.9 
3.22±11.7 
28.74±12.3 
7.32±15.2 
8.24±11.5 
24.14±4.8 
70.79±1.8 
43.7±13 
91.41±2.3 
94.22±14.2 
13.21±2.7 
3.22±16.4 
28.74±7.5 
7.32±1.1 
8.24±14.6 
24.14±2.9 
70.79±9.7 
43.7±5.7 
91.41±3.5 
94.22±4.8 
13.21±3.8 
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Collection 
code 
Dry weight 
(mg) 
Inhibition rates (%) 
B. subtilis S. aureus E. coli P. aeruginosa C. albicans C. krusei 
SZMC 27072 
SZMC 27073 
SZMC 27074 
SZMC 27075 
SZMC 27076 
SZMC 27077 
SZMC 27078 
SZMC 27079 
SZMC 27080 
SZMC 27081 
SZMC 27082 
SZMC 27083 
SZMC 27084 
SZMC 27085 
SZMC 27086 
SZMC 27087 
SZMC 27088 
SZMC 27089 
SZMC 27090 
SZMC 27091 
SZMC 27092 
SZMC 27093 
103.24±5.5 
343.12±10.3 
24.32±3.3 
224.23±11 
246.34±8.3 
142.33±9.3 
333.17±5.9 
423.23±9.2 
342.12±16.3 
262.12±6.2 
321.31±10.9 
665.22±6.7 
250.22±14.9 
45.26±3 
134.23±9.9 
324.32±14.5 
364.02±15.8 
202.15±1.8 
322.32±13.5 
222.22±1.7 
201.14±12.8 
103.05±12.2 
6.04±3.7 
64.04±7.5 
18.46±10.5 
60±4.4 
39.32±8.2 
63.79±11.6 
76.21±4.3 
86.69±12 
53.27±7.2 
52.19±12.8 
65.31±13.5 
64±3.1 
47.35±8.5 
74.22±9.2 
92.42±12 
72.72±3.6 
12.65±12.9 
97.01±10.8
0 
56.03±10.6 
15.62±3.2 
92.92±7.6 
13.61±8.4 
27.92±14.1 
58.43±12.2 
32.22±4.4 
8.63±2.4 
55.54±12.6 
35.6±15.1 
56.67±1.9 
25.69±14.7 
88.41±3 
13.4±4.1 
6.88±9.4 
6.1±12.3 
35.68±4.4 
56.36±11 
51.6±11.6 
88.49±3 
92.26±8.4 
94.05±7 
49.72±1.5 
4.65±6.4 
85.26±12.1 
76.53±2.2 
5.05±8.6 
4.62±5.9 
46.74±2.5 
74.88±3.3 
37.85±13.3 
27.74±14.3 
68.18±15.5 
46.97±9.7 
99.3±6.1 
55.63±15.5 
30.99±7.5 
66.24±6.5 
31.97±12.4 
34.3±2.5 
42.59±1.3 
70.68±2 
33.74±8.9 
56.48±12.6 
16.95±14 
21.72±4.8 
70.13±13.3 
36.54±1.6 
13.43±7 
54.32±4.1 
37.41±9.6 
14.67±5.6 
24.4±15.3 
54.61±6.9 
33.95±2.1 
44.33±14.8 
17.44±15.4 
30.94±3.6 
52.13±11.5 
60.53±6.9 
6.42±9.9 
47.43±8.2 
30.06±2 
19.49±14.2 
11.22±2.6 
66.46±9.5 
57±13.7 
24.17±1.9 
13.39±14.9 
92.4±14.8 
5.05±4.5 
4.62±16 
46.74±2.6 
74.88±7.2 
37.85±6.7 
27.74±14.8 
68.18±11.8 
46.97±9.8 
99.3±10.5 
55.63±12.5 
30.99±3 
66.24±7.3 
31.97±14 
34.3±15.8 
42.59±11 
70.68±11.9 
33.74±15.1 
56.48±7 
16.95±7.6 
21.72±12.7 
70.13±2.6 
36.54±2.6 
13.43±4.5 
54.32±8 
37.41±1.1 
14.67±10.6 
24.4±15.9 
54.61±4.3 
33.95±8.7 
44.33±1.4 
17.44±1.3 
30.94±6 
52.13±13.8 
60.53±10.2 
56.42±7.5 
47.43±9.9 
30.06±8.5 
19.49±4.6 
11.22±2.9 
66.46±3.6 
57±3.8 
24.17±15.5 
13.39±9.1 
92.4±16 
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Collection 
code 
Dry weight 
(mg) 
Inhibition rates (%) 
B. subtilis S. aureus E. coli P. aeruginosa C. albicans C. krusei 
SZMC 27094 
SZMC 27095 
SZMC 27096 
SZMC 27097 
SZMC 27098 
SZMC 27099 
SZMC 27100 
SZMC 27101 
SZMC 27102 
SZMC 27103 
SZMC 27104 
SZMC 27105 
SZMC 27106 
SZMC 27107 
SZMC 27108 
SZMC 27109 
SZMC 27110 
SZMC 27111 
SZMC 27112 
SZMC 27113 
SZMC 27114 
SZMC 27115 
435.22±7.4 
225.25±14.5 
560.66±9.9 
245.33±8.4 
322.2±12.4 
234.02±11.9 
222.22±10.9 
622.32±8.5 
63.62±3.3 
233.31±13.6 
156.24±10 
110.62±15.8 
222.22±2.7 
622.21±3 
336.54±11.4 
20.13±12.9 
252.44±12.7 
226.23±9.5 
203.2±10.4 
225.22±1.8 
363.23±3 
452.35±5.8 
93.46±4 
58.73±14.3 
90.86±16 
62.18±15.6 
82.3±10.5 
96.71±8.4 
18.03±3.3 
23.73±8.1 
78.39±15.6 
47.68±14.8 
79.84±8.6 
48.94±4.7 
0.18±14.3 
60.57±12.3 
2.27±1.1 
29.04±13.9 
14.55±7.3 
31.27±13.6 
36.32±1.9 
33.75±11 
17.67±7.3 
36.19±13.4 
3.89±4.2 
30.93±2.8 
1.64±9.9 
45.35±6.1 
3.86±10.8 
74.42±4.5 
71.88±5.7 
16.6±12 
60.25±16.3 
53.9±4.3 
36.85±8.5 
9.39±9.3 
10.99±9.1 
77.85±10.3 
51.43±10.4 
1.15±5.9 
50.36±3.2 
9.94±1.3 
49.86±7.6 
62.22±2.2 
0.57±2.3 
6.2±9.2 
55.3±16.4 
69.93±13.1 
24.8±2.3 
21.1±7.8 
5.08±10.8 
44.22±8.9 
89.16±12.1 
35.29±13.1 
74.7±6.7 
3.97±10.3 
47.36±10.6 
48.43±15.5 
73.6±11.4 
0.19±14.7 
15.98±6.8 
50.28±7.6 
44.25±14.3 
37.23±5.5 
22.89±4.4 
54.95±14 
60.6±12.4 
29.13±3.3 
44.06±8.6 
10.34±10.9 
93.51±8.3 
5.39±14.2 
3.61±1.7 
14.42±13.8 
60.41±5.7 
94.17±6.8 
55.29±7.1 
96.12±11.8 
4.36±14.4 
41.79±7.4 
94.16±11.3 
71.33±12.8 
44.12±9.7 
20.22±8.3 
47.64±7.9 
2.22±1.2 
27.39±1.8 
64.7±2.9 
94.43±9 
19.05±3.3 
55.3±14.9 
69.93±12.1 
24.8±11.3 
21.1±7.1 
5.08±13.1 
44.22±13.6 
89.16±6.9 
35.29±8.2 
64.7±11.3 
3.97±9.6 
47.36±2.4 
48.43±15.3 
73.6±8.4 
0.19±11.8 
15.98±14 
50.28±11.4 
44.25±7.1 
37.23±7.5 
22.89±10.5 
54.95±14.3 
60.6±9.6 
29.13±11.5 
44.06±15.5 
10.34±8.3 
93.51±1.9 
5.39±5.6 
3.61±15.7 
14.42±13 
0.41±15.9 
94.17±7.8 
55.29±12.5 
96.12±15 
4.36±7.9 
41.79±13.1 
94.16±13.3 
71.33±3.8 
44.12±8.8 
20.22±7.7 
47.64±1.4 
52.22±8.4 
27.39±2.7 
64.7±7.9 
94.43±12.5 
19.05±6.5 
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Collection 
code 
Dry weight 
(mg) 
Inhibition rates (%) 
B. subtilis S. aureus E. coli P. aeruginosa C. albicans C. krusei 
SZMC 27116 
SZMC 27117 
SZMC 27118 
SZMC 27119 
SZMC 27120 
SZMC 27121 
SZMC 27122 
SZMC 27123 
SZMC 27124 
SZMC 27125 
SZMC 27126 
SZMC 27127 
SZMC 27128 
SZMC 27129 
SZMC 27130 
SZMC 27131 
SZMC 27132 
SZMC 27133 
SZMC 27134 
SZMC 27135 
SZMC 27136 
SZMC 27137 
325.24±5.5 
234.15±8 
246.34±6.1 
165.33±6.2 
420.26±11.7 
335.64±10.1 
142.04±13.2 
362.33±7.6 
222.22±15.6 
221.52±11.8 
362.25±6.8 
252.1±2.8 
135.22±1.3 
622.34±15.6 
452.02±5.3 
223±11.9 
240.54±3.5 
326.16±8.8 
56.2±11.8 
306.14±5.1 
322.34±7.8 
242.42±16.4 
73.25±10.2 
36.2±12.1 
20.91±13.1 
52.61±12.5 
87.8±4.5 
55.89±5.5 
52.57±15.8 
20.38±8.2 
62.97±12.8 
20.99±12.9 
59.62±14.8 
52.2±11.6 
35.31±5.2 
3.1±5.8 
50.58±5.8 
27.78±15.4 
66.43±8.9 
82.58±10.5 
97.42±14.7 
71.29±14.8 
25.88±13.7 
97±1.2 
93.33±11.4 
97.08±3.6 
96.85±10.5 
30.92±5.2 
22.57±1.8 
77.07±11.1 
73.08±12.5 
97.29±14.5 
98.63±12.7 
97.05±7 
15.23±8.2 
54.27±2.5 
40.59±10.7 
45.07±5.5 
35.11±3.9 
92.49±13.5 
55.49±14.6 
21.72±9.8 
3.13±8.1 
16.01±6.4 
31.3±5.4 
63.22±8.9 
38.12±5.9 
12.41±16.4 
8.41±9.2 
30.89±8.3 
82.08±10.6 
38.41±5.9 
14.77±4.5 
32.27±3.6 
32.47±3.2 
39.21±6.8 
86.4±3.6 
42.6±4.7 
42.08±3.1 
28.46±7.5 
57.9±12.1 
37.41±8.1 
19.76±10.4 
20.32±5.9 
36.44±3.7 
33.24±8.1 
11.17±12.1 
23.62±1.2 
55.01±6.8 
13.43±7.3 
4.97±12.1 
41.9±9.7 
62.47±14 
74.95±13.7 
6.44±8.7 
97.71±7.7 
34.57±7.6 
17.67±12.7 
94.11±11.3 
70.79±12.7 
22.95±6.8 
44.23±6.6 
33.52±5.1 
3±2.8 
47.74±8.4 
4.57±10.4 
35.46±9.8 
40.64±12.3 
12.34±7.3 
95.65±15.6 
38.12±4.9 
12.41±4.9 
8.41±16 
30.89±9.5 
82.08±1.3 
38.41±2 
14.77±16.3 
32.27±7.1 
32.47±3.4 
39.21±8.5 
56.4±8.6 
42.6±11.1 
42.08±11.6 
28.46±12.8 
57.9±4.9 
37.41±4.5 
19.76±6.2 
20.32±7.8 
36.44±13.2 
33.24±5.7 
11.17±11.4 
23.62±6.7 
55.01±11 
13.43±13 
4.97±6.1 
41.9±12.8 
12.47±10 
4.95±14.4 
6.44±7.2 
97.71±4.8 
34.57±3 
17.67±13.6 
4.11±1.5 
70.79±5.9 
22.95±3.1 
44.23±14.2 
33.52±16.1 
3±14.1 
47.74±16.3 
4.57±10 
35.46±14.2 
40.64±8.1 
12.34±9.5 
55.65±5.5 
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Collection 
code 
Dry weight 
(mg) 
Inhibition rates (%) 
B. subtilis S. aureus E. coli P. aeruginosa C. albicans C. krusei 
SZMC 27138 
SZMC 27139 
SZMC 27140 
SZMC 27141 
SZMC 27142 
SZMC 27143 
SZMC 27144 
SZMC 27145 
SZMC 27146 
SZMC 27147 
SZMC 27148 
623.32±3.5 
212.06±7.3 
220.12±1.5 
242.34±1.4 
20.35±13.2 
44.23±2.1 
646.11±4.7 
254.15±13.2 
124.25±1.7 
623.23±10.2 
12.33±13.2 
73.64±2.4 
32±5.2 
73.63±1.8 
63.29±11.4 
15.83±13.8 
63.86±5.6 
93.72±12.7 
65.98±2.1 
98.66±9.1 
90.06±1.6 
57.78±12.5 
18.8±6.1 
4.69±1.2 
6.78±1.6 
46.51±14.5 
97.14±2.7 
42.33±2.8 
28.42±2 
2.92±15 
17.74±8.8 
74.93±13.8 
28.63±10.6 
91.97±13.8 
13.38±8.1 
44.62±3.4 
4.22±12.1 
42.9±1.1 
8.08±1.2 
40.48±13.1 
29.6±8.3 
34.45±3.5 
49.14±4.7 
40.98±7.5 
40.21±13.7 
93.04±2.6 
0.29±12.4 
5.73±10.4 
71.46±6 
42.02±2.3 
64.52±9.9 
44.92±12 
4.04±9.3 
27.46±15.8 
34.45±1.1 
91.97±16.4 
13.38±12.1 
44.62±4.2 
4.22±4.6 
42.9±6.6 
8.08±4.5 
40.48±13.6 
29.6±7.6 
34.45±11.9 
49.14±2.1 
40.98±1.7 
40.21±5 
23.04±8.5 
0.29±15.1 
5.73±4.4 
21.46±1.7 
42.02±8.8 
24.52±7 
44.92±2.2 
4.04±3.4 
27.46±6.3 
34.45±5.5 
 
Table S 10. Antimicrobial effects of EFs’ metabolites of mosses extracted with chloroform from 
ferment broth. 
Collection 
code 
Inhibition rates (%) 
B. subtilis S. aureus E. coli 
P. 
aeruginosa 
C. albicans C. krusei 
SZMC 27223 
SZMC 27224 
SZMC 27225 
SZMC 27226 
44.92±12.8 
57.65±11 
69.73±1.4 
19.43±8.3 
56.02±15.8 
83.68±10.2 
82.49±2.4 
17.91±4.3 
0.24±10.2 
95.13±9.2 
72.58±10.9 
82.31±16.4 
62.83±7.9 
92.69±5.2 
33.66±4.5 
40.25±9.4 
0.78±3.4 
45.54±8 
43.34±4.3 
50.42±12.1 
20.12±10 
53.02±4 
12.27±1.6 
52.51±15.7 
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Collection 
code 
Inhibition rates (%) 
B. subtilis S. aureus E. coli 
P. 
aeruginosa 
C. albicans C. krusei 
SZMC 27227 
SZMC 27228 
SZMC 27229 
SZMC 27230 
SZMC 27231 
SZMC 27232 
SZMC 27233 
SZMC 27234 
SZMC 27235 
SZMC 27236 
SZMC 27237 
SZMC 27238 
SZMC 27239 
SZMC 27240 
SZMC 27241 
SZMC 27242 
SZMC 27243 
SZMC 27244 
SZMC 27245 
34.11±9.1 
92.29±6.6 
75.34±13 
35.77±15.9 
72.32±7.9 
55.35±3.4 
90.08±13.5 
24.34±11.5 
68.6±6.9 
4.7±15.8 
97.65±6.8 
60.07±13.8 
35.23±11.7 
44.4±10.1 
3.2±1.3 
89.02±8.5 
68.9±2.2 
60.89±12.6 
64.85±9.5 
83.81±7.2 
93.37±9.4 
32.22±3.4 
62.86±8.8 
45.29±9.7 
60.5±9.1 
85.46±14.3 
52.97±9 
35.68±10.3 
18.02±2.9 
13.34±6.2 
4±1.2 
8.22±4.6 
53.88±6.9 
9.05±11.2 
89.71±14.4 
33.61±5.4 
68.33±8 
93.97±12.9 
97.47±8.2 
45.67±7.4 
57.25±5.4 
48.37±6 
95.57±15.4 
56.82±1.4 
41.77±4.8 
7.49±11.6 
47.79±2.6 
44.57±2.6 
43.35±5.5 
2.62±5.9 
11.46±15.4 
48.29±11.7 
7.08±14 
2.81±10.3 
51.82±4.6 
27.79±11.4 
93.09±13.9 
65.13±3.4 
38.61±8.1 
62.45±15.5 
27.06±7.6 
10.21±7.4 
31.57±12.3 
23.95±13.5 
77.61±16 
14.94±10.4 
75.01±16 
48.53±9.1 
20.51±3.3 
54.84±4 
23.88±16.4 
25.09±1.6 
32.09±13.2 
7.61±6.9 
20.02±8.8 
64.92±7.7 
34.12±14.5 
43.27±11.2 
23.44±13.3 
41.08±3.4 
40.45±4.2 
56.53±13.5 
47.51±13 
11.24±16.2 
70.04±9.4 
62.73±13.2 
85.67±4.8 
54.24±5.7 
20.77±12.4 
13.15±8.4 
14.31±7.6 
40.18±5.2 
52.14±7.2 
38.42±15.6 
24.47±6.9 
3.25±1.4 
42.43±11.6 
32.12±7.4 
24.34±10.3 
4.12±9.2 
35.02±1.1 
1.15±6 
23.44±13.7 
47±11.1 
44.42±6.1 
52.81±3.8 
10.83±9.9 
2.77±14.7 
35.4±3.7 
70.22±1.2 
4.71±6.5 
35.41±5.9 
44.28±12.2 
30.44±14.1 
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Collection 
code 
Inhibition rates (%) 
B. subtilis S. aureus E. coli 
P. 
aeruginosa 
C. albicans C. krusei 
SZMC 27246 
SZMC 27247 
SZMC 27248 
SZMC 27249 
SZMC 27250 
SZMC 27251 
SZMC 27252 
SZMC 27253 
SZMC 27254 
SZMC 27255 
SZMC 27256 
SZMC 27257 
SZMC 27258 
SZMC 27259 
SZMC 27260 
SZMC 27261 
SZMC 27262 
5.25±10.7 
29.1±13.7 
93.37±6.9 
88.28±15.5 
9.36±7.8 
87.64±8.1 
20.07±14.4 
79.88±9.6 
9.28±13.1 
34.07±4.8 
33.4±14 
61.89±11.5 
11.13±12.4 
74.13±5.7 
73.91±7.3 
33.62±16.4 
31.39±11 
56.58±1.9 
0.28±4 
82.36±1.1 
79.35±8.7 
66.51±13.8 
22.71±14.2 
23.48±6.2 
37.03±8.5 
29.49±15.2 
29.79±13 
95.74±15.9 
33.13±9.1 
68.41±6.1 
45.22±13.1 
68.22±8.6 
27.28±13.3 
27.29±10.5 
80.13±3.3 
3.86±8.8 
13.58±2.9 
12.27±5.6 
52.37±9 
39.44±9.2 
1.21±9 
69.6±3.3 
37.47±6 
14.24±9 
38.73±1.7 
63.3±13.5 
24.29±12.9 
44.31±2.4 
75.63±5.6 
42.55±7.3 
74.74±2.1 
5.91±11.6 
25.52±11.1 
4.09±1.7 
93.15±4.7 
88.76±15.8 
26.05±11.4 
25.65±10.5 
61.59±6.9 
24.06±5 
34.92±16 
   32.08±3.4 
 30.96±8.5 
 44.14±12.7 
  14.14±14 
32.52±2.4 
22.3±2 
69.2±9.8 
45.84±12.2 
11.33±11 
42.02±5.8 
37.47±11.8 
53.66±3.4 
41.25±14.2 
53.18±7.5 
57.83±2.2 
32.45±13.4 
60.12±14 
42.04±8.7 
44.45±11.1 
41.82±12.4 
17.82±6.7 
70.12±11.6 
28.47±3.4 
16.82±12.2 
78.4±1.3 
12.22±6.3 
18.44±12.2 
20.07±13.8 
23.23±1.8 
32.35±14.6 
44.24±13 
34.48±7.4 
54.32±12.7 
33.23±9.7 
54.74±13.4 
42.83±8.4 
11.43±6.9 
48.4±12.8 
24.3±13.2 
34.43±10.6 
38.42±11.5 
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Table S 11. Antimicrobial effects of EFs’ metabolites of mosses extracted with ethyl acetate from 
ferment broth. 
Collection 
code 
Inhibition rates (%) 
B. subtilis S. aureus E. coli 
P. 
aeruginosa 
C. albicans C. krusei 
SZMC 27223 
SZMC 27224 
SZMC 27225 
SZMC 27226 
SZMC 27227 
SZMC 27228 
SZMC 27229 
SZMC 27230 
SZMC 27231 
SZMC 27232 
SZMC 27233 
SZMC 27234 
SZMC 27235 
SZMC 27236 
SZMC 27237 
SZMC 27238 
SZMC 27239 
97.89±1.3 
85.29±7.2 
51.75±12.1 
27.94±13.4 
63.27±2.6 
98.33±6.4 
27.35±10.5 
58.15±8.6 
22.67±9.5 
74.08±11.6 
33.85±10.7 
89.54±8.8 
62.54±8.4 
20.64±13.5 
32.41±4.6 
3.43±14.9 
34.58±10.4 
68.65±4.3 
26.99±16.2 
85.04±15.4 
94.12±4.4 
50.18±3.2 
23.02±1.2 
76.77±2 
90.24±5.1 
37.44±11.2 
4.15±4 
44.43±14.9 
19.24±12.5 
13.25±3 
30.86±11.3 
71.26±10.2 
9.11±11.8 
13.89±10.8 
8.7±7.1 
55.39±11.7 
96.51±1.6 
40.93±15.2 
13.79±8.5 
8.23±8.2 
16.1±4 
40.47±16.1 
50.11±13.9 
51.99±4.5 
29.26±6.3 
47.99±6.9 
97.46±3 
51.37±5.4 
29.96±7 
68.15±1.6 
64.02±6.3 
4.96±6.7 
21.96±12.5 
39.67±4.7 
87.55±8.7 
77.45±5.4 
93.13±7.8 
37.26±11.6 
18.46±13.9 
36.33±3 
1.7±2.9 
56.12±12.4 
58.59±7.3 
83.85±7.5 
96.93±10.4 
42.6±9.2 
84.71±4 
48.81±12.1 
40.13±6.4 
43.77±4.5 
87.4±1.8 
44.88±7.5 
27.87±6.9 
43.84±5.5 
74.83±15.5 
18.14±6.1 
30.3±5.5 
30.44±8.9 
24.34±6.2 
12.01±7.7 
53.74±9.3 
44.87±5.7 
48.54±6 
2.37±13.7 
34.57±6.2 
44.8±16.2 
24.7±6.9 
20.12±1.3 
0.2±9.4 
27.44±12.4 
35.27±8.7 
24.18±16 
28.23±12.5 
15.04±15.6 
91.74±15.8 
11.74±3.1 
1.17±3.1 
53.44±14.5 
40.54±1.9 
42.24±11.7 
40.41±2 
56.87±11.6 
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Collection 
code 
Inhibition rates (%) 
B. subtilis S. aureus E. coli 
P. 
aeruginosa 
C. albicans C. krusei 
SZMC 27240 
SZMC 27241 
SZMC 27242 
SZMC 27243 
SZMC 27244 
SZMC 27245 
SZMC 27246 
SZMC 27247 
SZMC 27248 
SZMC 27249 
SZMC 27250 
SZMC 27251 
SZMC 27252 
SZMC 27253 
SZMC 27254 
SZMC 27255 
SZMC 27256 
SZMC 27257 
SZMC 27258 
90.85±1.3 
92.39±14.4 
62.29±2.6 
13.26±14.8 
53.93±10.2 
52.17±10.7 
90.68±14.3 
53.53±5.5 
20.38±15.3 
61.09±10.9 
73.3±16.3 
96.05±11 
28.62±3.5 
19.82±16.1 
34.9±16.2 
32.01±6.5 
24.44±6.2 
94.09±5.7 
1.04±16 
36.62±6.9 
58.36±4.9 
66.84±8 
80.02±15.2 
94.58±12.5 
79.22±4.1 
59.05±6.1 
53.01±15.6 
38.79±8.7 
17.08±11.7 
84.71±14.9 
81.15±8.1 
5.17±10.3 
23.6±12.2 
90.81±10.9 
57.74±13.4 
81±14 
87.28±16.4 
13.63±14.5 
8.92±14.9 
29.08±11 
5.66±9 
64.02±12.6 
36.34±11.8 
67.69±5.7 
65.92±6.1 
66.13±3.5 
23.84±7.6 
13.25±8.2 
31.93±14.3 
77.39±1.2 
98.85±15 
36.71±10.8 
58.56±8.8 
66.71±11.2 
87.38±14.7 
97.12±2 
91.67±16.4 
51.6±10.6 
40.05±6 
83.32±6.9 
18.94±10.5 
50.07±5.6 
76.65±15.1 
21.01±7.9 
88.22±13.7 
28.93±5.6 
35.55±3.4 
30.39±15.6 
9.47±16 
50.72±3 
65.09±9.2 
39.83±3.5 
49.18±10.1 
74.57±8.1 
81.6±9.5 
56.7±12.8 
35.04±8.7 
61.83±10.4 
66.26±14.1 
41.34±9.5 
78.37±4.6 
36.51±14.6 
48.63±2.9 
60.05±6 
34.1±6.1 
31.63±9.9 
34.38±14 
41.5±2.4 
21.71±6.8 
12.22±6.3 
17.43±8.1 
91.24±15.7 
30.76±15 
37.26±13.5 
43.22±7.7 
46.45±12.6 
92.25±3.4 
75.11±16.4 
74.73±4.9 
44.3±1.7 
43.24±13.9 
30.48±5.9 
22.26±2 
44.82±14.1 
95.83±15.5 
24.71±13.3 
47.3±4.7 
44.03±1.3 
46.62±9.9 
43.22±14.3 
27.46±9 
36.06±14.5 
4.46±2.5 
90.46±10.9 
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Collection 
code 
Inhibition rates (%) 
B. subtilis S. aureus E. coli 
P. 
aeruginosa 
C. albicans C. krusei 
SZMC 27259 
SZMC 27260 
SZMC 27261 
SZMC 27262 
35.27±1.4 
23.17±9.3 
15.89±2.4 
35.38±1.8 
45.9±1.2 
7.64±4.6 
53.8±12.9 
79.27±1.4 
96.51±5.1 
18.63±13.8 
44.42±15.6 
15.83±4.4 
14.8±6.8 
82.8±13.8 
80.36±8.2 
17.39±11.5 
50.88±2.5 
27.83±8 
54.27±12.5 
93.84±15.2 
41.66±3.2 
23.16±2.5 
41.65±8.7 
25.26±7.5 
 
 
Table S 12. Antimicrobial effects of EFs’ metabolites of mosses extracted with hexane from 
ferment broth. 
Collection 
code 
Inhibition rates (%) 
B. subtilis S. aureus E. coli 
P. 
aeruginosa 
C. albicans C. krusei 
SZMC 27223 
SZMC 27224 
SZMC 27225 
SZMC 27226 
SZMC 27227 
SZMC 27228 
SZMC 27229 
SZMC 27230 
52.32±8.8 
48.22±8.9 
39.59±7.1 
48.41±8.5 
12.13±13.2 
71.8±10.4 
76.2±16 
49.38±12.6 
38.95±10.7 
31±13.2 
94.56±5.4 
50.08±9.1 
77.36±15.7 
27.69±4.3 
69.52±2.5 
98.09±5.8 
4.23±5.2 
8.25±16.1 
10.39±7.3 
81.6±2.3 
75.6±6.9 
9.8±12.6 
55.64±14.9 
50.25±1.2 
92.09±3.9 
35.47±4.4 
76.59±10.3 
13.12±11.6 
22.82±4.1 
72±11.3 
0.37±13.2 
85.7±2.9 
15.13±6 
45.45±13.1 
24±6.6 
0.62±11.2 
45.54±15.8 
30.58±5 
40.1±13 
24.41±5.9 
4.34±6.8 
41.74±10.9 
40.37±4.3 
22.14±9.9 
36.17±3.8 
14.56±13.3 
64.1±9 
15.04±6.4 
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Collection 
code 
Inhibition rates (%) 
B. subtilis S. aureus E. coli 
P. 
aeruginosa 
C. albicans C. krusei 
SZMC 27231 
SZMC 27232 
SZMC 27233 
SZMC 27234 
SZMC 27235 
SZMC 27236 
SZMC 27237 
SZMC 27238 
SZMC 27239 
SZMC 27240 
SZMC 27241 
SZMC 27242 
SZMC 27243 
SZMC 27244 
SZMC 27245 
SZMC 27246 
SZMC 27247 
SZMC 27248 
SZMC 27249 
24.18±14.1 
60.16±3.7 
30.33±2.2 
3.3±4.7 
37.72±4 
8.31±3.4 
94.04±7.7 
18.42±8 
73.49±9 
85±11.2 
68.88±11.6 
49.28±11.8 
32.38±12.3 
66±2 
43.39±7.5 
78.05±12.5 
35.5±15.7 
17.43±2.8 
16.15±4 
54.03±10.1 
89.03±13.7 
66.17±12.5 
63.76±12.9 
27.05±13.4 
25.55±12.4 
48.9±3.8 
15.31±15.6 
59.08±4.3 
14.84±1.1 
3.25±6.9 
59.4±5.3 
10±8.9 
22.16±16.2 
62.79±6.4 
37.61±12.4 
94.68±7 
65±5.8 
84.29±6.6 
69.76±15.6 
21.87±5.7 
2.33±2.3 
26.12±3.7 
80.3±12.6 
91.22±1.9 
51.19±12.9 
35.83±4.1 
89.65±13.8 
32.56±13 
6.64±6.8 
62.77±9.7 
23.68±8.4 
71.82±6.9 
15.19±4.6 
24.17±2 
88.89±3.4 
64.82±9.2 
55.4±16.4 
57.33±14.8 
21.95±9.6 
60.4±8.1 
41.49±12.2 
33.65±10.1 
14.14±11.4 
89.43±1.4 
73.79±5.2 
21.24±16.2 
11.32±2.8 
57.63±1.8 
77.22±6.1 
98.99±5.6 
15.15±6.5 
18.13±2.5 
21.23±10.8 
93.46±16 
44.89±7.8 
68.11±5.2 
57.05±6.7 
43.44±16.3 
22.77±10.2 
53.02±6.5 
0.07±4.2 
21.83±11.7 
43.42±13.3 
44.83±7.5 
47.54±8.4 
2.83±9.7 
43.68±13.2 
36.74±7.7 
13.03±12.5 
36.37±16.2 
24.27±11 
14.43±5.9 
55.24±14.8 
47.04±9.8 
32.64±14.5 
84.75±16.4 
48.7±4.6 
42.74±1.3 
45.44±4.5 
50.75±10.1 
2.34±9.1 
3.33±7.9 
12.66±8.5 
26.5±11.5 
54.8±8.7 
44.54±12.7 
57.76±2.6 
23.24±9.4 
12.61±15.4 
8.26±4.5 
36.44±4.7 
4.73±14 
24.4±14.1 
1.11±8.3 
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Collection 
code 
Inhibition rates (%) 
B. subtilis S. aureus E. coli 
P. 
aeruginosa 
C. albicans C. krusei 
SZMC 27250 
SZMC 27251 
SZMC 27252 
SZMC 27253 
SZMC 27254 
SZMC 27255 
SZMC 27256 
SZMC 27257 
SZMC 27258 
SZMC 27259 
SZMC 27260 
SZMC 27261 
SZMC 27262 
12.78±8.9 
82.23±6.4 
45.68±16.1 
28.31±1.8 
69.94±2.1 
33.63±3 
30.07±13.3 
78.13±9.2 
53.71±1.4 
36.6±11.4 
24.3±6 
44±7 
43.17±7.4 
34.18±4.9 
87.65±12.2 
51.1±8 
72.3±7.3 
13.6±8.2 
96.74±15 
6.88±12.9 
81.56±7.4 
61.13±6.2 
5.58±13.3 
45.99±12.8 
68.48±10.4 
90.36±12.4 
73.92±14.8 
91.55±5.8 
80.55±11.6 
57.62±5.3 
24.55±5.5 
72.61±2.5 
37.32±8.3 
50.61±8.3 
75.34±5 
88.55±10.5 
5.68±16.1 
80.06±13.5 
69.4±2.6 
34.26±4.9 
23.84±10.9 
38.95±12.5 
32.64±4.8 
84.35±5.3 
98.84±5.7 
91.45±3.4 
1.96±14.1 
77.8±2.8 
45.32±16.3 
41.21±10.9 
85.92±6.5 
95.21±9.2 
27.28±8.2 
10.8±10.5 
8.43±1.8 
23.6±1.5 
36.25±9.8 
28.68±1.3 
53.54±15.9 
37.14±13.4 
58.41±5.8 
44.73±8.4 
27.72±7.3 
27.41±14 
43.61±10.5 
5.52±4.4 
31.41±4.4 
16.52±12.1 
31±4.5 
42.34±4.7 
3.51±8.5 
25.15±16 
17.88±15.1 
35.46±1.7 
53.44±10.3 
32.72±1.2 
27.1±10.9 
10.18±13.1 
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Table S 13. Antimicrobial effects of EFs’ metabolites of mosses extracted with 
chloroform/methanol from mycelia. 
Collection 
code 
DW (mg) 
Inhibition rates (%) 
B. subtilis S. aureus E. coli 
P. 
aeruginosa 
C. albicans C. krusei 
SZMC 27223 
SZMC 27224 
SZMC 27225 
SZMC 27226 
SZMC 27227 
SZMC 27228 
SZMC 27229 
SZMC 27230 
SZMC 27231 
SZMC 27232 
SZMC 27233 
SZMC 27234 
SZMC 27235 
SZMC 27236 
SZMC 27237 
SZMC 27238 
SZMC 27239 
SZMC 27240 
SZMC 27241 
SZMC 27242 
221.23±14 
242.05±14.5 
323.22±12.7 
198.35±4 
202.6±3 
265.43±16.4 
124.04±7.3 
230.01±11.3 
261.26±12.1 
232.1±7.2 
244.31±11 
212.3±2.3 
324.64±5.9 
330.61±6.5 
211.32±3.9 
255.65±12 
226.01±7.7 
220.6±16.1 
232.23±11.8 
233.44±2.7 
40.71±5 
35.38±7.2 
19.27±10 
83±11.6 
24.23±7.9 
89.78±5.8 
62.97±5.9 
17.95±7.3 
2.98±11.6 
47.83±1.1 
59.8±10.2 
4±16 
31.15±5.9 
19.99±7.4 
89.24±13 
45.86±3.8 
44.02±8.6 
2.65±12.2 
16.97±1.5 
40.25±14.8 
27.55±11.5 
19.75±7.2 
33.68±4.3 
36.02±2.5 
50.36±9.3 
18.72±12.9 
10.21±12.8 
42.16±7.1 
41±6.3 
87.96±14 
95.86±9 
80.65±16.3 
4.86±6.6 
53.62±16.3 
72.69±15.5 
29.76±15.4 
66.97±2.4 
18.1±14.6 
95.94±11.6 
29.75±1.3 
83.13±10.1 
42.37±14.9 
18.82±15.2 
35.13±7.1 
66.95±13 
93.72±2.3 
83.83±10.9 
95.26±16 
85.89±12.3 
43.69±9 
98.63±2.1 
56.11±2.6 
12.37±11.1 
21.36±9 
0.06±4 
40.88±15.7 
90.63±6.7 
59.76±6.2 
39.03±5.6 
38.42±10 
39.1±14 
19.22±16.4 
77.36±4.3 
13.65±12.6 
13.8±4.2 
1.18±14.5 
91.55±13.8 
90.48±8.3 
82.74±8.2 
12.73±6.1 
92.02±3 
38.49±7.8 
77.22±5.4 
95.66±6.4 
59.87±1.9 
11.55±11.8 
36.24±8.4 
21.33±2.6 
90.35±16.4 
26.61±11.3 
0.15±10.6 
23.43±3.7 
12.33±9.1 
24.35±4.3 
14.84±13.1 
75.04±8 
47.85±5.2 
40.15±5.3 
44.87±14 
36.6±14.8 
43.42±7.3 
75.73±6.8 
11.42±2.2 
32.55±9 
45.71±15.4 
60.15±12.5 
27.44±2 
18.04±16.1 
57.22±2.4 
56.57±5 
21.88±4.8 
58.04±7.4 
32.47±11 
43.18±7.5 
28.21±9.9 
33.75±10.6 
32.85±7.6 
41.72±8.7 
12.42±9.1 
25.03±6 
51.45±13.3 
13.28±12.2 
43.4±12.9 
0.74±3.9 
50.43±4.5 
27.57±15.2 
38.47±9 
85.21±6.5 
41.33±11.4 
0.73±12.5 
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Collection 
code 
DW (mg) 
Inhibition rates (%) 
B. subtilis S. aureus E. coli 
P. 
aeruginosa 
C. albicans C. krusei 
SZMC 27243 
SZMC 27244 
SZMC 27245 
SZMC 27246 
SZMC 27247 
SZMC 27248 
SZMC 27249 
SZMC 27250 
SZMC 27251 
SZMC 27252 
SZMC 27253 
SZMC 27254 
SZMC 27255 
SZMC 27256 
SZMC 27257 
SZMC 27258 
SZMC 27259 
SZMC 27260 
SZMC 27261 
SZMC 27262 
201.51±6.4 
309.16±3.9 
365.21±11.6 
262.55±11.9 
981.31±15 
10.72±13.6 
338.82±8.1 
348.21±6.4 
274.39±15.1 
237.14±6.5 
635.12±10.3 
753.15±12.9 
276.99±3.7 
308.91±15.4 
356.77±7.1 
368.17±5.4 
387.72±7.4 
321.78±14.9 
226.99±3.8 
363.52±16.1 
96.36±13.4 
44.51±2.3 
57.05±14.2 
78.53±3.3 
28.04±15 
14.19±3.4 
20.89±12.1 
1.42±2.3 
83.07±2.7 
93.39±14.2 
48.43±5.3 
5.77±6.4 
29.96±7.9 
33.71±8.4 
64.12±1.1 
40.32±2.1 
50.15±15.9 
71.91±11 
50.73±6.3 
64.62±15.8 
87.07±7.7 
14.8±9.1 
9.01±14.7 
45.58±15.3 
90.91±3.1 
53.75±13.3 
68.47±6.4 
60.61±16.4 
83.14±4.3 
43.01±13.6 
88.38±10.7 
29.38±2.2 
92.44±5 
64.3±11.1 
61.02±3.5 
93.17±9 
5.61±5.9 
71.65±9.4 
52.13±13.6 
21.21±4.7 
37.95±6 
62.81±7.3 
81.15±7.8 
59.39±9.3 
1.92±12.5 
3.68±10.2 
39.22±9.8 
57.85±5.5 
17.1±11 
11.77±11.8 
44.74±4.7 
14.89±11.9 
87.4±3.3 
66.38±11.5 
38.27±11.4 
84.81±11.7 
29.76±14.9 
91.78±10.4 
38.67±10 
50.62±4.5 
46.74±2.1 
93.94±12.4 
85.82±7.5 
24.85±5.2 
49.74±6.1 
79.44±15.7 
20.15±4.5 
15.92±3.8 
46.43±5.7 
69.47±2.9 
76.74±14.2 
25.88±1.2 
3.51±2.3 
73.71±10.1 
52.9±7.5 
31.24±3.4 
16.47±11.3 
9.84±2.9 
69.2±7.4 
86.26±7.8 
90.66±9.5 
27.41±13.7 
6.55±10.7 
16.83±2 
52.22±9.2 
33.14±11 
77.34±14.6 
8.01±3.1 
18.58±5 
95.06±7.8 
58.41±2.2 
48.56±8.6 
34.5±1.1 
48.03±6.6 
10.03±8.5 
54.32±13.7 
38.14±16.2 
26.6±12.1 
10.37±15.7 
3.47±3.4 
12.35±9.1 
23.32±3.3 
4.25±4.7 
41.44±15.6 
72.74±3.6 
23.73±2.3 
54.88±5.2 
14.53±14.7 
25.05±3.6 
2.44±9.5 
40.73±13.8 
62.43±14.4 
10.22±7.3 
2.5±16.1 
40.27±14.4 
7.28±7.7 
31.23±4.5 
34.25±8 
50.27±15.7 
1.44±4.5 
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Table S 14. List of the EF extracts showing inhibitory activities against plant pathogenic fungi 
(C:M-chloroform: MeOH (4:1) extract of mycelia). 
 
Collection 
code 
Plant 
F. culmorum R. solani 
Hexane CHCl3 EtOAc 
Mycelia 
(C:M) 
Hexane CHCl3 EtOAc 
Mycelia 
(C:M) 
SZMC 
27132 
A. asiatica - - - - - + - ++ 
SZMC 
27133 
A. asiatica - - - - - - - + 
SZMC 
27134 
A. asiatica - - - - - + - + 
SZMC 
27135 
A. asiatica - - - - - - - + 
SZMC 
27136 
A. asiatica - - + - - - - + 
SZMC 
27137 
A. asiatica - - - + - - - ++ 
SZMC 
27138 
A. asiatica - - - + - - - - 
SZMC 
27141 
A. asiatica - - - - - + - +++ 
SZMC 
27198 
J. 
communis 
- - -  - - - + 
SZMC 
27206 
J. 
communis 
- - - + - - ++ - 
SZMC 
27209 
J. 
communis 
- - - + - - - - 
SZMC 
27210 
J. 
communis 
- - - - - - - + 
SZMC J. - - - - - - - + 
174 
 
Collection 
code 
Plant 
F. culmorum R. solani 
Hexane CHCl3 EtOAc 
Mycelia 
(C:M) 
Hexane CHCl3 EtOAc 
Mycelia 
(C:M) 
27211 communis 
SZMC 
27212 
J. 
communis 
- - - + - - - +++ 
SZMC 
27213 
J. 
communis 
- - - - - - - + 
SZMC 
27214 
J. 
communis 
- - - - - - + - 
SZMC 
27215 
J. 
communis 
- - - - - - + ++ 
SZMC 
27216 
J. 
communis 
- - - - - - - + 
SZMC 
27218 
J. 
communis 
- - - - - - - +++ 
SZMC 
27228 
Mosses - - - - - - - +++ 
SZMC 
27232 
Mosses - - - - - - - ++ 
SZMC 
27233 
Mosses - - - - - + - - 
SZMC 
27236 
Mosses - - - - - + - - 
SZMC 
27242 
Mosses - - - - - - - + 
SZMC 
27244 
Mosses - - - - - + + - 
SZMC 
27245 
Mosses - - - - - - - + 
SZMC 
27247 
Mosses - - - - - - - ++ 
SZMC 
27250 
Mosses - - - - - - - +++ 
SZMC Mosses - - - - - - - +++ 
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Collection 
code 
Plant 
F. culmorum R. solani 
Hexane CHCl3 EtOAc 
Mycelia 
(C:M) 
Hexane CHCl3 EtOAc 
Mycelia 
(C:M) 
27251 
SZMC 
27252 
Mosses - - - - - - - ++ 
SZMC 
27254 
Mosses - - - - - - - + 
SZMC 
27255 
Mosses - - - - - - - + 
SZMC 
27256 
Mosses - - - - - - - + 
SZMC 
27257 
Mosses - - - - - - - + 
SZMC 
27258 
Mosses - - - - - - - + 
SZMC 
27259 
Mosses - - - - - - - + 
SZMC 
27260 
Mosses - - - - - - - + 
SZMC 
27261 
Mosses - - - - - - - +++ 
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Table S 15. List of the ex-type and reference strains as well as the outgroup strain (Woudenberg 
et al 2013) used to phylogenetic analysis of host metabolite producer Alternaria strains. 
1T: ex-type strain; R: representative strain; O: outgroup 
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